<!DOCTYPE html>
<html lang="en" dir="ltr" 
  xmlns="http://www.w3.org/1999/xhtml"
  xmlns:mml="http://www.w3.org/1998/Math/MathML">
  <head prefix="og: http://ogp.me/ns# article: http://ogp.me/ns/article# book: http://ogp.me/ns/book#" >
    <!--[if IE]><![endif]-->
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<link rel="dns-prefetch" href="//journals.asm.org" />
<link rel="dns-prefetch" href="//www.googletagservices.com" />
<link rel="dns-prefetch" href="//scholar.google.com" />
<link rel="dns-prefetch" href="//stats.g.doubleclick.net" />
<link rel="dns-prefetch" href="//www.google-analytics.com" />
<link rel="dns-prefetch" href="//www.google.com" />
<meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=3, minimum-scale=1, user-scalable=yes" />
<link rel="shortcut icon" href="https://aac.asm.org/sites/default/files/images/favicon.ico" type="image/vnd.microsoft.icon" />
<link rel="canonical" href="https://aac.asm.org/content/48/11/4322" />
<meta name="Generator" content="Drupal 7 (http://drupal.org)" />
<link rel="alternate" type="application/pdf" title="Full Text (PDF)" href="/content/48/11/4322.full.pdf" />
<link rel="alternate" type="text/plain" title="Full Text (Plain)" href="/content/48/11/4322.full.txt" />
<link rel="alternate" type="application/vnd.ms-powerpoint" title="Powerpoint" href="/content/48/11/4322.ppt" />
<meta name="issue_cover_image" content="https://aac.asm.org/sites/default/files/highwire/default/covers/AAC_Cover_0.jpg" />
<meta name="type" content="article" />
<meta name="category" content="research-article" />
<meta name="HW.identifier" content="/aac/48/11/4322.atom" />
<meta name="HW.pisa" content="aac;48/11/4322" />
<meta name="DC.Format" content="text/html" />
<meta name="DC.Language" content="en" />
<meta name="DC.Title" content="LB11058, a New Cephalosporin with High Penicillin-Binding Protein 2a Affinity and Activity in Experimental Endocarditis Due to Homogeneously Methicillin-Resistant Staphylococcus aureus" />
<meta name="DC.Identifier" content="10.1128/AAC.48.11.4322-4327.2004" />
<meta name="DC.Date" content="2004-11-01" />
<meta name="DC.Publisher" content="American Society for Microbiology Journals" />
<meta name="DC.Rights" content="Copyright В© 2004 American Society for Microbiology" />
<meta name="DC.AccessRights" content="restricted" />
<meta name="DC.Description" content="LB11058 is a new synthetic cephalosporin with good affinity for staphylococcal penicillin-binding protein 2a (PBP2a). LB11058 was tested in vitro and in rats with experimental aortic endocarditis against three methicillin-resistant Staphylococcus aureus (MRSA) strains, one penicillinase-negative strain (strain COL), and two penicillinase-producing strains (COL-Bla+ and P8-Hom). The MICs of LB11058 for the organisms were 1 mg/liter. The MICs of vancomycin and ceftriaxone were 1 and в‰Ґ64 mg/liter, respectively. In population analysis profiles, none of the MRSA strains grew at в‰Ґ2 mg of LB11058/liter. Rats with endocarditis were treated for 5 days. LB11058 was highly bound to serum proteins in rats (в‰Ґ98%). However, binding was saturable above a threshold of 250 mg/liter. Therefore, continuous concentrations of 250 mg/liter in serum were infused to ensure a free fraction (в‰Ґ5 mg/liter) above the drug's MIC for the entire infusion period. Control treatments included simulation of human serum kinetics produced by intravenous vancomycin (1 g twice daily, free drug concentration above MIC, в‰Ґ90% of infusion period) or ceftriaxone (2 g/24 h, free drug concentrations above the MIC, 0% of infusion period). LB11058 successfully treated 10 of 10 (100%) and 13 of 14 (93%) of rats infected with COL-Bla+ and P8-Hom, respectively. This was comparable to vancomycin (sterilization of 8 of 12 [66%] and 6 of 8 [75%] rats, respectively). Ceftriaxone was inactive. Low concentrations of LB11058 (5 and 10 mg/liter, continuously infused) in serum were ineffective, as predicted by the pharmacodynamic parameters. At appropriate doses, LB11058 was highly effective both in vitro and in vivo. This finding supports the development of this beta-lactam with high PBP2a affinity for the treatment of MRSA infections." />
<meta name="DC.Contributor" content="Jacques Vouillamoz" />
<meta name="DC.Contributor" content="JosГ© M. Entenza" />
<meta name="DC.Contributor" content="Peter Hohl" />
<meta name="DC.Contributor" content="Philippe Moreillon" />
<meta name="article:published_time" content="2004-11-01" />
<meta name="article:section" content="EXPERIMENTAL THERAPEUTICS" />
<meta name="citation_title" content="LB11058, a New Cephalosporin with High Penicillin-Binding Protein 2a Affinity and Activity in Experimental Endocarditis Due to Homogeneously Methicillin-Resistant Staphylococcus aureus" />
<meta name="citation_abstract" lang="en" content="&lt;h3&gt;ABSTRACT&lt;/h3&gt;
&lt;p&gt;LB11058 is a new synthetic cephalosporin with good affinity for staphylococcal penicillin-binding protein 2a (PBP2a). LB11058 was tested in vitro and in rats with experimental aortic endocarditis against three methicillin-resistant &lt;i&gt;Staphylococcus aureus&lt;/i&gt; (MRSA) strains, one penicillinase-negative strain (strain COL), and two penicillinase-producing strains (COL-Bla+ and P8-Hom). The MICs of LB11058 for the organisms were 1 mg/liter. The MICs of vancomycin and ceftriaxone were 1 and в‰Ґ64 mg/liter, respectively. In population analysis profiles, none of the MRSA strains grew at в‰Ґ2 mg of LB11058/liter. Rats with endocarditis were treated for 5 days. LB11058 was highly bound to serum proteins in rats (в‰Ґ98%). However, binding was saturable above a threshold of 250 mg/liter. Therefore, continuous concentrations of 250 mg/liter in serum were infused to ensure a free fraction (в‰Ґ5 mg/liter) above the drug9s MIC for the entire infusion period. Control treatments included simulation of human serum kinetics produced by intravenous vancomycin (1 g twice daily, free drug concentration above MIC, в‰Ґ90% of infusion period) or ceftriaxone (2 g/24 h, free drug concentrations above the MIC, 0% of infusion period). LB11058 successfully treated 10 of 10 (100%) and 13 of 14 (93%) of rats infected with COL-Bla+ and P8-Hom, respectively. This was comparable to vancomycin (sterilization of 8 of 12 [66%] and 6 of 8 [75%] rats, respectively). Ceftriaxone was inactive. Low concentrations of LB11058 (5 and 10 mg/liter, continuously infused) in serum were ineffective, as predicted by the pharmacodynamic parameters. At appropriate doses, LB11058 was highly effective both in vitro and in vivo. This finding supports the development of this beta-lactam with high PBP2a affinity for the treatment of MRSA infections.&lt;/p&gt;" />
<meta name="citation_journal_title" content="Antimicrobial Agents and Chemotherapy" />
<meta name="citation_publisher" content="American Society for Microbiology Journals" />
<meta name="citation_publication_date" content="2004/11/01" />
<meta name="citation_mjid" content="aac;48/11/4322" />
<meta name="citation_id" content="48/11/4322" />
<meta name="citation_public_url" content="https://aac.asm.org/content/48/11/4322" />
<meta name="citation_abstract_html_url" content="https://aac.asm.org/content/48/11/4322.abstract" />
<meta name="citation_full_html_url" content="https://aac.asm.org/content/48/11/4322.full" />
<meta name="citation_pdf_url" content="https://aac.asm.org/content/aac/48/11/4322.full.pdf" />
<meta name="citation_issn" content="0066-4804" />
<meta name="citation_issn" content="1098-6596" />
<meta name="citation_doi" content="10.1128/AAC.48.11.4322-4327.2004" />
<meta name="citation_pmid" content="15504859" />
<meta name="citation_volume" content="48" />
<meta name="citation_issue" content="11" />
<meta name="citation_article_type" content="Research Article" />
<meta name="citation_section" content="EXPERIMENTAL THERAPEUTICS" />
<meta name="citation_firstpage" content="4322" />
<meta name="citation_lastpage" content="4327" />
<meta name="citation_author" content="Jacques Vouillamoz" />
<meta name="citation_author_institution" content="Department of Infectious Diseases, Centre Hospitalier Universitaire Vaudois" />
<meta name="citation_author" content="JosГ© M. Entenza" />
<meta name="citation_author_institution" content="Department of Infectious Diseases, Centre Hospitalier Universitaire Vaudois" />
<meta name="citation_author" content="Peter Hohl" />
<meta name="citation_author_institution" content="Department of Fundamental Microbiology, University of Lausanne, Lausanne, Switzerland" />
<meta name="citation_author" content="Philippe Moreillon" />
<meta name="citation_author_institution" content="Department of Fundamental Microbiology, University of Lausanne, Lausanne, Switzerland" />
<meta name="citation_author_email" content="Philippe.Moreillon@imf.unil.ch" />
<meta name="citation_reference" content="Chambers, H. F. 2001. The changing epidemiology of Staphylococcus aureus? Emerg. Infect. Dis.7:178-182." />
<meta name="citation_reference" content="Chambers, H. F., B. J. Hartman, and A. Tomasz. 1985. Increased amounts of a novel penicillin-binding protein in a strain of methicillin-resistant Staphylococcus aureus.J. Clin. Investig.76:325-331." />
<meta name="citation_reference" content="Chambers, H. F., M. Sachdeva, and S. Kennedy. 1990. Binding affinity for penicillin-binding protein 2a correlates with in vivo activity of beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus.J. Infect. Dis.162:705-710." />
<meta name="citation_reference" content="Chang, S., D. M. Sievert, J. C. Hageman, M. L. Boulton, F. C. Tenover, F. P. Downes, S. Shah, J. T. Rudrik, G. R. Pupp, W. J. Brown, D. Cardo, and S. K. Fridkin. 2003. Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene. N. Engl. J. Med.348:1342-1347." />
<meta name="citation_reference" content="Craig, W. A., and B. Suh. 1991. Protein binding and the antimicrobial effects: methods for the determination of protein binding, p. 367-402. In V. Lorian (ed.), Antibiotics in laboratory medicine, 3rd ed. The Williams and Wilkins Co., Baltimore, Md." />
<meta name="citation_reference" content="de Jonge, B. L., and A. Tomasz. 1993. Abnormal peptidoglycan produced in a methicillin-resistant strain of Staphylococcus aureus grown in the presence of methicillin: functional role for penicillin-binding protein 2A in cell wall synthesis. Antimicrob. Agents Chemother.37:342-346." />
<meta name="citation_reference" content="de Lencastre, H., and A. Tomasz. 1994. Reassessment of the number of auxiliary genes essential for expression of high-level methicillin resistance in Staphylococcus aureus.Antimicrob. Agents Chemother.38:2590-2598." />
<meta name="citation_reference" content="Entenza, J. M., I. Caldelari, M. P. Glauser, and P. Moreillon. 1999. Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci. J. Antimicrob. Chemother.44:775-786." />
<meta name="citation_reference" content="Entenza, J. M., U. Fluckiger, M. P. Glauser, and P. Moreillon. 1994. Antibiotic treatment of experimental endocarditis due to methicillin-resistant Staphylococcus epidermidis.J. Infect. Dis.170:100-109." />
<meta name="citation_reference" content="Entenza, J. M., P. Hohl, I. Heinze-Krauss, M. P. Glauser, and P. Moreillon. 2002. BAL9141, a novel extended-spectrum cephalosporin active against methicillin-resistant Staphylococcus aureus in treatment of experimental endocarditis. Antimicrob. Agents Chemother.46:171-177." />
<meta name="citation_reference" content="Entenza, J. M., Y. A. Que, J. Vouillamoz, M. P. Glauser, and P. Moreillon. 2001. Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance. Antimicrob. Agents Chemother.45:3076-3083." />
<meta name="citation_reference" content="Entenza, J. M., J. Vouillamoz, M. P. Glauser, and P. Moreillon. 1999. Efficacy of trovafloxacin in treatment of experimental staphylococcal or streptococcal endocarditis. Antimicrob. Agents Chemother.43:77-84." />
<meta name="citation_reference" content="Entenza, J. M., J. Vouillamoz, M. P. Glauser, and P. Moreillon. 1997. Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant Staphylococcus aureus.Antimicrob. Agents Chemother.41:1662-1667." />
<meta name="citation_reference" content="Fluckiger, U., P. Francioli, J. Blaser, M. P. Glauser, and P. Moreillon. 1994. Role of amoxicillin serum levels for successful prophylaxis of experimental endocarditis due to tolerant streptococci. J. Infect. Dis.169:1397-1400." />
<meta name="citation_reference" content="Franciolli, M., J. Bille, M. P. Glauser, and P. Moreillon. 1991. Beta-lactam resistance mechanisms of methicillin-resistant Staphylococcus aureus.J. Infect. Dis.163:514-523." />
<meta name="citation_reference" content="Gillespie, M. T., J. W. May, and R. A. Skurray. 1985. Antibiotic resistance in Staphylococcus aureus isolated at an Australian hospital between 1946 and 1981. J. Med. Microbiol.19:137-147." />
<meta name="citation_reference" content="Gonzalez-Zorn, B., and P. Courvalin. 2003. VanA-mediated high level glycopeptide resistance in MRSA. Lancet Infect. Dis.3:67-68." />
<meta name="citation_reference" content="Hakim, L., D. W. Bourne, and E. J. Triggs. 1989. Disposition of ceftriaxone in rat: application of a pharmacokinetic-protein binding model and comparison with cefotaxime. Xenobiotica19:815-822." />
<meta name="citation_reference" content="Heraief, E., M. P. Glauser, and L. R. Freedman. 1982. Natural history of aortic valve endocarditis in rats. Infect. Immun.37:127-131." />
<meta name="citation_reference" content="Hirano, L., and A. S. Bayer. 1991. Beta-lactam-beta-lactamase inhibitor combinations are active in experimental endocarditis caused by beta-lactamase-producing oxacillin-resistant staphylococci. Antimicrob. Agents Chemother.35:685-690." />
<meta name="citation_reference" content="Kusama, M., K. Yamamoto, H. Kotaki, H. Sato, and T. Iga. 1998. Effect of cilastatin on renal handling of vancomycin in rats. J. Pharm. Sci.87:1173-1176." />
<meta name="citation_reference" content="Lim, D., and N. C. Strynadka. 2002. Structural basis for the beta lactam resistance of PBP2a from methicillin-resistant Staphylococcus aureus.Nat. Struct. Biol.9:870-876." />
<meta name="citation_reference" content="Lowy, F. D. 1998. Staphylococcus aureus infections. N. Engl. J. Med.339:520-532." />
<meta name="citation_reference" content="Malbruny, B., A. Canu, B. Bozdogan, B. Fantin, V. Zarrouk, S. Dutka-Malen, C. Feger, and R. Leclercq. 2002. Resistance to quinupristin-dalfopristin due to mutation of L22 ribosomal protein in Staphylococcus aureus.Antimicrob. Agents Chemother.46:2200-2207." />
<meta name="citation_reference" content="Moore, M. R., F. Perdreau-Remington, and H. F. Chambers. 2003. Vancomycin treatment failure associated with heterogeneous vancomycin-intermediate Staphylococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis. Antimicrob. Agents Chemother.47:1262-1266." />
<meta name="citation_reference" content="Moreillon, P., and P. Majcherczyk. 2000. Is there still a role for penicillins and cephalosporins in the treatment of bacterial infections? Int. J. Clin. Pract. Suppl.2000:99-105." />
<meta name="citation_reference" content="National Committee for Clinical Laboratory Standards. 2000. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th ed. Document M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa." />
<meta name="citation_reference" content="Pillai, S. K., G. Sakoulas, C. Wennersten, G. M. Eliopoulos, R. C. Moellering, Jr., M. J. Ferraro, and H. S. Gold. 2002. Linezolid resistance in Staphylococcus aureus: characterization and stability of resistant phenotype. J. Infect. Dis.186:1603-1607." />
<meta name="citation_reference" content="Pinho, M. G., H. de Lencastre, and A. Tomasz. 2001. An acquired and a native penicillin-binding protein cooperate in building the cell wall of drug-resistant staphylococci. Proc. Natl. Acad. Sci. USA98:10886-10891." />
<meta name="citation_reference" content="Que, Y. A., J. M. Entenza, P. Francioli, and P. Moreillon. 1998. The impact of penicillinase on cefamandole treatment and prophylaxis of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.J. Infect. Dis.177:146-154." />
<meta name="citation_reference" content="Ramos, M. C., M. Ing, E. Kim, M. D. Witt, and A. S. Bayer. 1996. Ampicillin-sulbactam is effective in prevention and therapy of experimental endocarditis caused by beta-lactamase-producing coagulase-negative staphylococci. Antimicrob. Agents Chemother.40:97-101." />
<meta name="citation_reference" content="Sader, H. S., D. M. Johnson, and R. N. Jones. 2004. In vitro activities of the novel cephalosporin LB 11058 against multidrug-resistant staphylococci and streptococci. Antimicrob. Agents Chemother.48:53-62." />
<meta name="citation_reference" content="Tomasz, A. 2003. вЂњIntelligence coupвЂќ for drug designers: crystal structure of Staphylococcus aureus beta-lactam resistance protein PBP2A. Lancet361:795-796." />
<meta name="twitter:title" content="LB11058, a New Cephalosporin with High Penicillin-Binding Protein 2a Affinity and Activity in Experimental Endocarditis Due to Homogeneously Methicillin-Resistant Staphylococcus aureus" />
<meta name="twitter:card" content="summary" />
<meta name="twitter:image" content="https://aac.asm.org/sites/default/files/highwire/default/covers/AAC_Cover_0.jpg" />
<meta name="twitter:description" content="LB11058 is a new synthetic cephalosporin with good affinity for staphylococcal penicillin-binding protein 2a (PBP2a). LB11058 was tested in vitro and in rats with experimental aortic endocarditis against three methicillin-resistant Staphylococcus aureus (MRSA) strains, one penicillinase-negative strain (strain COL), and two penicillinase-producing strains (COL-Bla+ and P8-Hom). The MICs of LB11058 for the organisms were 1 mg/liter. The MICs of vancomycin and ceftriaxone were 1 and в‰Ґ64 mg/liter, respectively. In population analysis profiles, none of the MRSA strains grew at в‰Ґ2 mg of LB11058/liter. Rats with endocarditis were treated for 5 days. LB11058 was highly bound to serum proteins in rats (в‰Ґ98%). However, binding was saturable above a threshold of 250 mg/liter. Therefore, continuous concentrations of 250 mg/liter in serum were infused to ensure a free fraction (в‰Ґ5 mg/liter) above the drug's MIC for the entire infusion period. Control treatments included simulation of human serum kinetics produced by intravenous vancomycin (1 g twice daily, free drug concentration above MIC, в‰Ґ90% of infusion period) or ceftriaxone (2 g/24 h, free drug concentrations above the MIC, 0% of infusion period). LB11058 successfully treated 10 of 10 (100%) and 13 of 14 (93%) of rats infected with COL-Bla+ and P8-Hom, respectively. This was comparable to vancomycin (sterilization of 8 of 12 [66%] and 6 of 8 [75%] rats, respectively). Ceftriaxone was inactive. Low concentrations of LB11058 (5 and 10 mg/liter, continuously infused) in serum were ineffective, as predicted by the pharmacodynamic parameters. At appropriate doses, LB11058 was highly effective both in vitro and in vivo. This finding supports the development of this beta-lactam with high PBP2a affinity for the treatment of MRSA infections." />
<meta name="og-title" property="og:title" content="LB11058, a New Cephalosporin with High Penicillin-Binding Protein 2a Affinity and Activity in Experimental Endocarditis Due to Homogeneously Methicillin-Resistant Staphylococcus aureus" />
<meta name="og-url" property="og:url" content="https://aac.asm.org/content/48/11/4322" />
<meta name="og-site-name" property="og:site_name" content="Antimicrobial Agents and Chemotherapy" />
<meta name="og-description" property="og:description" content="LB11058 is a new synthetic cephalosporin with good affinity for staphylococcal penicillin-binding protein 2a (PBP2a). LB11058 was tested in vitro and in rats with experimental aortic endocarditis against three methicillin-resistant Staphylococcus aureus (MRSA) strains, one penicillinase-negative strain (strain COL), and two penicillinase-producing strains (COL-Bla+ and P8-Hom). The MICs of LB11058 for the organisms were 1 mg/liter. The MICs of vancomycin and ceftriaxone were 1 and в‰Ґ64 mg/liter, respectively. In population analysis profiles, none of the MRSA strains grew at в‰Ґ2 mg of LB11058/liter. Rats with endocarditis were treated for 5 days. LB11058 was highly bound to serum proteins in rats (в‰Ґ98%). However, binding was saturable above a threshold of 250 mg/liter. Therefore, continuous concentrations of 250 mg/liter in serum were infused to ensure a free fraction (в‰Ґ5 mg/liter) above the drug's MIC for the entire infusion period. Control treatments included simulation of human serum kinetics produced by intravenous vancomycin (1 g twice daily, free drug concentration above MIC, в‰Ґ90% of infusion period) or ceftriaxone (2 g/24 h, free drug concentrations above the MIC, 0% of infusion period). LB11058 successfully treated 10 of 10 (100%) and 13 of 14 (93%) of rats infected with COL-Bla+ and P8-Hom, respectively. This was comparable to vancomycin (sterilization of 8 of 12 [66%] and 6 of 8 [75%] rats, respectively). Ceftriaxone was inactive. Low concentrations of LB11058 (5 and 10 mg/liter, continuously infused) in serum were ineffective, as predicted by the pharmacodynamic parameters. At appropriate doses, LB11058 was highly effective both in vitro and in vivo. This finding supports the development of this beta-lactam with high PBP2a affinity for the treatment of MRSA infections." />
<meta name="og-type" property="og:type" content="article" />
<meta name="og-image" property="og:image" content="https://aac.asm.org/sites/default/files/highwire/default/covers/AAC_Cover_0.jpg" />
    <title>LB11058, a New Cephalosporin with High Penicillin-Binding Protein 2a Affinity and Activity in Experimental Endocarditis Due to Homogeneously Methicillin-Resistant Staphylococcus aureus | Antimicrobial Agents and Chemotherapy</title>  
    <link type="text/css" rel="stylesheet" href="https://aac.asm.org/sites/default/files/advagg_css/css__kTVyDAOL5NkNO3djn2rimjhdkOw28Y0e-6AJ2ClHgfU__2T2VYhFSTHiMKD_qnEoA-dRink7GcnC3XqIduXK87Lw__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://aac.asm.org/sites/all/modules/highwire/highwire/highwire.style.highwire.css?qjdf71" media="all" />
<link type="text/css" rel="stylesheet" href="https://aac.asm.org/sites/default/files/advagg_css/css__BX3nCkChknRoE-aDbdxprlFaypp4fXWeczbX7JvfqrM__g-t84A-r74kQSXvr21Rgbefb9LKqLm96c9xLvHou54w__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.css" media="all" />
<link type="text/css" rel="stylesheet" href="//cdn.jsdelivr.net/qtip2/2.2.1/jquery.qtip.min.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://aac.asm.org/sites/default/files/advagg_css/css__LAPMf2_D41coKgF9GMvNabGOxgOc_VLT-xXm2EsAliA__2jNUX6ja6sF12c6BfrluuTZt_7EDEMHSb2LyUdWuTXA__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.css" media="all" />
<style type="text/css" media="all">
/* <![CDATA[ */
.panels-flexible-region{padding:0}.panels-flexible-region-inside{padding-right:.5em;padding-left:.5em}.panels-flexible-region-inside-first{padding-left:0}.panels-flexible-region-inside-last{padding-right:0}.panels-flexible-column{padding:0}.panels-flexible-column-inside{padding-right:.5em;padding-left:.5em}.panels-flexible-column-inside-first{padding-left:0}.panels-flexible-column-inside-last{padding-right:0}.panels-flexible-row{padding:0 0 .5em 0;margin:0}.panels-flexible-row-last{padding-bottom:0}.panels-flexible-column-new-main{float:left;width:99.0000%}.panels-flexible-new-inside{padding-right:0}.panels-flexible-new{width:auto}.panels-flexible-region-new-center{float:left;width:99.0000%}.panels-flexible-row-new-main-row-inside{padding-right:0}
/* ]]> */
</style>
<link type="text/css" rel="stylesheet" href="https://aac.asm.org/sites/default/files/advagg_css/css__PnFOUU3wwEeMc-3uTp-rJi3xEd6b9xBIOyZ99akvv-4__xNoeDncIFLwvGXSGvArCoLrv5_DoXvtueK4yDbpLy4U__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.css" media="all" />
<style type="text/css" media="all">
/* <![CDATA[ */
.user-menu-dropdown-logo>.menubar-nav>.nice-menu>.menuparent a:first-child{background:url('https://aac.asm.org/sites/default/files/uber-ASMJournals.png') transparent no-repeat left center;padding-left:106px}
/* ]]> */
</style>
<link type="text/css" rel="stylesheet" href="https://aac.asm.org/sites/default/files/advagg_css/css__7CYEtfDxMu3CEBZ53TQrEfMpO7duR_XdIuTLye9W7Cc__CzzPXev2zJRWVry4kyDAKuuERTizWaGzrN8gCp2auaE__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.css" media="all" />
<style type="text/css" media="all">
/* <![CDATA[ */
#sliding-popup.sliding-popup-bottom,#sliding-popup.sliding-popup-bottom .eu-cookie-withdraw-banner,.eu-cookie-withdraw-tab{background:#000}#sliding-popup.sliding-popup-bottom.eu-cookie-withdraw-wrapper{background:transparent}#sliding-popup .popup-content #popup-text h1,#sliding-popup .popup-content #popup-text h2,#sliding-popup .popup-content #popup-text h3,#sliding-popup .popup-content #popup-text p,.eu-cookie-compliance-secondary-button,.eu-cookie-withdraw-tab{color:#fff !important}.eu-cookie-withdraw-tab{border-color:#fff}.eu-cookie-compliance-more-button{color:#fff !important}
/* ]]> */
</style>

<!--[if lte IE 7]>
<link type="text/css" rel="stylesheet" href="https://aac.asm.org/sites/default/files/advagg_css/css__ElJr3PIJEvw3qLXc1cnYiLj2G4KgDPSXFOfm6Phf8hw__JdWGm15cDWjsK6KrFlQVXQix9YgNeYysf22XZHj-Y-c__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.css" media="all" />
<![endif]-->
<link type="text/css" rel="stylesheet" href="https://aac.asm.org/sites/default/files/advagg_css/css__vP96nkAt3EeLU62QRdHXKZuS9tqQ1EMDJC_PSKd7hEk__tdZg4qOJpqrCbkbGYbpNeWgJZN-ltlK3uYdisQZuHX0__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://aac.asm.org/sites/default/files/advagg_css/css__WTIsRlLrkKgFz0Dd4Y-MRkV_8c933CL255PlZPb2RqI__uBvc03D0c_E7-EfMZ-LlXTnA0SGx13NNJeQaFUTS0Yc__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.css" media="all" />

<!--[if (lt IE 9)&(!IEMobile)]>
<link type="text/css" rel="stylesheet" href="https://aac.asm.org/sites/default/files/advagg_css/css__XH6bpcI0f2dImc-p674DLCZtWBGb-QwxJK1YexVGtno__vUceGprdo5nIhV6DH93X7fI3r8RcTJbChbas9TQXeW4__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.css" media="all" />
<![endif]-->

<!--[if gte IE 9]><!-->
<link type="text/css" rel="stylesheet" href="https://aac.asm.org/sites/default/files/advagg_css/css__2WBMox6sOrN42ss5lCnH7WWVRdFdJCxtTKnQJYRwTE4__yqNvNYLvMpjy3ffuJrjjm9uW2i-Me1c23KLYuWHaqio__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.css" media="all" />
<!--<![endif]-->
<link type="text/css" rel="stylesheet" href="https://aac.asm.org/sites/default/files/advagg_css/css__jC-UM4y5ea0GptlS8YSVWKZyyOO1Cqf3MmlsxANgy3Y__BK4cyZQdrIENRK8aL8B6_rAV69WxBtzchyITAvs6YHg__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.css" media="all" />
<link type="text/css" rel="stylesheet" href="https://journals.asm.org/sites/default/files/additional_assets/journals-advpages.css" media="all" />
    <script type="text/javascript">
<!--//--><![CDATA[//><!--
/*!
 * yepnope1.5.4
 * (c) WTFPL, GPLv2
 */
(function(a,b,c){function d(a){return"[object Function]"==o.call(a)}function e(a){return"string"==typeof a}function f(){}function g(a){return!a||"loaded"==a||"complete"==a||"uninitialized"==a}function h(){var a=p.shift();q=1,a?a.t?m(function(){("c"==a.t?B.injectCss:B.injectJs)(a.s,0,a.a,a.x,a.e,1)},0):(a(),h()):q=0}function i(a,c,d,e,f,i,j){function k(b){if(!o&&g(l.readyState)&&(u.r=o=1,!q&&h(),l.onload=l.onreadystatechange=null,b)){"img"!=a&&m(function(){t.removeChild(l)},50);for(var d in y[c])y[c].hasOwnProperty(d)&&y[c][d].onload()}}var j=j||B.errorTimeout,l=b.createElement(a),o=0,r=0,u={t:d,s:c,e:f,a:i,x:j};1===y[c]&&(r=1,y[c]=[]),"object"==a?l.data=c:(l.src=c,l.type=a),l.width=l.height="0",l.onerror=l.onload=l.onreadystatechange=function(){k.call(this,r)},p.splice(e,0,u),"img"!=a&&(r||2===y[c]?(t.insertBefore(l,s?null:n),m(k,j)):y[c].push(l))}function j(a,b,c,d,f){return q=0,b=b||"j",e(a)?i("c"==b?v:u,a,b,this.i++,c,d,f):(p.splice(this.i++,0,a),1==p.length&&h()),this}function k(){var a=B;return a.loader={load:j,i:0},a}var l=b.documentElement,m=a.setTimeout,n=b.getElementsByTagName("script")[0],o={}.toString,p=[],q=0,r="MozAppearance"in l.style,s=r&&!!b.createRange().compareNode,t=s?l:n.parentNode,l=a.opera&&"[object Opera]"==o.call(a.opera),l=!!b.attachEvent&&!l,u=r?"object":l?"script":"img",v=l?"script":u,w=Array.isArray||function(a){return"[object Array]"==o.call(a)},x=[],y={},z={timeout:function(a,b){return b.length&&(a.timeout=b[0]),a}},A,B;B=function(a){function b(a){var a=a.split("!"),b=x.length,c=a.pop(),d=a.length,c={url:c,origUrl:c,prefixes:a},e,f,g;for(f=0;f<d;f++)g=a[f].split("="),(e=z[g.shift()])&&(c=e(c,g));for(f=0;f<b;f++)c=x[f](c);return c}function g(a,e,f,g,h){var i=b(a),j=i.autoCallback;i.url.split(".").pop().split("?").shift(),i.bypass||(e&&(e=d(e)?e:e[a]||e[g]||e[a.split("/").pop().split("?")[0]]),i.instead?i.instead(a,e,f,g,h):(y[i.url]?i.noexec=!0:y[i.url]=1,f.load(i.url,i.forceCSS||!i.forceJS&&"css"==i.url.split(".").pop().split("?").shift()?"c":c,i.noexec,i.attrs,i.timeout),(d(e)||d(j))&&f.load(function(){k(),e&&e(i.origUrl,h,g),j&&j(i.origUrl,h,g),y[i.url]=2})))}function h(a,b){function c(a,c){if(a){if(e(a))c||(j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}),g(a,j,b,0,h);else if(Object(a)===a)for(n in m=function(){var b=0,c;for(c in a)a.hasOwnProperty(c)&&b++;return b}(),a)a.hasOwnProperty(n)&&(!c&&!--m&&(d(j)?j=function(){var a=[].slice.call(arguments);k.apply(this,a),l()}:j[n]=function(a){return function(){var b=[].slice.call(arguments);a&&a.apply(this,b),l()}}(k[n])),g(a[n],j,b,n,h))}else!c&&l()}var h=!!a.test,i=a.load||a.both,j=a.callback||f,k=j,l=a.complete||f,m,n;c(h?a.yep:a.nope,!!i),i&&c(i)}var i,j,l=this.yepnope.loader;if(e(a))g(a,0,l,0);else if(w(a))for(i=0;i<a.length;i++)j=a[i],e(j)?g(j,0,l,0):w(j)?B(j):Object(j)===j&&h(j,l);else Object(a)===a&&h(a,l)},B.addPrefix=function(a,b){z[a]=b},B.addFilter=function(a){x.push(a)},B.errorTimeout=1e4,null==b.readyState&&b.addEventListener&&(b.readyState="loading",b.addEventListener("DOMContentLoaded",A=function(){b.removeEventListener("DOMContentLoaded",A,0),b.readyState="complete"},0)),a.yepnope=k(),a.yepnope.executeStack=h,a.yepnope.injectJs=function(a,c,d,e,i,j){var k=b.createElement("script"),l,o,e=e||B.errorTimeout;k.src=a;for(o in d)k.setAttribute(o,d[o]);c=j?h:c||f,k.onreadystatechange=k.onload=function(){!l&&g(k.readyState)&&(l=1,c(),k.onload=k.onreadystatechange=null)},m(function(){l||(l=1,c(1))},e),i?k.onload():n.parentNode.insertBefore(k,n)},a.yepnope.injectCss=function(a,c,d,e,g,i){var e=b.createElement("link"),j,c=i?h:c||f;e.href=a,e.rel="stylesheet",e.type="text/css";for(j in d)e.setAttribute(j,d[j]);g||(n.parentNode.insertBefore(e,n),m(c,0))}})(this,document);

//--><!]]>
</script>
<script type="text/javascript" src="https://aac.asm.org/sites/all/libraries/modernizr/modernizr.min.js?qjdf71"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
yepnope({
  test: Modernizr.matchmedia,
  nope: '/sites/all/libraries/media-match/media.match.min.js'
});
//--><!]]>
</script>
<script type="text/javascript" src="https://aac.asm.org/sites/default/files/advagg_js/js__wH8myWXKi4A-QKdUKDXzJAnGs-FRS1A2ZzTTNzjRAdI__4MCtOZK_Ov0QKyRlXNLGQ2LRlYRGWj9ArT-NpFox3QA__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
var googletag = googletag || {};
googletag.cmd = googletag.cmd || [];
googletag.slots = googletag.slots || {};
//--><!]]>
</script>
<script type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js"></script>
<script type="text/javascript" src="https://aac.asm.org/sites/default/files/advagg_js/js__9rXDBIhVBkP0BsyHk1wbescXWFIxRy4CVuUwfiESLj4__F1JmUI65uDfzw6swVIdx2_0bzIaKP9u0qg-RNYe3m3s__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
googletag.slots["asm_box"] = googletag.defineSlot("/13678947/asm_box", [300, 250], "dfp-ad-asm_box")
  .addService(googletag.pubads())
  .setTargeting("asmjournals", "aac");
//--><!]]>
</script>
<script type="text/javascript" src="https://aac.asm.org/sites/default/files/advagg_js/js__bQc6kyz_Gw2afC1F6wguCBh8Z8nev-hxX6F2Tw4bq6k__CO2faEsYCquY82rVj6as9HScSnogGHeR-oh5fSQydG0__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
var mapping = googletag.sizeMapping()
  .addSize([980, 1], [728, 90])
  .addSize([1, 1], [320, 50])
  .build();
googletag.slots["asm_leader_mob"] = googletag.defineSlot("/13678947/asm_leader-mob", [[728, 90], [320, 50]], "dfp-ad-asm_leader_mob")
  .addService(googletag.pubads())
  .setTargeting("asmjournals", "aac")
  .defineSizeMapping(mapping);
//--><!]]>
</script>
<script type="text/javascript" src="https://aac.asm.org/sites/default/files/advagg_js/js__dpHWPO8-QXPRsQXkx2RcUYOOrnCKh7SfUDVV0G48YII__-_Atd1qh6XaeX6cPmbvx5CNihEYhVDjwEQrkcRWbbk8__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
document.createElement( "picture" );
//--><!]]>
</script>
<script type="text/javascript" src="https://aac.asm.org/sites/default/files/advagg_js/js__UK1ygaa8bCfT-jsjqYRdRLDZ5N17950T7K5WPC9XtpI__NqLYT1T1SMBsKukLWIe82VgCZYYCMHZX_f609-a1rj8__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
googletag.cmd.push(function() {
  googletag.pubads().enableAsyncRendering();
  googletag.pubads().enableSingleRequest();
  googletag.pubads().collapseEmptyDivs();
  googletag.pubads().addEventListener("slotRenderEnded", function (event) {
    if (event.isEmpty) {
      var id = event.slot.getSlotElementId();
      var x = document.getElementById(id);
      if (x.parentElement.classList.contains("dfp-tag-wrapper")) {
        x.parentElement.style.display = "none";
      }
    }
  });
});

googletag.enableServices();
//--><!]]>
</script>
<script type="text/javascript" src="https://aac.asm.org/sites/default/files/advagg_js/js__3vwOA0BwlnyBkt9H4CLg6FgNyKAh--OmfOxFOIu_5S4__EXTgktcHbQ7BQfelY6CnrqgPRc4i4eD6XcZ4i3xs5RU__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.js"></script>
<script type="text/javascript" defer="defer" async="async" src="//cdn.foxycart.com/asm.ecommerce.highwire.org/loader.js"></script>
<script type="text/javascript" src="https://aac.asm.org/sites/default/files/advagg_js/js__IBM5LrU6V_9IHDow9uvaTZj6hSk8OauPIL06zKFXP9E__sSVK9Wk1leVNQSDhpslSC7eHBDkvUkwvqpqFBoR55fE__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.js"></script>
<script type="text/javascript" async="async" src="https://scholar.google.com/scholar_js/casa.js"></script>
<script type="text/javascript" src="https://aac.asm.org/sites/default/files/advagg_js/js__3uCzzYE5jr6ly9nvsM8PRBRkhh4p0NWCMDja4EKBy4M__dmGGVYcB8LhnbR2iAmVW0ZyXI6QuFVYFRORa5XxglXs__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.js"></script>
<script type="text/javascript" src="//cdn.jsdelivr.net/qtip2/2.2.1/jquery.qtip.min.js"></script>
<script type="text/javascript" src="https://aac.asm.org/sites/default/files/advagg_js/js__yiXGyyzC1oV2sZBtAUN2DFoM2mAH5KP0iYCqS1dmafE__UiTPqZo1iNHqhqhx1lKGu2xkUGpxmin5ny6_22C53JA__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
if(typeof window.MathJax === "undefined") window.MathJax = { menuSettings: { zoom: "Click" } };
//--><!]]>
</script>
<script type="text/javascript" src="https://aac.asm.org/sites/default/files/advagg_js/js__9cszWACvqfgGHxZ9cYu77EmgUl5PS06bWWNMHQWXAzs__r43EInI51Aw344uPml6V9wbOCwCPY3JUCv0myrWhWJ8__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.js"></script>
<script type="text/javascript" src="https://www.google.com/recaptcha/api.js?hl=en&amp;render=explicit&amp;onload=drupalRecaptchaOnload"></script>
<script type="text/javascript" src="https://aac.asm.org/sites/default/files/advagg_js/js__wv9tKCDrA0z5A6V5iIUk8KuqnrSwkhwD8xBY49vTnGw__XpJxKcSFHszUXwo83u22u-X8Nm3hRoKB-ZRewjwMTwk__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
(function(i,s,o,g,r,a,m){i["GoogleAnalyticsObject"]=r;i[r]=i[r]||function(){(i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)})(window,document,"script","//www.google-analytics.com/analytics.js","ga");ga("create", "UA-5821458-3", {"cookieDomain":"auto"});ga("set", "anonymizeIp", true);ga("send", "pageview");ga('create', 'UA-189672-34', 'auto', {'name': 'hwTracker'});
ga('set', 'anonymizeIp', true);
ga('hwTracker.send', 'pageview');
//--><!]]>
</script>
<script type="text/javascript" src="https://aac.asm.org/sites/default/files/advagg_js/js__o0sqMT5Ga6hDKg0ZzJ2O7bLSX1bhj6Edl5UUgbwRffM__gX3BEX_JCocmWnJuIrEZ-5f80gTLiRTdLwiABEY_Aq8__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
  setTimeout(function(){var a=document.createElement("script");
  var b=document.getElementsByTagName("script")[0];
  a.src=document.location.protocol+"//script.crazyegg.com/pages/scripts/0043/7461.js?"+Math.floor(new Date().getTime()/3600000);
  a.async=true;a.type="text/javascript";b.parentNode.insertBefore(a,b)}, 1);
//--><!]]>
</script>
<script type="text/javascript" src="https://aac.asm.org/sites/default/files/advagg_js/js__zZf2JqHvQzUqy4IxpDf7IpgqVlzNZCKiFz1EjRjvrVo___zmTm_XlL04QiV3YGJI8uAySe9z0WRlaXXOFu3pDumE__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0];var j=d.createElement(s);var dl=l!='dataLayer'?'&l='+l:'';j.src='//www.googletagmanager.com/gtm.js?id='+i+dl;j.type='text/javascript';j.async=true;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer','GTM-PZPCQN5');
//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
jQuery.extend(Drupal.settings,{"basePath":"\/","pathPrefix":"","ajaxPageState":{"theme":"jcore_1","theme_token":"A-w7dMTJLrIYr8FOOgh0rf7otEigztaKJGqVanbfuzA","jquery_version":"1.8","css":{"modules\/system\/system.base.css":1,"modules\/system\/system.menus.css":1,"modules\/system\/system.messages.css":1,"modules\/system\/system.theme.css":1,"misc\/ui\/jquery.ui.core.css":1,"misc\/ui\/jquery.ui.theme.css":1,"misc\/ui\/jquery.ui.button.css":1,"misc\/ui\/jquery.ui.resizable.css":1,"misc\/ui\/jquery.ui.dialog.css":1,"misc\/ui\/jquery.ui.tooltip.css":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/themes\/base\/minified\/jquery.ui.accordion.min.css":1,"sites\/all\/modules\/contrib\/date\/date_api\/date.css":1,"sites\/all\/modules\/contrib\/date\/date_popup\/themes\/datepicker.1.7.css":1,"modules\/field\/theme\/field.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_draw\/css\/highwire-draw.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_folders\/highwire_folders.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_foxycart\/highwire_foxycart.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_responsive\/css\/highwire-responsive.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_saved_searches\/highwire_saved_searches.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_user\/highwire_user.css":1,"sites\/all\/modules\/shared\/jnl_asm_styles\/css\/shared-styles.css":1,"modules\/node\/node.css":1,"sites\/all\/modules\/contrib\/picture\/picture_wysiwyg.css":1,"modules\/search\/search.css":1,"modules\/user\/user.css":1,"sites\/all\/modules\/contrib\/views\/css\/views.css":1,"sites\/all\/modules\/contrib\/ckeditor\/css\/ckeditor.css":1,"sites\/all\/modules\/contrib\/colorbox\/styles\/default\/colorbox_style.css":1,"sites\/all\/modules\/contrib\/ctools\/css\/ctools.css":1,"sites\/all\/modules\/contrib\/foxycart\/foxycart.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire.style.highwire.css":1,"sites\/all\/modules\/highwire\/highwire\/css\/nlm-elements.css":1,"sites\/all\/modules\/contrib\/panels\/css\/panels.css":1,"public:\/\/ctools\/css\/263bfdb18936424f0ade19d6bd885f37.css":1,"sites\/all\/modules\/contrib\/panels_ajax_tab\/css\/panels_ajax_tab.css":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/css\/highwire_corrections.css":1,"\/\/cdn.jsdelivr.net\/qtip2\/2.2.1\/jquery.qtip.min.css":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/css\/highwire_collapsible_supplemental.css":1,"sites\/all\/libraries\/iToggle\/src\/engage.itoggle.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire.style.markup.css":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/layouts\/highwire_2col_stacked\/highwire-2col-stacked.css":1,"sites\/all\/modules\/contrib\/forward\/forward.css":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/css\/highwire_share_link.css":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/css\/highwire_copy_permalink.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_responsive\/plugins\/styles\/highwire_responsive_toggle\/highwire_responsive_toggle.css.less":1,"sites\/all\/modules\/contrib\/nice_menus\/css\/nice_menus.css":1,"sites\/all\/modules\/contrib\/nice_menus\/css\/nice_menus_default.css":1,"sites\/all\/modules\/contrib\/panels\/plugins\/layouts\/onecol\/onecol.css":1,"sites\/all\/modules\/contrib\/panels\/plugins\/layouts\/flexible\/flexible.css":1,"0":1,"sites\/all\/modules\/contrib\/eu_cookie_compliance\/css\/eu_cookie_compliance.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/userbar-dropdown-menu.css":1,"2":1,"sites\/all\/modules\/highwire\/highwire\/highwire_theme_tools\/css\/font-hwicons.css":1,"sites\/all\/modules\/highwire\/highwire\/highwire_theme_tools\/css\/font-hwicons-glyphs.css":1,"1":1,"sites\/all\/themes\/highwire\/jcore_1\/eu_cookie_compliance.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/font-awesome-ie7.css":1,"sites\/all\/themes\/contrib\/omega\/alpha\/css\/alpha-reset.css":1,"sites\/all\/themes\/contrib\/omega\/alpha\/css\/alpha-mobile.css":1,"sites\/all\/themes\/contrib\/omega\/alpha\/css\/alpha-alpha.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/formalize.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/omega-text.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/omega-branding.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/omega-menu.css":1,"sites\/all\/themes\/contrib\/omega\/omega\/css\/omega-forms.css":1,"sites\/all\/modules\/highwire\/highwire\/css\/highwire-forms.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/mobile-reset.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/font-awesome.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/forms.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/global.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/jquery-ui-elements.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/text.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/colors.css.less":1,"ie::normal::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default.css":1,"ie::normal::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default-normal.css":1,"ie::normal::sites\/all\/themes\/highwire\/jcore_1\/css\/grid\/jcore_default\/normal\/jcore-default-normal-30.css":1,"narrow::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default.css":1,"narrow::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default-narrow.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/grid\/jcore_default\/narrow\/jcore-default-narrow-30.css":1,"normal::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default.css":1,"normal::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default-normal.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/grid\/jcore_default\/normal\/jcore-default-normal-30.css":1,"wide::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default.css":1,"wide::sites\/all\/themes\/highwire\/jcore_1\/css\/jcore-1-jcore-default-wide.css":1,"sites\/all\/themes\/highwire\/jcore_1\/css\/grid\/jcore_default\/wide\/jcore-default-wide-30.css":1,"sites\/all\/modules\/shared\/jnl_asm_styles\/css\/jnl_asm_styles.css.less":1,"https:\/\/journals.asm.org\/sites\/default\/files\/additional_assets\/journals-advpages.css":1},"js":{"sites\/all\/libraries\/enquire.js\/enquire.min.js":1,"sites\/all\/modules\/contrib\/picture\/picturefill2\/picturefill.min.js":1,"sites\/all\/modules\/contrib\/picture\/picture.min.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/highwire_panels_ajax_tab.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_openurl.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_google_scholar_sprinkle.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_tables.js":1,"sites\/all\/libraries\/lazysizes\/lazysizes.min.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_figures.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/highwire_article_trendmd.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_user\/plugins\/content_types\/js\/highwire_user_salutation.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_foxycart\/highwire_foxycart.js":1,"sites\/all\/modules\/contrib\/eu_cookie_compliance\/js\/eu_cookie_compliance.js":1,"sites\/all\/libraries\/modernizr\/modernizr.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/jquery\/1.8\/jquery.min.js":1,"misc\/jquery-extend-3.4.0.js":1,"misc\/jquery.once.js":1,"https:\/\/www.googletagservices.com\/tag\/js\/gpt.js":1,"misc\/drupal.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.core.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.widget.min.js":1,"sites\/all\/libraries\/iToggle\/src\/engage.itoggle.1.8.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.button.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.mouse.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.draggable.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.position.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.resizable.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.dialog.min.js":1,"sites\/all\/modules\/contrib\/eu_cookie_compliance\/js\/jquery.cookie-1.4.1.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/misc\/jquery.form.min.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.tooltip.min.js":1,"sites\/all\/libraries\/jquery.bgiframe\/jquery.bgiframe.js":1,"sites\/all\/libraries\/jquery.hoverIntent\/jquery.hoverIntent.js":1,"sites\/all\/libraries\/superfish\/superfish.js":1,"sites\/all\/modules\/contrib\/nice_menus\/js\/nice_menus.js":1,"sites\/all\/modules\/contrib\/jquery_update\/replace\/ui\/ui\/minified\/jquery.ui.accordion.min.js":1,"misc\/ajax.js":1,"sites\/all\/modules\/contrib\/jquery_update\/js\/jquery_update.js":1,"sites\/all\/modules\/highwire\/highwire\/js\/highwire.equal-heights.js":1,"sites\/all\/modules\/highwire\/highwire\/js\/highwire.panels-ajax-tab.js":1,"sites\/all\/libraries\/colorbox\/jquery.colorbox-min.js":1,"sites\/all\/modules\/contrib\/colorbox\/js\/colorbox.js":1,"sites\/all\/modules\/contrib\/colorbox\/styles\/default\/colorbox_style.js":1,"\/\/cdn.foxycart.com\/asm.ecommerce.highwire.org\/loader.js":1,"sites\/all\/modules\/contrib\/foxycart\/foxycart.js":1,"https:\/\/scholar.google.com\/scholar_js\/casa.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_log\/highwire_log.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_nps_survey\/js\/nps_survey.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_user\/js\/highwire_user_meta.js":1,"sites\/all\/modules\/contrib\/panels\/js\/panels.js":1,"sites\/all\/modules\/contrib\/panels_ajax_tab\/js\/panels_ajax_tab.js":1,"\/\/cdn.jsdelivr.net\/qtip2\/2.2.1\/jquery.qtip.min.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_article_reference_popup.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_collapsible_supplemental.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/highwire_markup_process\/js\/highwire_at_symbol.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_citation\/plugins\/content_types\/js\/highwire_citation_export.js":1,"misc\/progress.js":1,"sites\/all\/modules\/contrib\/captcha\/captcha.js":1,"misc\/textarea.js":1,"sites\/all\/modules\/contrib\/recaptcha\/js\/recaptcha.js":1,"https:\/\/www.google.com\/recaptcha\/api.js?hl=en\u0026render=explicit\u0026onload=drupalRecaptchaOnload":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/minipanel_dialog_link.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/highwire_share_dialog.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/clipboard.min.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/highwire_clipboard.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/highwire_article_nav.js":1,"sites\/all\/modules\/highwire\/highwire\/plugins\/content_types\/js\/highwire_nav_float.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_responsive\/plugins\/styles\/highwire_responsive_toggle\/highwire_responsive_toggle.js":1,"sites\/all\/modules\/contrib\/google_analytics\/googleanalytics.js":1,"sites\/all\/modules\/contrib\/panels_ajax_pane\/panels_ajax_pane.js":1,"sites\/all\/modules\/contrib\/panels_accordion\/js\/panels_accordion.js":1,"sites\/all\/modules\/highwire\/highwire\/js\/highwire.article-citation-author-tooltip.js":1,"sites\/all\/themes\/highwire\/jcore_1\/js\/theme-scripts.js":1,"sites\/all\/themes\/contrib\/omega\/omega\/js\/jquery.formalize.js":1,"sites\/all\/themes\/contrib\/omega\/omega\/js\/omega-mediaqueries.js":1,"sites\/all\/themes\/contrib\/omega\/omega\/js\/omega-equalheights.js":1,"sites\/all\/modules\/highwire\/highwire\/highwire_responsive\/js\/highwire-mediaqueries.js":1,"sites\/all\/modules\/shared\/jnl_asm_styles\/js\/asm_gtm_scripts.js":1}},"colorbox":{"opacity":"0.85","current":"{current} of {total}","previous":"\u00ab Prev","next":"Next \u00bb","close":"Close","maxWidth":"98%","maxHeight":"98%","fixed":true,"mobiledetect":true,"mobiledevicewidth":"480px"},"highwire":{"nid":"79746","apath":"\/aac\/48\/11\/4322.atom","pisa":"aac;48\/11\/4322","ac":{"\/aac\/48\/11\/4322.atom":{"access":{"full":true},"pisa_id":"","apath":"\/aac\/48\/11\/4322.atom","jcode":"aac"}},"processed":["highwire_math"],"collapsible_supplemental":{"title_expand":"\u003Ca href=\u0022#nogo\u0022 class=\u0022link-icon\u0022\u003E\u003Ci class=\u0022icon-plus\u0022\u003E\u003C\/i\u003E \u003Cspan class=\u0022title\u0022\u003EExpand view\u003C\/span\u003E\u003C\/a\u003E","title_collapse":"\u003Ca href=\u0022#nogo\u0022 class=\u0022link-icon\u0022\u003E\u003Ci class=\u0022icon-minus\u0022\u003E\u003C\/i\u003E \u003Cspan class=\u0022title\u0022\u003ECollapse view\u003C\/span\u003E\u003C\/a\u003E","title_all":"Expand all view","title_subtitle":0,"expand_all":1},"markup":[{"requested":"full-text","variant":"full-text","view":"full","pisa":"aac;48\/11\/4322"},{"requested":"full-text","variant":"full-text","view":"full","pisa":"aac;48\/11\/4322"}],"modal_window_width":"560","share_modal_width":"560","share_modal_title":"Share this Article","trendmd":{"trendmd-suggestions":"{\u0022element\u0022:\u0022#trendmd-suggestions\u0022,\u0022track_id\u0022:\u0022null\u0022}"}},"user_uid":0,"foxycart_subdomain":"asm.ecommerce.highwire.org","foxycart_always_show_cart_link":true,"hw_fc_cookie_domain":".asm.org","jcarousel":{"ajaxPath":"\/jcarousel\/ajax\/views"},"highwire_panel_tabs":[{"panel_name":"jnl_asm_tab_pdf","panel_ajax_tab":"jnl_asm_tab_pdf"}],"panel_ajax_tab":{"path":"sites\/all\/modules\/contrib\/panels_ajax_tab"},"instances":"{\u0022highwire_abstract_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:20,\u0022height\u0022:20,\u0022border\u0022:1,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-abstract-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-abstract-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022right center\u0022,\u0022my\u0022:\u0022left center\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022shift\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter click \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}},\u0022highwire_author_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:15,\u0022height\u0022:15,\u0022border\u0022:1,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-author-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-author-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022top center\u0022,\u0022my\u0022:\u0022bottom center\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}},\u0022highwire_reflinks_tooltip\u0022:{\u0022content\u0022:{\u0022text\u0022:\u0022\u0022},\u0022style\u0022:{\u0022tip\u0022:{\u0022width\u0022:15,\u0022height\u0022:15,\u0022border\u0022:1,\u0022mimic\u0022:\u0022top center\u0022,\u0022offset\u0022:0,\u0022corner\u0022:true},\u0022classes\u0022:\u0022qtip-custom hw-tooltip hw-ref-link-tooltip qtip-shadow qtip-rounded\u0022,\u0022classes_custom\u0022:\u0022hw-tooltip hw-ref-link-tooltip\u0022},\u0022position\u0022:{\u0022at\u0022:\u0022bottom left\u0022,\u0022my\u0022:\u0022top left\u0022,\u0022viewport\u0022:true,\u0022adjust\u0022:{\u0022method\u0022:\u0022flip\u0022}},\u0022show\u0022:{\u0022event\u0022:\u0022mouseenter \u0022,\u0022solo\u0022:true},\u0022hide\u0022:{\u0022event\u0022:\u0022mouseleave \u0022,\u0022fixed\u0022:1,\u0022delay\u0022:\u0022100\u0022}}}","qtipDebug":"{\u0022leaveElement\u0022:0}","highwire_foxycart_add_to_cart_link":{"apath":"\/aac\/48\/11\/4322.atom","text":"Add to Cart (%short-price)","type":"link"},"panels_ajax_pane":{"new-20":"{\u0022encrypted\u0022:\u0022{\\\u0022encrypted\\\u0022:\\\u0022sODRLCvv\\\\\\\/3+62C9DK5RJRhNWwGsPWw3nQDX9olcqQlraLCOfuSVYwx8LB0E3xH\\\\\\\/DVPrCqqLax\\\\\\\/LeNJBfmb7OBnO7MPkYxrcf4ItLBCQkr+XOgwsSWbQDhtqHqA\\\\\\\/3h2Kz1KiU1dU6\\\\\\\/KzZ6OCYhBfIUTzBtg9CdV+NMXoQAWnI4FX8Kjg55BHlNny53WuJAwQZ0mNOVYfQi6RTQis3J1c4KAi3Rbj9Oliqu5Fvdd8Wh58nxR+dsfW3crbF69Vc3qm6gMC\\\\\\\/2N5dCl9dYiu2Vnztj+qjTqlvH6jZOTAI2BfXun2JtAZ8PKdNfaNExkmtqvnKP+FPLN21ZARwDAjYXcIsUph0WzHjviCqwDi2w0wMl2\\\\\\\/Jc9nKXCiUo0VFqTVvD9KzW+v+TY2maENLS28OZ3Ak\\\\\\\/tfFpb7aFY3ZQK\\\\\\\/+KoD63D2agiAh2I2X1rNfytCC9vts\\\\\\\/LWOamg0fBaYhX0fLZ4oLtw\\\\\\\/fjxxQzJ5Yk4fkupAjb\\\\\\\/dSTu2ZOI8WLzjuuasG0GV5Sp3lh1IjbzPTAiIt\\\\\\\/9yk0eU7qGppNEoLtBbTfdTY66H+DisL9sRkbCQPVq06t74r9\\\\\\\/A9UqSy7rcF70BbD4tML3oxUVy19Qv1ClirEDqWoGlLBT2sY7Fs65oRXomxlMSuE3ux5QQdy94RnVwjcjribqG9FFQxYzl5F64pboWH4wqwFUOH9i8HxTM63TCvFyJqfHLfYUbx+TcZ\\\\\\\/mptJz7cr9DM9Fnv\\\\\\\/gPM3kw\\\\\\\/+o4SsnGaephA4m0jWlq2cFQQq+tjxJqQRpP7giZsP3LgzqN6wsijqmJbSyvn2H0kObYZIUy+YmfgXJsfO8eorWkZ7Ih5t4afsdn9ZhRVx3lWixfLVGth1DlJMc29pjHGc6O8pDp8DcXiWODfrz8rNrzQXDk++uxkL\\\\\\\/oHm1YK76JnFameSMt3SaDHsAmeNjuFqYA8DkdNP1+dOPDC1xXbLvBl2k\\\\\\\/dUQSt3WKzJaBhkAsaAGRBGwT4QPvFRz0sW8o\\\\\\\/Q1\\\\\\\/PvUGtJbUCci6Gq9he694etHWjrAL23oRhLCbaUl9X3AY6AdsWhhaMDR+3yBINIGpZPcC05hF3fwfeRhZLDwqLHCQ7fvltuTwUF2lyKRvJMy7ZNZ5ZXS0FB\\\\\\\/T8pqef8riLYEkHqihHxSbuvU\\\\\\\/VZnTSNo27y5TxNSMXAeSqYCVz8ZwP8cCDGOa3PPtdHc8xFD9lCdKNYVw+8qqMai990jElCyCioNvvuGUSC2I4GjkDltWFL5AdhF8zClEdlYccVxp9ouG0d7cebrJr8AzlfK3Fw7qA+pttasa0yXq\\\\\\\/87g86Dw++k971H7IbLgFxv\\\\\\\/Tduci222Uc45L5hQzJn+y+OtfgQANSh15PUmWFCfDLERPIYD6RlrgNBD9UHFc2+DwqHKojv5z8wDrWtQAa4S+WfiFJfGL4vUugBwEO8WkXB5+NFzjBP3AvQqwmqlOG+ALuvWTGUslipMTlWY45NCgT\\\\\\\/xJ5kdLVGOYDhWiKqdVHA8Fe7oaomfyvD+ph3I5b33QKaojW+DTR2w\\\\\\\/jBy\\\\\\\/l\\\\\\\/fOoin1TG9k7thLbdkv4cSeRWWSKAl3ZF7qWRT+kBbwtkQWt2od1yD0X1WRvionch\\\\\\\/5IbRh9gFnGTqD9tVcb+6PBoAcussEH\\\\\\\/ZB1bGLQUrRenNRVp0ke8WowdNREQFQYm8Ml2Z+u4IfQMnTw3ctTMmjNvwlJuhgrRRhwnzz8rapRYPVbGp7t0A0h9q50JobKvRRx3hzXVBlBW+CnqfIyYUGTzSvb47\\\\\\\/Bh0sXl3HqSJRIyEmzXgxtGQl1iMq0CnD2EuWoFToQ0feKjEbwIWbLd78cLVrbOafxQCr5Y5XXiwduHcx\\\\\\\/vpsKye8yT\\\\\\\/nze47CQpP9bT+MLNHxTp06e93HwdpQx5bQW0XYKt8cuu3lbVuRH49QI8JlZRVRHl2zdx2xV6z23RKS2oib+ASuwxMYYQGDrxElMlVan\\\\\\\/T3gdnJTUonxj3tsVupBE+9rtMOTBY6oD\\\\\\\/M4NAD9nZU9pcABFI2aqlXrO\\\\\\\/+9kndnHnKB816UqzpagWsydBiysCsF5w8aWNEfbz\\\\\\\/mgS4v32xZIdxZEAkDhrhsdMyzFk53F0qKsnP8oedLMgAHTHzyxQJDMFGBt1gYGM5z4nXAkpEg2SSqiW04kyYfn62IBwXzZyl06bO5DyJRcEjGGZO0KHRhZFbU\\\\\\\/HHzE42x0uDcePmb3+QCg3BIxu\\\\\\\/2bYMRtw9WhqelVrnjhwxfFcCsQlFGAlzezhnB+BV4EZpc7UhKcimzTO6lGrbSdIiMWWvS4paadK1FRWnMiVgHvIO8mUkM5MlyaT8zVThNLz8mvGZbfFRY2rnYzJMNMkBXodc0tIuLz5BOzsMV48jC5sIYeiPmgVLN9AZtvj6tAu9JiZ51E\\\u0022,\\\u0022iv\\\u0022:\\\u0022Ae1mWis1UEM+p2TgORMWfw==\\\u0022,\\\u0022salt\\\u0022:\\\u0022c61521e99d992105f48078da3e31e17d\\\u0022}\u0022,\u0022hmac\u0022:\u0022ee7c57fe4a46ffb964cc09f49e5c1b5ea7e1d0ebb8367378c33c6c72e908f37c\u0022}","new-1":"{\u0022encrypted\u0022:\u0022{\\\u0022encrypted\\\u0022:\\\u00226nDHInV06lU5aNaSfUWKH90Kxzc7+BGRxU3+xPhFJqYXPOAk\\\\\\\/bUmvLSO+BAuu0lDg6fvux0\\\\\\\/taztWvSn8W47vfCtYxsXgGZXl+Ykm6fcg\\\\\\\/knOHE8YnwSGDJSzdljlr5No\\\\\\\/cWmI0TBNAJRcn3iq\\\\\\\/bgSSLiaSfdgupJZsvPd2L4SYyLReIcvfFWAokDfhe4YwdwNdSJQrwZiVcB5ydDAr5d69W0AvZ\\\\\\\/4jG9u5Jx2WCkA8fKFcpdUXPo65XVWtbQNtXr5DnuE209Zd2hxgvAtsD8GkapbngQur5+hicUoegVHNureuYrSC\\\\\\\/bbXWA1sEe\\\\\\\/XRXizUJ+bYEwGz0Czfqw7gLN8xQVN1TQNiRRs3j7xiQAxRp7dS4ElrE\\\\\\\/d7QXgd6EZAAqbkeAm5xHtD47iSkrptbUMETP+uJ8YgxcvndFxqcENvEr4LIqBs51nzQEMsZ7vNx6PKe3\\\\\\\/N\\\\\\\/mlqI1P2cWPocyjACK0f0RGFwKHdQ9Nz70rWKAwvtglRGM5EtZFwsngSrH+\\\\\\\/jzF8vyQcH4280TANlmMGBdWF8F13qdXpfx77ycSAinIaBu50sRGBA7TW4hVC55TJiGe12sPePZD0hw9mG7PA26UpeVjobdxKBWeEwHbPkh4HEV47d4aApWRS26ahYoegcyHR3dmwhYsJz+gF7Yv+zJh6OOpnu6DFBfWI+p7nVtsKPb1FGjti5AkaWVB94BckFG8KNh\\\\\\\/8Fgu5LaPT9wCGeMBFuoClAx8YOtVuhjXAbq7UIBRx+NlpVzjVobFlJLJbuZgcGHMRqsI1IbUFnUGSYhQCt7B9SDV8kaxDpXe\\\\\\\/\\\\\\\/klRsBCHmFgGKaqh0HWrUdbwhmmPVUX4duj\\\\\\\/EBDFX1IS+gjtOvFwtLGDDux2FibClS\\\\\\\/e\\\\\\\/2CKSSHKBbZ5RmStivOB7AfeW\\\\\\\/qBwzcVa92ZB0loq9Rsrff21Q8jFbqAFWBqlLoGOehcA\\\\\\\/jD1MJYXPbmDeSO3bto2osnyE+L7I5LemIpDNS2hwGOXGzDNPZ2ITAvX5eSGrJ76LmkQgnTVPgZ48I2GC7hZjw0gmNSugw00iaSO9fV4+UJjz1YFzK3o06VCoUxiLrwQLOePPN6LZ8MV\\\\\\\/q0DZ2z4VRaE3f7URSiBVusAghsdjJFlv8meAjmU2WcnkG2C1XrTSSa3WtlR8TqbZH75aSFko3n6d5XZfCTZcElsQSNMaEICgVh4fjz8uU44OETPh3Yy7WIUXas7+YXiXReeZgk0rF01jkUqzqUCDLjBTmVcOwp6UU8wAFw4uVe8wxeKCNlsOejBAbdM2dMdRzsSugAeQOYoSQtJn1Do9AT81nlXuJrTtWGeoW22ipl2S62IqD6qadGYEVcwLzEtdW4U1xf15KSUc8F\\\\\\\/HaljBwkm\\\\\\\/Ly0HLS2qlBCoGbHyWfeHaoTbz2yv7VUI0Tx0qJ1R8k+0Ox07tikXddfejDOmZU7nKEWDeU5F4u4Gs9qUhB6a3gB\\\\\\\/YLuwXfpbR2L3KZoOmPyKUY0BuZkN0ef7IgVerZtGMdbc20GkgkTQh353DR7fwnssu+yZsLmrgiRLJ6uMCvAP1bvXEKuCiEabcbb56LaI\\\\\\\/RylRg3hxvD0aA4Zz2NJLYWNEMXLLBJmRh\\\\\\\/ESu0Ta58mXMwwdnQJVrnujkiXQko7o95I8zFgQFllKDk77p8NkPHXFAauTwXmGWqx1ngPo5MTd5eCF71I5\\\\\\\/Dbxd6x6\\\\\\\/\\\\\\\/yEc0t6muf8nGmyui8nZu1tEGis706WhiEkqjNiOR0vfU4XzLUKMnHuA3fzgxkCFx31D5bYTk4cwAO7\\\\\\\/pmpmJmLhaA\\\\\\\/8W2hUX8hpO370ucrtxnt4G5PTUfnkE2FxxHNZieib+oMbaMt5cEMZJm7JJgNS1ZLSGcyfHwryjghcHaooGMXtkhqrek+rG0kJ6HPwxy1ccnVaumMXzeoNEFTLA4xyE6TschDKA2n1a8Cer9qsZ2ky4jcnA3Zpj+FV6urDqy4hMnA0Md015DhrDqB5IHQXRtD2jnQ0421EfDYybv9YwSgNsZG5T57CFnd1MDtxhkYOeXkffmwVr3oS4BhApmNTJPzTT2aFZp6Ic+ORp\\\\\\\/HPYGFD0kmvQVXc3xzvWRuuzAeuSc6d86YTcq\\\\\\\/HEWmjxPLj1fiGuD3EhsGtqfTHEPXN3kqquD0S1UjM0b+ypBCA+q23nJl2AlHd7qnacb4+HdLBNNyMJRUOrsVm3bL38q5cxboCiiI4fMU1BPTdXwlv5Qeq0Yog0gNsiu+Xl+luQ3e6N69AmBdDbQpSyfqOnm0xcqKwI9GL7QWvsuRtqvCwkjWbBgfRgteG75hER0QG4+EiZAUWrZAeYI8HVCQULAvZZ3Z9Bp3+Y9InaM0Lfb7tyh19gId2fieAD9d2gFCMb2YtyMVvz+pUuCuwnk2yNZcaDRWsUBH1YOEoUk5l9uBpBicH59VW\\\\\\\/XXxQLMp2sy\\\\\\\/8UxXPxiNYaTRYqMyO5wJRWjE8rhpGwWQ7kdTCS1OHy1iPGLFg\\\\\\\/UiHvXKD6Sn8G6KQ7h+se\\\\\\\/T\\\\\\\/VQWsjPhokxfHPEb2fsiH8fUT7ePXTf\\\\\\\/nhUM\\\\\\\/JaTl5+iP5HaOfs6xV45wj5p7KplPqPg6sxLh\\\\\\\/Hcz0shWIW4sHNoBaK+JDXEWQKOBjeaapg9YNbe+k4U0DKvcseYEIAUYw\\\\\\\/H1gRNbmkt3vaAzTrWzV+tZ0UDj6do6MgNHb5ZyFX2ippmMTW7sjFCknshFehBGzv96INT2TOQ8XbgvHDo9TIwRNOrZ+JhXovyIOG798oikYpEZSJo2RBTErxqwDwiVJRxfMipnWYiK1hqOZmuVjf4n6yzkHJT+uWttU9F6ZnUstsmyOVTx2d1SdjKdIz8uzpdJnyUXQ5R7JPrztIl\\\\\\\/zBQoPTnvxJYcUBnwVDG4XPbwaFMcOEezG7AzZMNt5fpaa+DuI9VJv0qdii971L+WQp9l7oNI6kk1qRmdb8KKv7E8Vr6gPrhmHJQ73Fpwd+RRu4LB03sD6yXsey5hS9Ebs3xGZ+LSHjVltg\\\\\\\/BCRvKzrm16KES\\\\\\\/0Y0aYB9dpvWKjHUYq6h2m+28JPhdak\\\\\\\/gQH2BJBNknVfJmxwue+C\\\\\\\/3updlqsMM4abu7ZwigmjKkUsjoBlvztqivQiaL\\\\\\\/jxRgItVxsjQ8cNCy4rHHR6gFotZxtvnQRa76uAOXh4eQejb6gUb+M94gccKUt3XIX6sUNyO6FAYVoBYBUH7+E3yuhvnL9y6zYXIjd3pvPr8YwNMQMn4DKpcyZ2Gazvsdcn1TOnllHg0W6XiwqM3z7KDDv+0nPtmiHWrygtbshIVPZmW02M8wTTfj3ILsc\\\\\\\/\\\\\\\/L6ZlGvmLmdgT8bltn3b+MPVU4MI5YTT0Ig7VXKYmTrgmxUauttBEbeIAtsNyIuYurmFaiEG96RJwhS8vSEijtGDQS86Xlb2c+ByMJgEJz8w6Zk5B+mwl\\\\\\\/Lxpfr5RWqmbK9hUPCYwJ+wBd4IvVTAZ8ViZMY4zCTuqBPGWWGUOHJzbjkXQXE24yANyx5NXYyZImcR0ju9066n0NL8v93r1SV0vaMIiCD8HsuCvJlasDfbINL9yodzpI+peqTjRrepjYxYsEySO\\\\\\\/y86S\\\\\\\/T+wdW+JWJmYafhtKlcelZuuc9yUmBf6TXExJIG0MBqj9f\\\\\\\/xbIDvtZp47bCmHuzVAX8UoqxasypjgdV9bZNHPaRdCEiTuGg3pQkKBNLx3So+NrkV\\\\\\\/E7eDayf5k41srDTgMINZSz4PKL+R\\\\\\\/xjpI2HYn60+L7hK\\\\\\\/P\\\\\\\/x7JTHSF61ePdk\\\\\\\/IO9jH4NCfya7Hnz3UYP213+Pjn2hZE7eTUm5bcAgG3CXK9SX9F\\\\\\\/zSNLw979dgey+Jf3\\\\\\\/AK1nvUpyovhxMwt7CmN4rE37juAUzc1IgtYP2gFMPknF9LENrNK3O2+xuHQS0nstb+Vp049M8swNHmNDwXO0Q+LwTmi9rWagDpBM+Hvg4LOJpvvH+UVLmxcXi31FOQrigxLzbfil3I8Po8Mm9zMfmnDYCKuA9fdoRDub1oO5PqilO\\\\\\\/s7\\\\\\\/ssLBK26I4wB2ZihTdZwOYzxBsym1J6yIWqEkMVZ2imNeVBz\\\\\\\/nVIwGnanhvyv+D7Y4B3\\\\\\\/QF3gdRS3J3KvsHuwb89ypWtZAiONLL5\\\\\\\/CV4LevIWKW280aHoM9m70enZUc5U8FflAVEy8jvk7TmrizOcFaRT3hR2kKtIW93KHexuqz\\\\\\\/GEkYyxozwWeWa73txB2znpM9CMExtqxdCsjzmde0dli9aePmtvdn7OlY3KhwumMT\\\\\\\/oXtFvmxZbs2i+L3M5j\\\\\\\/fZKZEczO9xvwcaShSF8gAT0OEIL0IyvZrlbnICtaJ3Rq63jHQzpJg\\\\\\\/8d0Jtvrm9VEsA2dcbxd82zDIdC0hEBS3vVBNiDDIqsexvSMzgWF\\\\\\\/e6mslDl69SrXp7\\\\\\\/5fPUp+s4+JPlC\\\\\\\/qN4VwecrnEQgYX\\\\\\\/D+U4dcG16ucIGBrUiof6Tm7zCDchdXjYMw58MRC0Zz6rpPm2nS+dMtLmsgqI3VaTEyQ0OfpXk6vqmlonfcK\\\\\\\/LeoaXI9bi\\\\\\\/6ZR9o\\\\\\\/hnyQMIc0hygr7MWbDd2OarmS45B63oTPqsLehGcO1R3UFzSCIurcO9Ik4w9ZcysKvfhEKvuZEfIvDuwW+PYF3n0uwqVmchnQsi0R75LiSmRkCURNWNVZhDg7qKTruz6rVLFdYigLayvgVmhc3zWCNk3P7+4avm7CZYbWyAo3qQmMel94F7pOO\\\\\\\/1b\\\\\\\/xxokNq5NWa\\\\\\\/nTnPiPQtZK4Jf4VpubYpRu6EEzPmFNbifhA6cXDpGt3W3jKOIU1wSUY79eSWygKWrjLT9aQAkSesH5C97k03qB\\\\\\\/RS+A+3tUzV30PMW23tbVyGWM8\\\\\\\/naePurY8tf\\\\\\\/z4Fo861qNUaySpKbNvvfO2k+xttAR4TIrNgO5cKWF0cTVZZkXuRDSh95gKnLY8R4bMG2CO5fNSyxeLwjLevz\\\\\\\/VOqkc6J3xyL1Z\\\\\\\/3LTwTS+Kubr\\\\\\\/y\\\\\\\/0yUXJGPHo9EyGwI\\\\\\\/dUHy1ydE234CfYNUNpTuUBT\\\\\\\/qsPv2r3MaU\\\\\\\/eHFow7lFfG7atuN3saArEmvPgd1G4MKUQgY30U0\\\\\\\/8RzP86qpNJfnZHjoe7LAf\\\\\\\/tEeCAz0EA8jKfIwbnJQdZBqFi9j0wbHrilCPr7FsOY1MQs6xXNxVbv\\\\\\\/uEmaMsCAwYsFv2m0LaUkIwOH1w2P2aLhc1dlIZGYt2Hxh5p2eruummR\\\\\\\/lcIU5YSh2Sg9o0JotBiMkenPu0OuItBr0ikdzOEOCrrNHWb8rntViFG29PgjriuiDk1FqE7mBEHFLR6WXG8bHLd7W+pAVTxKAw44Fv4HZWTAKMsoBBY\\\\\\\/+Ah3kM7ntCRsNUsd8aOByv\\\\\\\/PPwqLlxXycf4A8WYNe7IXrSDSUyHnRnTpLZIazZnhD\\\\\\\/e37b9ry7buZwAIKRSM5qieilQW1yDZre+quR7wl5lqY7vF0no8NvOUkWgsUBZqtBJKCvt3EkIcRs+1U7XUYcSGUHpHGFatyAsNP750ZWdHPN\\\\\\\/eRqIoumal9lzlSFsuP30wtLtwnXJ\\\\\\\/wci\\\\\\\/027Te9fVT6thbD+0XhqDp6\\\\\\\/Ax3mfTcIqnJ5J+YVvrElSGOKA75m9ukAMkG57bTHdc6eZCpUYh\\\\\\\/Meme6eICk8w6M1mvljMY5bhjWoJ4a8QRSIGd5kYtjNEDLk1ztb1IIUq6\\\\\\\/jTOCatPRnyNcre3wwmzGxCAqCxgXgz9rsFPJwPize7BwYZ4+D9I5E7QnzidBHyp3Cw1XAF0HwtrO1dbR3j9QLKPRiGiHphg5aMV98j3Q4xgicNhGuds1cv6+DZ0lrP3EaYtJXpi8BojTVUv5BuORHsC\\\\\\\/h5f1tx8mrou40BOXgukD6CnT6st8DvYknkEA\\\\\\\/QOc7eHDAcOwAgv1MWSusDbvFoDW+V0NGJbD0Zb3yKlyZSjzTOuZoDwrC\\\\\\\/a+zaundrAiWAlYRV7l5ybDz6iMnI7j8+fLVJ6OO8mfy6H55GiFdPOq2poh4Krq+sCya3pVg\\\\\\\/7mNWOFVJRl023Oxry6ZQfaEPXNv609QiAAw62JRKjfvafMUqRi50VhAo0yZi+ogY8w21OhQSNLsTahEPhVm9iqbqKlCPq6JqoO4ZKBcaAEk\\\\\\\/2pacyx7PuD438DuHoQWBH\\\\\\\/8uQgGjWbsnsRNDiMKciULkMAnprpHo+LOQWJBsihToctSGvgr1LTtJRJfOzb9dteyGsDrbLoQlR7OcxfhZZcWMgSyISNgwNDponPVjZoLC+irgZ5ikXKzWJ3YolOhAvpP3wviAjjoArKyh8RY9jNxyhTJ5XqIn1WYD9YW1JGPkzrBTv3j7KqrezAenmcj1CjQl5AG6vguMBoJ2fAR5\\\\\\\/ir8mxIl7Rlhf0g1YwF72wY6dC6g88bhnmsz7IIEd8jiU8Y97foY2L7ER90xVVwmBK9CXXbKrtrFaxkPQ1ZmFH\\\\\\\/HLfhRimfQcWQOglmKGO1XI5+ZGmYHEbsHfBKzww5GDrEwYqlxPw4cOaHuGDMbf3zK4LAJOMeoJ4GUj0gBJG2qSq1L16ilz9xLBjK9XgRkFEUOdPJQeF8mEDg2iXavbNudXTa\\\\\\\/N8T39m8e6sLOJ3wYPFU2hhb96A6Wk7DgJiZx\\\\\\\/1vifnCZobYA0fkrQRlnZkhCiVqlPPhHFH73o4tE9tC1gyk6leMD8XLp8X2Wz80CYpur2RqlHao8OnpQcJgT\\\\\\\/lOeFDQHf+6\\\\\\\/CkJKFwCsAJssY4OYmv6Q+0554++mka\\\\\\\/Ql8UJ1l0AD9znCa8MFTSY3l6NTmowlC9d1y1EaynfZNEx\\\\\\\/+aIRWQTR4NIyO2WETAgWpcWrtozEN7LSxbH8iV\\\\\\\/lqf8GlJDh1ChcC5xiJ6z5LWDmUcI3V0Nr8OUuDenFX9frGdY4zOz5XTBlG\\\\\\\/133LHSulIUtSDJnkXZ6YEQT1bkkukVtxDJjeyF++qJ1lZZz9B2fcfJnFSPc84QVhkOdEfchbikE4g+ay8ofUxzKBYzyb3OlkBYqQmucMjng5ZyFgQlLnElUjRs6WexpWWFJ8gi2U9b4JF3AHwqBV0fMQM9g9CuAc+Cu9XNLQLJFoBeLepz0mqre\\\\\\\/vuEglsFG41qp0vinpVL5vrIUoImjkdBTvfpK8e74Kv8+8JigD+dgo1sDIVu42s4SF9BiERaR+i6IBTuqNvTXtVWhJg2Yc+1+ih0CsVofxZLlECPu6bmutqzAMCnb4mouj46nkj7AU51Tgc5af6e6+ZdumkSxGe4HTygulV3qJWZ4cst7qLPWysSXCX2RBTWCtTILcgbaPGyYnh3YxYo8HeJL8rX1f1VWIoLEwmCK2XPzalNg4EadW55+Zdxq6Yh+VzqX\\\\\\\/QxdUvOqkAANhhkqkNN7uipYb5hfgZZLanNdvONh01AicQGqSA4KvfmysAcTCat1p6NNjAxe16Z9Q9CEz41tqFRWicoTSeDZtZA2N+\\\\\\\/JNNlZalOD0FYe6G8di\\\\\\\/+a9oUVjTv5CPk9K7zbrmYuu9CHw1rOYDrzvCRi7Wuva6pehSxo0RWg7qNs9rc3lUIqymzg+pQ3SthKuUkUix1cYLnntpjVs57y\\\\\\\/THzdXox0xIjEdGVg\\\\\\\/dOw7gOCR7U8pmrv7IM6fcAr3HHpLMHxVSGRH4b4AOnEh7vfWckyp6gwZVyyd5DXjjVqXUyCYgE1lt2qr2rv\\\\\\\/RJ9bvdk\\\\\\\/0czRMdD6i5Oh80ElChAhFRRonNJf57mxX6FFOnuCGD4SWddPzTUgdYNfMyUZOfISzYSXhRV05CHnkQFBowQwmK2EFsYJkJNcwLN50e5IK3twNoJXQE0Yfum\\\\\\\/c8UI0JUPetfD9VKJ6jxwsJq6rxsrsG0VKKkGzNDiBNgOyKra2bvJnwas4xkLjsfdRqb7q1Z7kMchum24pppm7CXOGcJwP4yHjR+es6HHGToyUGh94Ux+xsYCex+SdkZROWqsFU6zdqsiltXaBXkEsyUyP5CF3ntNoyLkrCxhSe02+CK79RLb4Cht4Ofy3F85Z+0zlwy93gPjFdkmBrs0f7OImL0jI\\\\\\\/zsuRZvMRcN\\\\\\\/\\\\\\\/BxLp9v1DVyCW4rTrKRy\\\\\\\/6EjAepxHe1nTw5CwlFn6fJyk2cQtEYzhocdwxrVXXXpoG1WMUPqvWVra8ZYbn0rmESlTLAihjaxXa2Pby6zazMwb1hgXHPBf5sGLfCHNnIYyhjQ7xDbTv085TNGPPzlh\\\\\\\/6L\\\\\\\/UFBWF1NTabVxF+R39Ga35pLakgl4H8taJWDE87himHVNjR4SurDUCSw2ZrZKTWs1buiVLLS1zRQ4DQtWHpQ8+kzTdd28mpH6JA+EM\\\\\\\/QKJtOKvMv\\\\\\\/Mxhd+n11JdQYSUsmTwsuC1FlpDZnIVy1qyDUNYFzTU9hgfOgrcUk3Xb4AIGD8RJ929JR6EJ6k1Uj4I+cEdXhbALzzhRtTd1ubJFysdiXLX6ELTo87fF6hqbbAyrJSf9IxKu4j0hDDymxTSNHBIKhnT6OXpx75ZJspC1nvqvTWL\\\\\\\/r1x0\\\\\\\/ZLdlu1jsk58uzHVnVDjNmpgH2KzPhxQiTavfC5cQ+YY9BTdcTFd+Fei4mjVykajp5OXhyAYMup6tSRZfRHE5SjtTpVVsK7I2EpYdxHzE1Olo1q+4GqOaBJ3WZASbS16DqzV65hwaIeOEHvJjJ+LdYx5vSGXlgSJ4+z15LpZrlvevZT5gxmSooJX44uulBLy76w5dPivK+Q089hMbxEBTi9D4HHxEk4ipw+YrJL3Kuhzmdoa2hBGWnkfahao6x\\\\\\\/DSA2K4AUpuNa8YlpAj2omAfcOqrN4EzzsL2sHccGSzecZnUuH+vhq\\\\\\\/jqrt\\\\\\\/0jIxEVMnyEeKa6d7mi8qFuzeDaF\\\\\\\/7UMrwbrMBHk+3Oyk76yqmpq\\\\\\\/UicVlc6SeAiYKMWCSDm10EwCFW\\\\\\\/K2+4mJ5jB9DaZwkBfr+8n59NVklKpHWE8a3l4mFQ62yKXE5G2lhzzBUQDXx6P5k+r3kv1+XVNKStg1TsCIAttymHEX75MWgwENDqLylGLoh+uPC7+1h0MzFM4YTUnE0RcIbBT\\\\\\\/TLcAgKJ7FCNwnzH1aEWZpq6aEy\\\\\\\/YGP63qLRGgrvV7nt9JsYBwm95Y\\\\\\\/sbyaCdmrWyDsL0SCfHtgzihBhyz8CTG1dPvm2CqVgxQBE\\\\\\\/LAIc4Dx0dckziJ5bbYCdUBA0LwIgpi2N8FHHLjqQYwiuW5NXBvUkyRqYoDjzCSfYLV8LR0xY1f5oBthWIHQ6hDgkUH9aVbi91f5CLTSuUfU1\\\\\\\/g+c\\\\\\\/tThKm9V7irA67O5mBUCaBBInmZNtHCpsvGeE0R298MaLe07xJ9LlkEf16LEQP+NvBfQ3YoKnfuBEz2u7pD1QoekJgZ1O5CwpEmpYnxyRCnV17CxT9YKzOMk1GMuiWH08CDQjq6p++3fNBWW4I2As7GBLviidNZf65wRznOJOrePq94oWYim318377t6tPT4IuzdvR8vp40gjw\\\\\\\/Mu0yeIDJ5GXZmxe9Lsj85tVgQq9TMaxyEY3JoTwG1Kl43z4mKT\\\\\\\/SduED\\\\\\\/L67Nfs6OMzTuzjd2trJsb7Lozyyw6k5VT5sR8+57eObn2rAOelEJsjDcg4tvw3SVd2j5O4Ff4NKa7AKY3xSEmtAxAS\\\\\\\/QLQDi44kXag3X6s8iZwjmHTXGoaEwi4bRFkf6oVc4ZFAE+luANm5hh0232n8wLZA\\\\\\\/cwRTZ10h74\\\\\\\/lpnDUx3rhPd1Mjw4hyrfIsk14ZbNDumQN+tx+SSv\\\\\\\/uLx+89UpqEQCa1H93bpmotc3NE+TdvtSKEJhGAZUCcgJj2AdXZShoVbwyQREhJ5OpRJ1kEEU\\\\\\\/aBm1iXsWeI1JmgTcQZOjMOwro7q3AtQwGFQ63MQdRojL7ImtbzzTt7kXEtHZ9m17qF88KOVR0uuXEH9jMAal\\\\\\\/itVGrqQSzekmQzxht9EZT8XKBSQVgs5jzSLieLebAx2B9RfxHLPEWVAtjH78cs8Z\\\\\\\/yCTvGhYo5005fGQS3UtvhjR3KBOSo5LaojL4eSEM29ilwl66rwuxUaJsqtS8wzi8lbkD2Ov7GuyAFVfaR3jqGDzqVqE\\\\\\\/TKFT1hW1qs5fugDm5kjZg+RhAm\\\\\\\/5U+pVrUE+DV0JiUiArmweBcD8rV1ggGGYGywWE0Xvp5q95iLtRdARfGhucO97mwa3nJ7BcpspccIxT0pdc5b0AJwMqVaHtV7rbb2SXXQOTL6IZWIWiZ1wopN3SrcfAK2MRwIwcswitbrt538xBpMYxaqOBqUtwVMgEl0U+\\\\\\\/bj66GcH5n6fxANEyNRZRcuyhX\\\\\\\/objLHj\\\\\\\/4+Da6wSj7BFSfFM0yT8HTIoLboOFqevtV3dhsQc9A73P5rjgxlhc8xx2Rht1tBzCQP496UA2tazPdmhuDZsWpkI+gSx+zdNk0c+qQgC\\\\\\\/0GSsfTEmSESjFd\\\\\\\/kzUDXQAmBZWX65cyZ2Na831VS1lP3Q8NJCZTyQP9IBDRyXREj+dvlmxveacJd+7EBTbXHWYGHf0zqT+TM7qVaNVwCHXZPfe1N4gDazNFrvYPzwI7qPnNCXFF2q\\\\\\\/sdurhRbfrDQt0y+Xo3h\\\\\\\/Z94UGEV6lwl3V5\\\\\\\/oZnYMqamuTKTsPpruk8qi4qMrDP+N52BdkYGchul8q7Nuk+sBgTGCuz7bvknt\\\\\\\/NuKw1asNFcsdSydUhrb2mQjf\\\\\\\/4h7VMuAeLCEB5wCwHpO07D81eISXTxRJtIv+jgnvtZnVNj80fr4x9DOp6K+XVARULsPFzrCmfoZyhfKqCsmebrUK8J4k535wICUfvzWFEIlaWVSy6WIU4py4Vg7QQZuS0ffNCoj41mRGeM9pr8hBzrgYJh60ee0eBl\\\\\\\/Lq+3yV2CpB9gsXjhF1cEZgI9oPmFeuuRMGGQZh6uTyaVJweiNm25j2grDERALAVXnYuDWePDQwQ1UlFVwonLM+3WXoA5Tt12GqKmySSISYTravJbujAI8aC+W+ZZXlK6UJW1NEn58A5oDXPoYXdEOFfvzCgpe\\\\\\\/aV2o2qHrxMcSwarEVNRB26TOGo2WJ+ZdRmFhWDUy4nqCiYinJ10r\\\\\\\/1R+bdXI7n9pr8J1+gWqCpRrG1AzUwX7pDcpulufq\\\\\\\/iYWNN3gLVDGX0N55LnCbqF40Ow4CWPZ2RywPZw38Kxt8o4b9NZJLZGhDJIcC5AA4FD7jFodd6q35xK9OcoPw6FJu7LgN\\\\\\\/jdYuznqxs7LE8aWWeOIATCf0dvHjXT7VIrSuYDuJWYcdOlO7ymVTv1VbbH7BMOONxSF9PCCsue3pvcJZ8SV7M\\\\\\\/UkURRBGm\\\\\\\/i7Hf9N6n1XARLmGBlJ24l+99iIgPFo78pxQ1BaXAgoimojgBrWUNFLsv1f\\\\\\\/5gQaKXWj720jOdvrg+pMeUQM5nVXd+9DDWo79cWvjBm74qgzHS1Xj9UkGPUNgvlAcrAHEZdRQTTeeAb0x76azG5kbQHIHP\\\\\\\/1hgdioTjgk1OrQbLqwoVtGSOLb\\\\\\\/awiY\\\\\\\/Te1mZ0bz+knL\\\\\\\/O5DyjI1i4SyGOXn7LVEdYWRWic07Fado92MFW8CdLGOCrSl4g7QdHiuRdb9llZ+mX58ZOgoxMTorqVOJ0jTAXdV4rF8\\\\\\\/u5\\\\\\\/IboTtQk5Suin6yTTa6rSwfM4SUjHfTFmbcEU6qse6beG0mrm65HjiDFi0X9yis+JyF9IUOJH+ukF0X2+sHW16\\\\\\\/VLDqpNK555zKtPL7SEReY8h5Rns8g6oorb8DjQAn0r4c+Hqljn5XQtBe6Akujj7DEBUrLRt3NVOE1mfVY8zZKbilY2HH7LV829CC7oJn9vitW\\\\\\\/7DKrDc5qQIshtl+lm3PhTZg4Sx5aqQCrpGThHadtCYxLzjf8q4F81EGLkGzO+XKXgOs3Yf3LPPzMvLHLarL5F8wsQIBu6XGmkHbJ+2Ayyl2LroW6rVhJDb+344DWh7pOtKvi9KSG0+P9saU6vY0JKB5+Hqf6+btYHvdkFyxG8YGYUKnljE6I9Oq2oA35bXaI1xPkcHxJ2Pftr7LoDePdpFG1+6TnpUn5WscmB3PFeifs6amHidnBJLp5adVb20WiZa1RD5pP1Yu+AEMUH8JfRXgjR47UaxnQgfoRm6zYxL9mBNywPUngSe+MUk2mKbCNdhLVM1zdgdsc3JakZRXOhokcmMDEex47blizCARcJmDJBXxTvskfa+VheYGL6\\\\\\\/2oucrXiGyKYu7GU4dJk7+\\\\\\\/enGtI52DoKSSeIJgzzmMancb3UYmYlj6scDOsHpeTsKAeF86I6AWDXjZTO4jg+hZUHJI5+QyJnBePytOYtbJB2YepgccLY17GD5xYanA5ml3SLGgTHRHNoY3sm\\\\\\\/2JJ7bVyZQ+wTBVNndRCdmRbk\\\\\\\/mE7LD9\\\\\\\/QVnyuRG\\\\\\\/ArUNHtcray6ei4WTcKwegCxYe+I0JFznAxb9fE\\\\\\\/5LbhL01df0jtQCepGiW4l2N6ZUzP4m3OzZ7RRBWpmiJ9HaOEom8Y09uI4Lnzto\\\\\\\/KIZuHanxFeH\\\\\\\/MGI1r4pzVLeP8Hek6ZxyM5VRgQme8b7FHihVW7xTcPyaCENOCw2N0nxUr79wgzCmhpQsmdtN+wDPPl\\\\\\\/I8wFdxDo1rdC2T+JgOVTyhktjB9G\\\\\\\/Ep4mZAeoaCHRI1FSCUkYUTyl24AiXUwygJcXzBipvsI6zumTfHXCmpftu003MvFB0YgNJYCP\\\\\\\/tfOsnsKhIsuOca5YDTZWXRhRBXA8GZeA0CSM3wNza8yYFitmgsFtygZHpAxDdjbI9cNt\\\\\\\/GwKTDppibc0VR6wVr5nUqnE0disHz2v6W5YOaOSoWO4+3V17wQEcobHfb4QAeAcFFt+\\\\\\\/7eHDEyCA3DPxUptA5zBupU97jcpkluUYP6Zt10KNm\\\\\\\/z27eqqJMEsV83d0o9Pa0LrwVKk54dZek\\\\\\\/R2qAr0hPx5U+AddCAkEjyqpHY9l+MThKCjk5UdxdcAZbubStNwxlJ5nywQpSrWTp4d8i+L89AJvDkULrP8jmlbPjuxRDl2\\\\\\\/sfGhdeXG7yuFMuuvwHzaif0B5rp6l4mMA2cCPQPJwCUFIH0ZTDUAsLGqA+EdOQGoAlW+TSDKOj5wJWgLxpNuw3v5JxQaJdrV+Sr\\\\\\\/2BUwJhEFr6Lsruh24JZijtxLB0\\\\\\\/fIwJhe\\\\\\\/D5NGrNXundRY4or2\\\\\\\/wRveGBKGEBPyfB3qalq9x7ErQrAYzv9BCYjqQh+UGHO+p9xZEGdmXVE3bSkCH05y+MU8scWc0bNbfoJOXo4TuVA0rbhgGTZWvQhR8efEx5yU+OotMIIvSCAVTeBAxLcHHxSxbnMlfxOWEHEdypZcMuZ0qGJysQJgz0et\\\\\\\/ww\\\\\\\/LM6EINw1OEdSl3Ffssa1zDQGZaDfrSPk8SkO+PiTCURsBqXptk0GoV3cf7FI0CV8vUlSCPY1Uyyyv6SGREAu0N5omrOVKhaKisZGmRNFGJ73ab4YzmDj5rfCi2zENN7W3hHz28WjwbD6mHh4xqBcK1VbDxXuTblWjGdRH7exlL4jQrbLXSJJoJqiG8ADm4+fXsN6X2Z9ug3HdMybEUnOe0JoABvrB\\\\\\\/\\\\\\\/sYiKINFoVAF9PhzyRXS5tOG3PLNw8YeU+4hzk5k2CMMjepdyrGMWHDXXQYw7LCHRVUN1TRhv+taNDeKoV80EwvRgAp52z0P7GNPz47UUenuKPJbqj9V6\\\\\\\/Wrfgugeni42L2+z\\\\\\\/lDQX9xVeapTLGOdvQEeBYpLqJSfJDP8fGIbwUdPoWxuo0kAOP\\\\\\\/+F73+cscGzB\\\\\\\/XvnR4eOPn8Dqv4qeNkaDMwU4+qMbxxHSeuvYGJtJSN2psl6qi06gWolwTERAyGpA3bi1sNabBPxjdozQnmgB8MLl\\\\\\\/XnFaWvgrnPK6SS2Pcdea4+30uA3CZGvIAiUK3pYG2NnXJqmWZ2+CNZPlTK8tZOTJFrigUl3yl1KfBOJUXxbOg6yhxhDj86RSGgSBMiMLD5MnGxPzCKGFGprap\\\\\\\/naA+DGOi6fH5h3viOd2bbJJtlYXYyVEkk8eeGf4gRrI1UrlVygHal7vTVb2h7Jm9xSg1H2Tg7s5S3RlCuXt6pVn17K3at2SeTD9cAgOq5WKVg17kw8vB7iuxsbXpSUp2KnG5\\\\\\\/YxcOhWXh8c1TMSLZ8M3GQBlL6PFkINmQYpDNBkM8W5c6HiwI73rbysK8cFCXR19z4ACY+SMaLwt\\\\\\\/KNz+zcCOVfcGorsXouBlzmf53g3CkA\\\\\\\/BDmsdPLXIPj6XhNjBLDbw9H1aBK0jhauaZRexxtuc2I3xkcZ+YXL7ZghtUUJIQtTs\\\\\\\/cAAhRK56UITcfx1xOmoa1SRHugQi9Nt0MjrZSzBGaImZOA\\\\\\\/WhsPBLkWWlmK3YsNachKGbZBW8oC3qYDpylO9g1cXyqowMNmNOYkOLFGz1stWBknRU23Ad4ORWUMqbn1pm2ShkbDuRBMtTGMygk4BVZB4rzClOThtp9ApMv8OQ+cbGEV6qlIR2EFIO1\\\\\\\/6yjI0HGlHrmhQACjXyl4K9moB3jBHjGCoJVt9tRQR0mO5DOLh4zVRp8yEP0DktNdCIqUWRjuL4IBP\\\\\\\/CyGmg7C\\\\\\\/ieM1Qajwm48wn7qEnTc10RNRLcCiPSHsaL5yfnkUmLwpv0ogAaK+Qtve7af1055JKrjekPRoCphm\\\\\\\/UOmgSu4PdIgibr\\\\\\\/WwEvBpmSkQlrVWJLGq+S25kaZLkmLtgwvAMQ0wjUcysVoBMN8lVuNzdJ\\\\\\\/hp3uD+rQsKYm2XAC8EWpI5hpd0K2xJmvE29QqZoiEc1B3MNkdk\\\\\\\/cbWvbp+yFEm\\\\\\\/uM4DARJVMBwogdHT4UFhw1VWoBSUW8x9KIJXy3Idc255qvMUGTC\\\\\\\/546uJKQC9+V6I4MnHXB\\\\\\\/iz+tQiE8QuS5uBnXM110QdiKsGspaYEwUkpNrcmo5qp3K0SosxLFdgcUi9j57iiVzAfZwBfTTUCEAfPJ4LevIzVzZyTzN7fjoxskv5Nh6PdoNg3tW78uHpnVVdgzXqP01jQzg2iEYDmoOHerSLF8TdHZtgvuAkATEqNmA45y1uGUW3oRosBmdvemp1fAoItYaboWGS7XUESvkuhqN9L3mAFisx+PzI4zGee38hkyp3X10EobQ0MumcSdRLRTHVTQJtuG1OAe6zdioL\\\\\\\/TxY1SAHb0pm\\\\\\\/4i8ZhKHiLCoH+T27qa7RFmVugWNgTlXABuJRdy1nyPHOJcHWcN6AUSfv2c4DKd9f3FaxigtSqPR51QN2aVm0Noj9VN6ke7UvG5VJK97m93zqW0erMWCk0zR2F5mhZp3OZR7lBelxYygDxLxSrmEmIMMgMGQQIV4Zmn7yhqGVuILTV49d3ZLs+kN+b08wG8OfyRTu8BelER6dgNy40XiafY89WYAtU5SuO4qga95yt3hnT\\\\\\\/RLGv2hAvMNopgYnAEUZebamaMdmtqqElzGuuCyWoEK3P4eLojdcxqXP\\\\\\\/5KTn1bwPEGpSJsUMo3pCVEni0NatvjUD78zMkfXKIHXZFQu0pYLW7sSCPyiCjcVnWAy1+dYSubVhhJ3SX7+FXQIkcYkqPNWxy0o5BLkXB3GCEbIvlv2J7Gu2IaIQcElZ1URvIryhbxMdx0uyD7A\\\\\\\/n2lx3NtNAasI8gz30rfC4Alt0ha+QVTNLu33xz\\\\\\\/VUk9JPNGwDzvU4E0rIIzedwEFkMak9L4U2DWTyVLt\\\\\\\/+tyiiricwx1qImYxUEt7Zljg21fJGlvMNrAbCG\\\\\\\/0\\\\\\\/598V\\\\\\\/zvpwk2ew+RfW9C22lSpg3frf44dMc\\\\\\\/lo\\\\\\\/BtI0wEFPpRvmBmWxluiLXXB1cs2rhXx6yvM61uowsYdd8DKeXTIZkrUZohW9fkee\\\\\\\/VttGqatVPGG+WAGt1Ajv5tzQFP8DFkchP4tNNdIJZdHFBxldPXZ8bpiydQr+jgwf93hEO4PwLCR0s0C9p2wItmcAhYzvhvaXnGhLIiEqix6+0tUFGLx2Os2Jgg1KJZAhzyQjJ2DMnr4cdhcCCgO9N\\\\\\\/2VPhSrEig3Clr6WjUonDpH4bItaSAps\\\\\\\/iQ2\\\\\\\/oRQFGRiMmaBPx1BLZpbzmE2+os0wg3zuuIufoiMIMnwCtVyjZ5vgubhNqe5jQ0PUag8EPfie5YHogDdV0K4J9\\\\\\\/8UuO0LJHaovuBKb9orNlVekcIOP5X3sLA1eHz9RFQ639tYgqM7Wzqe2+LpcbpKeo3FwGXlxypxJ7QYBRS1hdwxIyPhsUdHfDGHyER0KNBtx3hpGRCtnvRn80Cg+DubX4OVdaid7BuWcIo931kqudGSb96lLmLe14iMXjXIBhCiEbT2Abm073usoUz838lx3EFmLJ1fl8U5vw1qBUhAdY33sAek+ii+1HdfrtxaSl7OZhlGEWOfEbkETmNctnJdMglz9e7py9P3xBnd4Z4JB\\\\\\\/aiW\\\\\\\/SL6X+todQhJ8P4Y8CiqGRn8CjSg7Bfr8pEWN6JzTl7ScujeibIeNG0CG5fGA355ZuIQomMbOKabtTkkTUl+Y8GvHyV+HXH1CslcM3gP1oS+YWrVjoV5D8d\\\\\\\/e0IvKjzu0oZCZJrRRjVE0Ht4n74AF08\\\\\\\/W4ooitw6CihKyKCKsLVSJzWZpH3kgM131L0Mw2hwX56WxLbmXcTQoKil5bwmEv4uY0qaMWxl5f6kGr+1X58K0VCNABrj5PT6sUHJVDPKnGIrIw9rWo0gFInJ1VsMPOMR2Nb7OB2B1mHDCUwXtZY6G5uNKlT9vu7L43toQhha4ITGVwcmc6t1tOAgY\\\\\\\/ZgvDz7jsYJqDH03+wAi8b24P8OwIaDxz4XHa5oRqdND9\\\\\\\/QhY3QCt5NCkZ\\\\\\\/UBCbcsANoJzFlVQgr7Gt2Xol\\\\\\\/6uFhsxYS12n8sMioivVFu98a8vOC\\\\\\\/NcM09u1ZB+9\\\\\\\/JzGL8\\\\\\\/Q4WhkrkR\\\\\\\/6NazgLPEMiwcLHpDDBPsv9L\\\\\\\/yPKM4fo04LLWr5nQW3PkdwI8jVTilWlAQ12elPR32SdAUssPpaACi0wOArma5ujXCU1e3yMD5Qx\\\\\\\/wFN8m8aIk\\\\\\\/P6K629tFW+FoKsKjDKbKHAqCtY0w+6l6ZM\\\\\\\/1yieSN5wqhP5IgAEl7W+cLTx20vj1teIUCgyXl2\\\\\\\/qo0GCI0LHsDcxt1ZZxBgkQQw4nPXfnPlhEkjbimgdL+mEghtiGo34nXL9yDI\\\\\\\/BptIoC3Dqiz7dtInl\\\\\\\/Ri68Keabcj5i67evdbCzh8B\\\\\\\/9MMcgVJA2Un+SoSWs0\\\\\\\/arzqWeSq4IeYD+bIC60JRCNK08Dl7oiYh1Q2i9GwbQjpl6n4ZxwIYCHXJCPiurSLobueN7dlGKNglU+9VebDkDb9QynbwwAXE\\\\\\\/+9HQcHIEESqUGuzQt2ZM4m4qn76sHjhpabdv67miRzg97tB7QkrIZkOv8LiP8v+\\\\\\\/EEgU8kJpJ8YJ1lOMVTsMS74J847qVKDp+hTRQNPXPsY60ov3Ja+adkvElpBOUGwhBbJxhuT0xSGYQ891JMjHtp9Bzz4NvUEYrcn5RWECyiYaRasAKUzxj8\\\\\\\/IKO\\\\\\\/8wT6ORnCYfVuTgZzbZThbUW6hzqW6QPn63i5nqsPSqcrKg60iv5xq1A7ioletZNtSWJPll+3o8hqkXMhA6gzN0A3f5vsq4AdeyX9sQtvpnMolWGCxCXzDK83jHN4rYe1YTxZMpIStTBmKi2NkmG2n5oBXyIQDXBzWS8pdnHOchhclF0prRVQDLTk7iiaevIzDRzftpzH4nn9BwTzrfCWdG4TXidM5y9xAwA\\\\\\\/UWTLAIcSwNCimJvWylVVHFyAIJY13TgCQ1rwMQAVkddgZvjQQscFRTwLrGxqcIzY5Y9yiuB4kvpr+jxEP5LBtAtDF9TCMIzqWia9mfrUzZCNoUX5ifh\\\\\\\/UIsii2sOsawm9AtxuOFxQFyu1z19Dn\\\\\\\/ILo8xOTcR0L8Ck0q0fl82Aqf+ZOai\\\\\\\/iXCNc\\\\\\\/tgvUHdeWkpa\\\\\\\/2G7+k36gvu3Kjq+n\\\\\\\/yjneAb44V\\\\\\\/UfCQiOCROZpkzz+7de6mdb98suebdOQrjW1Zog8xJRiVpPWy\\\\\\\/JQOBMk5+zpXanaUE5rP+cIJRDF4Sxh9qHOGerA5drIx50XpzlCfrs0+t4UeZmuhoMK1sPMEeEed5iPLFc8yH6akTIjnfNuQGdqGz45aWiESnkdEMm7Ndi+2aFqOUKNwmsyLiqA0UJh\\\\\\\/aEI+2pJYBjJKDL+YqobEyAvZwrN0d4rihh5cuAmNvni34FtzhdKVzFT35sjw9tdwjlFZMAtvpY1wUEzWG5zu631G9suZmfLCq6kOzjxMy0dYTLvGny8A0IkCHMvjE0Ar4JLpJC1PqRR4tSx0yUWYZwK2lqJqzgLPEMLFbJaoLzGt1CrPwKF2q\\\\\\\/wlGXfH0EWB5sAZt\\\\\\\/5CwCxtTZct2G\\\\\\\/7LeVP6G9X4mQwfWBqRrA2agVnZQNO5veXUyKrIqKI+sPjsB9apeTDClc0dLE8AJPQjeVW7Rl13HTg9zWN4GvSqTHHK6rc6A58V9eFPKTIc0bf7jwFCBonMavI1eraiyDP074MPHeFq\\\\\\\/lNKUFDzJiPUWd7wTmfO336da4m8N4RWFTY7mTWvHQik7nY5pRXgNkpibBySGHsLhwAnCm1rq\\\\\\\/2ThIUvVoX3Woq9i23ct96HnynXXMQUMWX51SIQHR9kTLTFf0gljsj2xiHr+Qh2rvjvGqzPgUdeVizwPU5IxDLQOTtBPaAOdUeaeP7hmFq9ThDgLPUt7zua5nzuFGiXurdsd4wNhZohSHt70KUHAb0NZw+SZRqOHAMyutsuAz6LBUUcnpYHrRT0b04eipCYXP2B0bEQ25tZM6fmNjf1dds9WvbPfgVGXKkBtmgZxhKGV3tkMRN1bAy4Hm1+4JLJuzDhbCd0xU4iYgEbOjgtbenLxnP6G7OccoNTsEPG7mboCCH2vV\\\\\\\/j+DiEOYk6Sz\\\\\\\/vlKLd\\\\\\\/m\\\\\\\/aNoYQH9FWFvpNo5hcmEfPIZ7afXV1YQp8vjbRv8ns2CER8xv4Iq2ZPsR\\\\\\\/kvanrUWyOrnR+Kn1aLbYpVffQ55MTwFXpSZlnQzEigkDtIVA1+COmdhgt14H3bvumkEFdNWFqEi0Frcma+3zYmJVn9oR0Tg66PtAVi57iyxa2zfqFh1XnST9z\\\\\\\/E4xteb3fm+KDnliz1LG593y\\\\\\\/VBGE17EFnyWjTNRdRXxoIN5U6SI9xTnYnzag3eD4\\\\\\\/K3czhOv\\\\\\\/Ednq8KfBnIa7J\\\\\\\/9qAvXZJXaSMq\\\\\\\/bjyj0hE3t89e+mgDLcba2oLu87VyiMy1SJ3\\\\\\\/YIbnwdE0plCxR2+ganvVbmac+yd5HNuCVmqzt9rEJ5qOiRxpIkeOjxOBSkHOl6TlPHNRHtk1WHHhPbbfDUJzd4FyDlc83b0HgwcX42m3jnP7jq3RmktlVXkD9nRQ4zMVruITZflaB8w4M3AdJn6AwhYgEi0Y5Jpmcj5rpVvFZV54TuQYbx\\\\\\\/G7eSe8cEcWccyDjHDMw4oBAUWkL5uwkwKXd5T47+CQJjpz4ZuLRLEGn5YDl6MRDpshM7OvTeA2+y+ZcloitFBK86na2N80OFKyJJnkPCNsb\\\\\\\/esePAW6P6W4sTK84NgB0cVV5b5ybbKWiGKjfxEP4+28Z9Rw9WqHVbbBJvUQO7vdAGH80mZVPS3WLd5E4b1eXa2\\\\\\\/NYbq6Qwq0\\\\\\\/4o5UnWZol9aLrvrfJ8jnWk+BGWg5dlzw2ARvTY2sQor\\\\\\\/ql\\\\\\\/5nAjeA0igjNfEm8+Ig9bgIhulmszR0LDcViDN4qZ4qx28EUiGpkfqsvoXm82O6etsrAZCn3eP0+EQ8joLeECP8dQhgGbpZ6nkVfbqv4YDXVChCghYz5297Lx01gHBmeopwCjD52jU47d02VGFTtRewj8YspAo6mg\\\\\\\/7eIPv2oW\\\\\\\/p+LOU6Lpxw4B5EdvGxPVjIufeFRt5\\\\\\\/GtCB4kW+dkfk10yrl1G1H+NmUBczwo1Sadn4Ohv0pPNpzGyb76Ai05zrpTsPnahYOSgPqRSvAW0kqWjpqp2YyAGtdwxyYfCfK6xG5OMdUSo\\\\\\\/isytiwyc3TwaAwpxB0wywbmWZmuvsNuygkwfAJdJceKaZphjZpiWD76LSZLgsiSbyp27Li7t\\\\\\\/JDUn2\\\\\\\/mMpZBmOH9DSeVCcPeT3nIF3D5CxzUSdjIPIvh\\\\\\\/FTZ1qW9guKrXVly1WKSwBwftv+mBj2cKHgGPtn+1D+MT28rjVdMU2eC4k2DYue7jkXOX4ln5zIBUpNDryzJ1F9wX+mkMFxClM2\\\\\\\/vRMaOCin9P5\\\\\\\/MT89Eu8UX7cDzVARFN6u148KHGthi1HLe8x2zmbUYwbBXkCjkTtOyxOHcbvAYGJvGcAlQX7Fu7Mi\\\\\\\/DJEK9i29YdsZRoKj48EmgevuwAVIdpKa0OCAu++VvnHrSUAIVwE7pv65nENdxhhzrbZkKZP1o4QOS7KI2jz7mmwDmBK4UUXggRwUeXc5uQfGPLghRPEUh5yGdNqsjvbDApAoEeWtda4o7MpLZxieaQL7LesEuFLSiEQUZt+U8z\\\\\\\/el5rv+i7JLVMHJyGOcB6\\\\\\\/uNz678OuuHjceHd8nWbNsEKdRWKznOlo6PoB8F\\\\\\\/RyZyEPGwkmskVukKuWatDdfhKBufJBq5eHBOvrLrPlvQ5dY1tAXzJgDl9Fy7ZZ4GKJltpm6rsggUUAIg4+K\\\\\\\/Ud6UFx3iqOBuKxc8Q5fJhmhFN7FpDSsvgby5ncVjA9DMcrsKkOVdOwGtiGru2GzntzXmIV9y9YZWkKGZFbyb+O3MQH6XfjdToJ4AC01wY+dM35pD3gloqk0+FCaufkHlgJ1lWAsBSp4K\\\\\\\/5MaqoHr51YhdhgxYovXgeikUSARRNpG8ZNiYBGZ6Iy\\\\\\\/5rnY9hfS6mpFZn74RAkBeF6GxDswvyjhAjAmjeEglk0qQOYkpUxRpQp2xnx4OXQj\\\\\\\/VyqTfHUf\\\\\\\/Ql4deNN92wiOQq4X8JIpkhJ8oROcjtI3Qa6j07z\\\\\\\/aLjgeFAbmUafMnUAIYiWKpF2\\\\\\\/bLf\\\\\\\/xEuZ7EaWeQ58LsMRNRwSopqimbMn0KIzZ8BG4StQHyLuvIW\\\\\\\/yhoQZozEfhk\\\\\\\/RrhwlRNTeBiUFtsdzAKfWw\\\\\\\/\\\\\\\/EbxbJzV8LPa519Pwnp43fZq1ijF\\\\\\\/Te4wJQsqEWy1XYQC6CR6y1QXOTTvyPUjA8ir5cKIN4AFGFqYUSMabPiw3kkjFCWD0QNeUlcsjP5Sqk8pnajnu77ilpqm9WML\\\\\\\/y33cgvvcTKkfe4t2PkhN4nbaKSdOeiowsVVUVmozAWgV\\\\\\\/q5K50z1mmi9XDWIydBZVGlJWg6YcLt6OfmCppICMg+zlafQr7w5j16RBFIZpPNDPf7hZbd6grmEbmjQ+oblSubgEYOIJn1+ElITqCCJ4Pt8wfy1EhU14Fp3+M9JkAjfNXBaAWSQYzR+0kNOy54\\\\\\\/\\\\\\\/2fzjxv7F8Dwbia4091Z3RQfyBXiyG5qJt2gNxTv8IRityPnaB3Wnq4OT8k+P\\\\\\\/Er8U76bvc+53sC5uY18x26fQvaTZO\\\\\\\/ikyB825XJLoZeRNLfIXwC9XvgJzfUA\\\\\\\/ST0uHLJjNVre3YQaadvpUpQf63uImIAsPzbcVDfDPUczpURzE25+lat4fbUMdGe1ZybPhxKuzQtGgt\\\\\\\/\\\\\\\/+lajldOPQwOshgS1D5TrFB159HExbLM+BEUy5zltg2Va\\\\\\\/8UwMeHxn5Zx1dI5aCEY+a2ruGZ0m+C9MbXBixXwjVTR7NKjTnd5o5YpN9o7zsQL4e6Hm\\\\\\\/qoju+613lYQWxdNgMYm5VtUbuCoeGwRdBVwTpBl3JXClDkShg1sYPpM852pRl55lqmzKkQ1qeDqFTDpGCv6DJxqqpHMZS5ho9JWKpNP2POVqdKty2xmmWG272dArNxxg5\\\\\\\/FkAK29QnjPoX4aBdl3vcgyjRAbUQvIDvs6VoC2k16shBJ05dF9p61dvaJsnCYdUTdb64use3LBV7YtKcufjUgzEMrH\\\\\\\/gRM1i70T8KAoYjidloSCzIW0Y\\\\\\\/J3eMMipqCLc36\\\\\\\/T53S2+A0SYGNk5mCSeGfVew1unQVnayEvXuEeY73Z65DfstKF1CBN3n80R1ZGqkEvqIEvq8dlXu95\\\\\\\/Bls\\\\\\\/oDe+VAZPucjtuYPm6ODHlZ3Dd8AjQSwzn0fZVntdTmaL6TUCrs9HLZrpc1Ubq\\\\\\\/8VC5o+vw7g8f7vgz0WZvYzJiaZz5GoP942StA3\\\\\\\/tkfZjRQx\\\\\\\/MQotmhAU8goSjTw2uLWb6BiJVN\\\\\\\/swmluxz533ab5l1URPWD+wKPGe4GOm00lGQQzsCVN10tfaSeeo\\\\\\\/\\\\\\\/N4zKghYj00N0r5YSRV1XiCuAyrAimuXcpKsGmXtOWkaVI1bE8+EGkNTLUIkMkfVfgPLknsbS3N23vNIjYHngNdQw9Y2dMwtdPh8hqwKRKGg3V8q3XJVE0uHnvAYJMQIGNnAYoXFVpx917keTd85NDtBVgFT9G5X974eUVTV4Fv2wNJScSlHluIR3gZyiYLubODgWJKcHyo27OLdfwyQQn5MOvjQY9ZU0wqYHYAIWxZvrcExIjR8nrijVF5QwUKPf908+6stM0HG6Gx1xEWlQM7Xek19nryhv\\\\\\\/p9LUYSMX8uK+XEugre3e2hzN0k229WwcrJTpSoZeHaA2F+1fFS0Rl5VvE6lW8dukAdqHbMCTlQYsIj9\\\\\\\/I2OR9g7r8zL\\\\\\\/OZyFwZW2xvzaLnPdXbA+rkFSrZDtUYC58vVCtHy9UpeWVoxLsdDAOZKU7NdOdsJd9GYUATfxRPAppzEZ9P9RWI9QnQPNCu5YvQZqUysa9M64i15u2IIEabUqPO0AEUKnZnVT51tsOivsb9U3+wT2lWwf97MNdPagm+fne0bgL+GRbWI9XljM9KO52o+Km71miQfFwx7CGukCQH+YWKMuEfpISzcm5qqr5oSVPYOWOIDoImOJCQMVjWsc5umzbcBcjesvV2x2n94cnsjZzFAIscrbGNH34eEXQkFc7guJN6+dOQRs0IIMjbsg6zZXFjZHN6sBet5cHzYmWnf1bsmzBwsijlxfoOzZ\\\\\\\/qj6VR6cEty9EVlt36w0XmTnaDHWehMSm7Im9aY+NCujA+s+prdtnm6YKRuhMcJoKLnolu+voDs\\\\\\\/hXhU7pir+uIRTesDWsBRLHWrlLFq8l0ET4DiM47Z66yGS9E2srI2c637Pb6tbQ53qjqGHfdOdsUTMsa6Yg3r1+lMNqU72NWFAFPnFIh+1l8WtQVug9rUNPS4IgLeyK06up8AfRPU4TdaOzrPL\\\\\\\/PEmXmblTrqYme3fYIszhZYTXJS1VA+jQC6tEjeAJ14FYaYkwye1bSMdBJIO8ZxyYeMrZMKc0wUjILvGOYj8HVENNDRNFmYwcT3D8sYrfOK7o7D9luR+2FqCOE8w6HTueAKoGb9aKs5e424qK3\\\\\\\/j\\\\\\\/GdqQhzp37\\\\\\\/ZD4tgxkH+RWdyqMqGMNvx8m8uRosPLTjMLYZTGoGFqzIGoIQVVFARa50fdbIHt1ZdFE\\\\\\\/IQE88aJNa+bV0Eyc+iM1rvpiO2L\\\\\\\/LVMios2Dj9rOsrTXcgZy5PhMnyhGxMZl1+a1Wh2GbC3hB3mCMRDN8OWcUOYaUo1H9T67neRynan7VIQM3LASo\\\\\\\/w2ZYd\\\\\\\/dlefsw\\\\\\\/Ckn2fW9cl3tV5o6I90qNK\\\\\\\/8JE7cfuauNrDCerKe7oO5pn+NM5wgH7KGHb0T1GEzlDHB3ff4KsQh8u5V2eWZdMJAvf4OFyrUdEGW3ndNk9QEVdyc94GdMU0B362MAfc3cmw2W+fzUs8kirrPGUvejeA13vCAiNVCBOfUOfsz3qrjqOEqIynq3ydeO5vc4MZVHSpxW18Xb+Xp5iouD3p2QD+Z6G2AiPofpyjh31hjTUzwuIo\\\\\\\/WkF1La5CO7hgWxQspq1UqkBp8Pl7TyyP\\\\\\\/v1nYJzfRz1uY\\\\\\\/qG5f1SXB5p6FBgjC37Rcy+\\\\\\\/Tl\\\\\\\/58C9+YbrXXqdIuKIVo6ZRFlsa4LcGdV7srV4RYR5As4EuDA6B86jdIgT5Q50Q7YrZ+shFKlYHFcKGQ0QzfLis8THyqvOFpM3HrQ+Dbd4opr5KoMagzFN2D2o+fsmz6An8QsxFp1kCJ\\\\\\\/4GlSKZfWGL0ZuO9Dx6qDal0YVV49z9luYE\\\\\\\/g\\\\\\\/yk3Gq6FVSN3bPpyVBw9LgltlPnpNWa4DdwF7cFicYYH03YWxLEu2GYR8UvVsIrNoVt8z3eNMRRsqQQ9gc8SGBuSYg2HMYerDb+ab6xDWaZv8U9Xsf3JI6AnJ\\\\\\\/ke4XfcAMkmTFL\\\\\\\/22IjZv2ouEtcqC2j6BoKnub2q72FWJls3JT33daz9kZ2Qewv1bLWSd7k0Yw7YD0IaNl0jdNPof1eqxCI9i5UFsvCyub8jGaDs7ulK4rGnBVIMn3EdIqxCpMV1c1GQb1mcNNU8vWjrqbK\\\\\\\/70tVSDlORRBmhrD+1eTjhBeynqjnBAvEynccPYBW+CgMiXnsEOd0xa2SyrX7NVx+\\\\\\\/M3dT5Hvc3eNIje34uyCxc2wFai8wsx5rGZC9F27v0\\\\\\\/Xc\\\\\\\/4ZiQ2uH09bES\\\\\\\/aGZf54oh\\\\\\\/Y3e\\\\\\\/ESBHSQJLae52+ynMBSVvmIWdy5w1jpN\\\\\\\/NeyE+tvUk4Y4OGT1Fe5JCvHuSudoqEW\\\\\\\/w7UTLFhN+ex5dLW6z0k2q74MV06o3rYEcU7a3BziE6jl1YYknrBU1489DoKQG6Gx\\\\\\\/XXifAcZnWq9GiG\\\\\\\/SWyLrk2joocSAjBr+eJHhF8woIMDHHpcHZObX6dMsR1034vXOSwd9zb3f7q\\\\\\\/JLg6bIMKKFslG+bNglpqG5A7jXEvDm2S1397LqDIxejOB2J7EAMRAjE8cFlbzhqig1Cd8b0Q4Il0zWkLJ8cVpKXJhTIxFOvFIVseJbw1a2djp6entw+6b58fGhP7y4fYyJTc5HLX\\\\\\\/RToJvS2MfLekMwNzfUNW8PzVLR5VaSKlC38uPa3A\\\\\\\/aNOpJgqkaq6DJ988aB6WN7Tzgboo5aRrEKP1meAmUds1opqqSuZ\\\\\\\/SsYD18S40kbPYfMyL2\\\\\\\/FNmZWcGRWUKfkws7gI1s3DBP4D5xkIUsNFyCIkqlN9TdBQ++L\\\\\\\/zINCKdQuqgt9NJi4WiFGGgW6moA+u5OG1dI\\\\\\\/ydBwmE\\\\\\\/3FE\\\\\\\/FPNzBwdEwA29J0fh2BqH9YL2x0WgamxVBLkDXX+EKpkiBocxbMa1zzH9yW6FIR14RWlYi1UZsK2fE\\\\\\\/2NjXxW1JglSiyOd26GnDGQ6Fo515F5QCogrFU+J6yXgdFgPwxsEnpd0KS8JURq93foJLR16Uz+k4XmPkVP6WHKqdU06Hr5Wy+FOjWTrr4n0OUp4wMTHYiczg0mGuwQMiV+708O34MqeaBK4VZb9ZL02mBreanjnRFj4xyoS0FNA8QzoHIlmBGKofqIwRBx3UXeNJ4dwkmBfV56cu0Do\\\\\\\/ciwrcawB4ywbJR0HvxmhSMLkJUE+6v3ez9Jc4xxyhXB3if+KPicaQ6hlY8HBT5UxHYi6JrN9ZVQuPkSHwUIVEW0PoESQPxqSZOV7fmYLTWpzyZhKmVmtLrmgpp\\\\\\\/65O1PFZoadqElwZOBqtiYzuWPJ3SqqgHxJbs3Ra9Rcpt+UdW4KQVobUDoxHv2tM2XOI5tPeuO0AFCEUrcSfOhVl63dolyPDtalXNLu6\\\\\\\/LNitRxdhxbMCoB850e2mk\\\\\\\/sBEyMHCeQk8BEcqD69ZsldyondAe9ZLkBBTIpbGysjPS5HktMggBLi3LIMM4CRRVEm\\\\\\\/R9lZsiLW79taFC+Ovj5TiS1k6UYTW2FeEkH2ZrAsWe6oOwAWAadSTsdybI64EXfmg5dOfAXfGZhT7U5Qwhf63YOmRUeVCkJTWB1hQdg5k\\\\\\\/P6dEnoKWcNjq30f6pAws0J+kRXEAG8TDw0wE4EIahPT+1v1lTuVwPZWMDfmZC0ZJl9l15bY4a6T5VEmCN4j+YZL9xvXQQDXV\\\\\\\/AeXLBZCOdR17rtQK0ZKT32Cg0RQD5TW0ZCPTu+0SbSkXSFZuvMQ6+\\\\\\\/RFHAIc0047f4WIT2o\\\\\\\/noD5cfzZondlI8DA49Ty+QjeFO11siWlXbOeVyatikBp5tABxUmkyNbHz1ri\\\\\\\/wjScw7HWrOb\\\\\\\/sHS\\\\\\\/pPs4BaQpr21FOphLXwxrX7xSaUJDS3uEFLSd8G2exEB7lQQB3kpLbTjepH6im7HFe8X0TqHLQ\\\\\\\/W987GeDSYfUtZ0JUC3hRvlezhGKoMpRnWmL\\\\\\\/qJ0Xl18IbFL51HcitNiD7Rbcb2jHG05Md4uSYTqPnXXnDubgtn8g+D9IKlkcd7lr2x0wn0eReRLNAMZyU0Oa45bxNfF2xj0tZuKOSKFe5hlfI5epG9ri1WksDaOfXHiy7O83ZE+KxLWMrdDojd\\\\\\\/cigniLTNX6Mf09rCF14IDyYxrVwrjDVqIu8ACf+B5As6xpWUWv7FS+qnCbi2dPJ13sqZHd5QLvnzMgMwbg9SjcEtYqGTx4DSpHBpBBob2wpoh+DNr0zD7ZnAVc1Nh2CGurhXnkNg7JA9PEfHTaN9OzmxpbZiHLf0FjrIX5M5YK5nfODR2I5f\\\\\\\/DGslR7jju\\\\\\\/Hl7DaHggH+tv2JIPmBYmUZqzOrQI5dA0P6St6YLyk66RmM6ry+2AqoDwfZTDP3WshZPdX37i2FB4ZYlvtEeyUwDBTGfao9vw2NamJvWEKwyOwSwrJmkkpA8fPSBfX9DElvvUiutox0S1Jb7RSyhZM1YqAigKycKWCMy0JTXWU7UQNmrxHiqAznTKXhXur7MFTEePFORIhvbg89wNDGwk4Abu4MbqDCGmJu69VXrcVVd6xM8gLeYNpjybG3bVJgQnhlGmVDoSUCxS7iR3BDqyY9ALu\\\\\\\/ElizQFDIk78YYRFF83Bf\\\\\\\/Iq\\\\\\\/drV7UPRsLAQBHnHI2Cl5TEs5j4HkfwDxOa3ngGPGDjGTzQ4cncPD1QyPix0dFgotOXer7DYj6d\\\\\\\/0ZWbImMD\\\\\\\/4qzOsHnToJdUYLpI4oE8VSb9pztTbumsVmv+6vufz8FNcM+ribuNavPjELAPjc7Cv+CdIDLW\\\\\\\/YqGqKsTy8+GZf3DD3JqwGfNmBPqbMb1Y9O3Pi+bHNZ3SyKwqdy+qJAjVfBtXloTaPTidxmOJkHj8GDlBO7IkfprADHijemMpTlEhD8rxjf5JVaxtWJRCmQ5ok3sG7cRhmazwz7iD4fCYHasLChdGIZMcGjcfTxcy53fR+syLhePfbl5lSpB+HdTlSkYikw2dfZu6+hBIy2wScuvlfCecBeTYvfexLnjsg8wPILhpcAbRp\\\\\\\/\\\\\\\/MM64b4f6Ppefb7bxUwt\\\\\\\/Ov9Ocw0V8kP1kI209HAj9vrUuSLZ7h13uK2ITuowSNtfhHA7SSRK+HyM31ITC9GyXNIkEHGw25+llmyXBIFSqJm8FJ50LroDisD13ZSm3Lyc\\\\\\\/cvAUhYV\\\\\\\/fvyXSd2FoYPURKrG4+1vYNBmsnJglFZa+Fbd4Cb2AccSPt4\\\\\\\/hFhkoiyTouBMfeY1y1nnyIMV\\\\\\\/KROM3vvUDaiIehKrNzYMDvsbgNGiqTPQaviwkibs+Yeu4EMjMinacXNBeWeLJRK8EESiMWGGSOOJeUM+iUOuP3uu4zHTEHMbIbXZ\\\\\\\/ENm2YpFrfqhiTu7gxEE6WeKh85H+CqbFYWtdX7v+5yIaAosOr\\\\\\\/Y4aDVdlkzIKkxZiqlGBz+fbWRrDFVduAQXYgXV9bOjVD8ocbX5Vwv+51QXaw4WjKni7knO8KcJyZsRN7CB8gAMSUQ8\\\\\\\/h+RdIJssp\\\\\\\/cIpkw06EHTAsudfoPRRt\\\\\\\/451wlJuWIeSGGO3DawFWWox49QQJxEB27uw2p2ed8dfaDCQ0\\\\\\\/lBDGhB+kDMzHj2ByRs45xQRYC11XmskeLmrZFnAAb+XWZxtoH+Gylcc0b7mo9rbFoPTotFEsowfVtcAXRiVTcjuMqktE\\\\\\\/pymqEvGR4m9TijotdtfPD2QxQnP0SGfYGIra\\\\\\\/4BpfsYEgZ2hkaO0LUa9T\\\\\\\/5\\\\\\\/k+JBbDzO53HDMHfJIO+cN8SrjT5muHC16ehTH1XvuxZtH5jPafG9dylgSDt4jK8B1UAtyS94\\\\\\\/+jst3B1cHQxhnBwHHxitXOr39kvO63GT3osn+z+uRLJ6F8DbO+jU4Z9\\\\\\\/4n14\\\\\\\/1A7Tad+fqdWaT+i9d\\\\\\\/bjXN\\\\\\\/MgmXEtXJcxDUYW5WT6rqA0GjoRTULd6aRg5b8ghOtrcjh5sandTdCpAULJAAHwmepqhMdv66n1jdfMTlz4P6iRAf6oOV5sYMNKPYrKyECBAJrqKEowKz6uOxHtyZShQ0Bvi7\\\\\\\/qUmeGivLx6L6nk+J9gtZHoORZA\\\\\\\/pVosOI9mGTnKGs6KEmWgnffqm8b5lYQadYpYwQ1xmYLPi9HRhE8XpWk7Isy3pM9MvRSQQ1QMwPmcVBUf8DD0dX4lNLG4G86Cb6ZMxLyH7D7jTWnyT6aSMhNCUkVOJe6nH23PDgH+RLzwVenIwwrcL8nCWjQnXGPgIhXz9vt8Y73+fJggSk2W0+R5Y\\\\\\\/H1ecXY6CVf+zlUjmVGNQXtISALQph8wPSD0kTfitmHCOkhaj4BxJ73ZpMJs4dxEK6evjwZ2eFewjv+GTNLSHcVHpTBKCf2WBM8rcbRGSSNil2rHaVZPT3klArnQNC\\\\\\\/wnjmbGF\\\u0022,\\\u0022iv\\\u0022:\\\u0022sKKYKY68vbaU0RU7pxDTzg==\\\u0022,\\\u0022salt\\\u0022:\\\u0022c61521e99d992105f48078da3e31e17d\\\u0022}\u0022,\u0022hmac\u0022:\u0022d20f40836bc0907bca44f86872c2413aaf33cba5804a04ff3bdc89d2ec8647ca\u0022}","new-2":"{\u0022encrypted\u0022:\u0022{\\\u0022encrypted\\\u0022:\\\u0022TvTJ8U8EvoKnbS5E9YxBkGFYlIiIlbhqjKxIxasn04FYukFDSx8692p13\\\\\\\/CKcg6TWjGusjLNN06mZYYzoCI3rns3h8jOoFcVyg49Ues7AKIbv+rbQIr4fZTvYgqHZcTgFk5jpMidPDYwF\\\\\\\/MRQcbAhv4L1Mvf76xlhMyhzuKqelyOa1ZJaorKApkuXbUD\\\\\\\/qVKrbRIZ00AaB8cudQtJwOovi6fXdNZE9YaPWVqfb+9j6tpNZBSsxUHhjO70YT96W1849cDlZbDeIszkgxx519X1aaZyof6ObwzenXMlH9Lu\\\\\\\/sedzMvZF\\\\\\\/MyOFcPD7vlKPUdQ2b4fivEHmduTyjQSM\\\\\\\/58m4bZuejCg5KwU4ShvqSS\\\\\\\/ef2dyeVpNdSXXyMInMm49jXa6a2JOxjq05YflT2Z0OYSyXvM9Imj5fmtmiF1q+3aKrJFMsHbrw7k4ep4gTKI0A6yCkRM1to0nmxHgDtWcnLDnk\\\\\\\/gaX\\\\\\\/WvDb7HorpuRHAeMutrthi\\\\\\\/q9kt2W6PcZcY8c0no59jx59rV2xhOZAKYclgvHJX5N4pUGpcIoQMtD7KmOq3zT1T6OGzjX9SSHgyPBd+w20TnAkxV58RrLt+WQIY1BtElnSaREdo9qBiMvh\\\\\\\/9j4lY8e5s4eWw2ml+\\\\\\\/wVLylk3eH56NfZoaLtXO8f1KzaQ6ltdpsGebzi4ucIGLgPdqqC1gLJyEOomitOYTkMtcFzwDtWoTuSgkAjHKHnpEoTbE3JcCNbVAdMIWLlG7mV8OEgWm9PLKGoyTI2yJWD8fVpHWEOUeoBF\\\\\\\/HdXxgPdH8uiyGZahuVOu11I3USf8QDvOz3wanSFXAV5hjVZkyycrPjbYnUOPe9ZW4FqX9jqLcjlbenVojWXzs5DocjbxSQQ2djWuP4Ik5uYUVyvLCwhfJtLTljKc3QSrR8wlsBhpayOBQiqdKUd4fYeM3XaTmQsYkx4SCCdUrpPGglUlPsIsf\\\\\\\/pC\\\\\\\/hJeDSxa4N4ywqA6Phayx1za3MuNc9pJd2sM32kYJw6FiBaoT60Iz7rWxGXjeWlu7NcLahB0n7wg7Uo172spgFkctsm7DsDvhwSAIejI+74AoLe\\\\\\\/c\\\\\\\/OsJABqm59mH0XccraBQ9aKO9iaPpQVqLHwHEmDXZR\\\\\\\/pFm3VFM0WS5kSf6YA\\\\\\\/brFRSegPg9rP+pN+4fttgveQrZyt4v440DzaL89Bsw2Y86KWfPk3irvB97Y9xIrm++GWWmZLevrceiFAGj5UvjdiA\\\\\\\/n+zpR5DkqRGVkLaWQ4B3JsrIXuRye750LEaltP9Tx0d1Lw+2Zc0u2e2kCdAVrc8FRZZpjMeMdV3QviT6+gnR9+XvMIKsH0gt3RASYEPbawp1u7eQMGcyXwqgno+cl0WwMULD3OxXxmgLYNdx5c2sXAy4BBQ5onSowmR3ApMAFY+vtfnCTnI2ZB09\\\\\\\/5ACtSKpjLpXlQzdP5lJIfu5IutYSVXDM\\\\\\\/1Md\\\\\\\/pgLZVWKQpOROMCJvS+iBAzwwQNEgzpO\\\\\\\/ZycbzDv+g9eJ9NU6zcyJY\\\\\\\/tYkEIzi2Mogeh9nbD8+7LT+Ww99AmMdRmfU8fH1duRaSRYu7uF7w6gwP279ojeyk+uBAvVAXwnAQKz43C599uKQFb7VJkmzhlaEnAweNq0whC8N\\\\\\\/Va+hThrq1XA3JKaCPs8cuIVarIpSSd+mzxdeYA+movb2NIH1opcklYzkX6iOKtM85HT\\\\\\\/amAYettk\\\\\\\/stMLKj2llvPhb8RxBWUizHUKXEU6Nb\\\\\\\/NqprLie5gt1Cqh9ge7arvCM\\\\\\\/\\\\\\\/7OsXstkSmLtER9oFaoRp3ac0Zkf55TL9aWn8A9H0cJMsJrb3zaGE+T9qWuYIQDqLcKOPNxfnZ0c1b6bC9XH4WbRRCzLU0yYDwgXkbT2tPb04SOg0pCan96hJdoV6lcnEJZNj7bi+s8PAGhA2RcAP3Npkim\\\\\\\/+Nkqx51hL8UXDa6\\\\\\\/srYw62nIvpKpDPSYIzOGJkLNbZGTlTtUvd5u0jMSRFp+5K9g2D0bMqjckEeLtBSKNVjICgZtOCMHQhhh0dyk9AzQHEIkULLv5qWXMg\\\\\\\/ZLqkijVMOLaYNNKmhtmyQ8bIyD833hhUCpmdh1KRw8YRplwY4CsFJoBzwa6f4BWOQVEMKmCkQwo3NaQU5jjwm4MdPQ0\\\\\\\/bL0mk1CLRT\\\\\\\/Mpnr6Q==\\\u0022,\\\u0022iv\\\u0022:\\\u0022um0syA47I30yUo4Oh7UOIw==\\\u0022,\\\u0022salt\\\u0022:\\\u0022c61521e99d992105f48078da3e31e17d\\\u0022}\u0022,\u0022hmac\u0022:\u0022d27e45bfdb221035670a94dd83ae301fe9f98d1d883f9967257fe7c63b448f10\u0022}"},"ajax":{"edit-submit--3":{"callback":"highwire_alerts_login_form_submit","wrapper":"alerts-form-wrapper","event":"click","url":"\/system\/ajax","submit":{"_triggering_element_name":"op","_triggering_element_value":"Submit"}}},"urlIsAjaxTrusted":{"\/system\/ajax":true,"\/content\/48\/11\/4322.full?view=long\u0026pmid=15504859":true},"panels_accordion":{"highwire_article_accordion_container":{"heightStyle":"content","autoHeight":false,"collapsible":0,"region_accordion_id":"highwire_article_accordion_container","active":0,"animated":"slide"}},"nice_menus_options":{"delay":800,"speed":"fast"},"highwireResponsive":{"enquire_enabled":1,"breakpoints_configured":1,"breakpoints":{"zero":"all and (min-width: 0px)","xsmall":"all and (min-width: 380px)","narrow":"all and (min-width: 768px) and (min-device-width: 768px), (max-device-width: 800px) and (min-width: 768px) and (orientation:landscape)","normal":"all and (min-width: 980px) and (min-device-width: 980px), all and (max-device-width: 1024px) and (min-width: 1024px) and (orientation:landscape)","wide":"all and (min-width: 1220px)"}},"eu_cookie_compliance":{"popup_enabled":1,"popup_agreed_enabled":0,"popup_hide_agreed":0,"popup_clicking_confirmation":1,"popup_scrolling_confirmation":false,"popup_html_info":"\u003Cdiv\u003E\n  \u003Cdiv class =\u0022popup-content info\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Cp\u003EWe use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.\u003C\/p\u003E\n    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022agree-button eu-cookie-compliance-default-button\u0022\u003EContinue\u003C\/button\u003E\n                    \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button\u0022\u003EFind out more\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E","use_mobile_message":false,"mobile_popup_html_info":"\u003Cdiv\u003E\n  \u003Cdiv class =\u0022popup-content info\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n          \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022agree-button eu-cookie-compliance-default-button\u0022\u003EContinue\u003C\/button\u003E\n                    \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button\u0022\u003EFind out more\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E\n","mobile_breakpoint":"768","popup_html_agreed":"\u003Cdiv\u003E\n  \u003Cdiv class=\u0022popup-content agreed\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Cp\u003EThank you for accepting cookies. You can now hide this message or find out more about cookies.\u003C\/p\u003E\n    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022hide-popup-button eu-cookie-compliance-hide-button\u0022\u003EHide\u003C\/button\u003E\n              \u003Cbutton type=\u0022button\u0022 class=\u0022find-more-button eu-cookie-compliance-more-button-thank-you\u0022 \u003EFind out more\u003C\/button\u003E\n          \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E","popup_use_bare_css":false,"popup_height":"auto","popup_width":"100%","popup_delay":1000,"popup_link":"https:\/\/www.asm.org\/index.php\/privacy-policy-and-terms-of-use","popup_link_new_window":1,"popup_position":null,"popup_language":"en","store_consent":false,"better_support_for_screen_readers":0,"reload_page":0,"domain":"","popup_eu_only_js":0,"cookie_lifetime":"365","cookie_session":false,"disagree_do_not_show_popup":0,"method":"default","whitelisted_cookies":"","withdraw_markup":"\u003Cbutton type=\u0022button\u0022 class=\u0022eu-cookie-withdraw-tab\u0022\u003EPrivacy settings\u003C\/button\u003E\n\u003Cdiv class=\u0022eu-cookie-withdraw-banner\u0022\u003E\n  \u003Cdiv class=\u0022popup-content info\u0022\u003E\n    \u003Cdiv id=\u0022popup-text\u0022\u003E\n      \u003Cp\u003E\u0026lt;h2\u0026gt;We use cookies on this site to enhance your user experience\u0026lt;\/h2\u0026gt;\u0026lt;p\u0026gt;You have given your consent for us to set cookies.\u0026lt;\/p\u0026gt;\u003C\/p\u003E\n    \u003C\/div\u003E\n    \u003Cdiv id=\u0022popup-buttons\u0022\u003E\n      \u003Cbutton type=\u0022button\u0022 class=\u0022eu-cookie-withdraw-button\u0022\u003EWithdraw consent\u003C\/button\u003E\n    \u003C\/div\u003E\n  \u003C\/div\u003E\n\u003C\/div\u003E\n","withdraw_enabled":false},"googleanalytics":{"trackOutbound":1,"trackMailto":1,"trackDownload":1,"trackDownloadExtensions":"7z|aac|arc|arj|asf|asx|avi|bin|csv|doc(x|m)?|dot(x|m)?|exe|flv|gif|gz|gzip|hqx|jar|jpe?g|js|mp(2|3|4|e?g)|mov(ie)?|msi|msp|pdf|phps|png|ppt(x|m)?|pot(x|m)?|pps(x|m)?|ppam|sld(x|m)?|thmx|qtm?|ra(m|r)?|sea|sit|tar|tgz|torrent|txt|wav|wma|wmv|wpd|xls(x|m|b)?|xlt(x|m)|xlam|xml|z|zip","trackColorbox":1},"asmGTM":{"user_type":"Non-member","is_article":true,"date":"October 25 2004","date_split":{"year":"2004","month":"10","day":"25"}},"color":{"logo":null},"omega":{"layouts":{"primary":"normal","order":["narrow","normal","wide"],"queries":{"narrow":"all and (min-width: 768px) and (min-device-width: 768px), (max-device-width: 800px) and (min-width: 768px) and (orientation:landscape)","normal":"all and (min-width: 980px) and (min-device-width: 980px), all and (max-device-width: 1024px) and (min-width: 1024px) and (orientation:landscape)","wide":"all and (min-width: 1220px)"}}}});
//--><!]]>
</script>
    <!--[if lt IE 9]><script src="http://html5shiv.googlecode.com/svn/trunk/html5.js"></script><![endif]-->
  </head>
  <body class="html not-front not-logged-in page-node page-node- page-node-79746 node-type-highwire-article context-content hw-default-jcode-aac hw-article-type-research-article hw-article-category-experimental-therapeutics"><noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-PZPCQN5" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
    <div id="skip-link">
      <a href="#main-content" class="element-invisible element-focusable">Skip to main content</a>
    </div>
    <div class="region region-page-top" id="region-page-top">
  <div class="region-inner region-page-top-inner">
      </div>
</div>    <div class="page clearfix page-box-shadows footer-borders panels-page panels-layout-jcore_2col" id="page">
      <header id="section-header" class="section section-header">
  <div id="zone-user-wrapper" class="zone-wrapper zone-user-wrapper clearfix mobile-hidden print-hidden">  
  <div id="zone-user" class="zone zone-user clearfix equal-height-container mobile-hidden print-hidden container-30">    
  	    <div class="grid-10 region region-user-first equal-height-element" id="region-user-first">
  <div class="region-inner region-user-first-inner">
    <div class="block block-nice-menus block-2 block-nice-menus-2 odd block-without-title" id="block-nice-menus-2">
  <div class="block-inner clearfix">
                
    <div class="content clearfix user-menu-dropdown user-menu-dropdown-logo user-menu-dropdown-logo-only">
      <nav class="menubar-nav"><ul class="nice-menu nice-menu-down nice-menu-umbrella-menu" id="nice-menu-2" role="menu"><li class="menu-653 menuparent  menu-path-journalsasmorg- first odd last" role="menuitem"><a href="http://journals.asm.org/" data-hide-link-title="0" class="" data-icon-position="">ASM</a><ul role="menu"><li class="menu-654 menu-path-aacasmorg- first odd " role="menuitem"><a href="http://aac.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Antimicrobial Agents and Chemotherapy</span></a></li>
<li class="menu-765 menu-path-aemasmorg-  even " role="menuitem"><a href="http://aem.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Applied and Environmental Microbiology</span></a></li>
<li class="menu-767 menu-path-cmrasmorg-  odd " role="menuitem"><a href="http://cmr.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Clinical Microbiology Reviews</span></a></li>
<li class="menu-766 menu-path-cviasmorg-  even " role="menuitem"><a href="http://cvi.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Clinical and Vaccine Immunology</span></a></li>
<li class="menu-768 menu-path-asmscienceorg-content-journal-ecosalplus  odd " role="menuitem"><a href="http://www.asmscience.org/content/journal/ecosalplus" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">EcoSal Plus</span></a></li>
<li class="menu-1425 menu-path-ecasmorg-  even " role="menuitem"><a href="http://ec.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Eukaryotic Cell</span></a></li>
<li class="menu-770 menu-path-iaiasmorg-  odd " role="menuitem"><a href="http://iai.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Infection and Immunity</span></a></li>
<li class="menu-771 menu-path-jbasmorg-  even " role="menuitem"><a href="http://jb.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Journal of Bacteriology</span></a></li>
<li class="menu-772 menu-path-jcmasmorg-  odd " role="menuitem"><a href="http://jcm.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Journal of Clinical Microbiology</span></a></li>
<li class="menu-773 menu-path-asmscienceorg-content-journal-jmbe  even " role="menuitem"><a href="http://www.asmscience.org/content/journal/jmbe" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Journal of Microbiology &amp; Biology Education</span></a></li>
<li class="menu-774 menu-path-jviasmorg-  odd " role="menuitem"><a href="http://jvi.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Journal of Virology</span></a></li>
<li class="menu-775 menu-path-mbioasmorg-  even " role="menuitem"><a href="http://mbio.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">mBio</span></a></li>
<li class="menu-776 menu-path-mmbrasmorg-  odd " role="menuitem"><a href="http://mmbr.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Microbiology and Molecular Biology Reviews</span></a></li>
<li class="menu-769 menu-path-mraasmorg-  even " role="menuitem"><a href="http://mra.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Microbiology Resource Announcements</span></a></li>
<li class="menu-777 menu-path-asmscienceorg-content-journal-microbiolspec  odd " role="menuitem"><a href="http://www.asmscience.org/content/journal/microbiolspec" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Microbiology Spectrum </span></a></li>
<li class="menu-778 menu-path-mcbasmorg-  even " role="menuitem"><a href="http://mcb.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Molecular and Cellular Biology</span></a></li>
<li class="menu-779 menu-path-msphereasmorg-  odd " role="menuitem"><a href="http://msphere.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">mSphere</span></a></li>
<li class="menu-780 menu-path-msystemsasmorg-  even last" role="menuitem"><a href="http://msystems.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">mSystems</span></a></li>
</ul></li>
</ul></nav>
    </div>
  </div>
</div>  </div>
</div><div class="grid-20 region region-user-second equal-height-element" id="region-user-second">
  <div class="region-inner region-user-second-inner">
    <div class="block block-panels-mini highwire-uid-string block-jnl-asm-uid-strng block-panels-mini-jnl-asm-uid-strng odd block-without-title" id="block-panels-mini-jnl-asm-uid-strng">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <div class="panel-display panel-1col clearfix" id="mini-panel-jnl_asm_uid_strng">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-highwire-user-identities" >
  
      
  
  <div class="pane-content">
    <div class="highwire-user-message" data-separator=" | "><span class="highwire-user-institution" data-id-type="institution" data-identity="a%3A2%3A%7Bs%3A4%3A%22show%22%3Bi%3A1%3Bs%3A7%3A%22message%22%3Bs%3A85%3A%22%3Cspan%20class%3D%22narrow-hidden%22%3EInstitution%3A%20%3C%2Fspan%3E%5Bidentity%3Ainstitutional_display_name%5D%22%3B%7D"></span></div>  </div>

  
  </div>
<div class="panel-pane pane-block pane-system-user-menu links inline pane-system" >
  
      
  
  <div class="pane-content">
    <nav class="menubar-nav"><ul class="menu" role="menu"><li class="first leaf" role="menuitem"><a href="/user/login?destination=/content/48/11/4322%3Fview%3Dlong%26pmid%3D15504859%26variant%3Dfull-text" class="" data-icon-position="" data-hide-link-title="0">Log in</a></li>
<li class="leaf" role="menuitem"><a href="/alerts" class="" data-icon-position="" data-hide-link-title="0">My alerts</a></li>
<li class="last leaf" role="menuitem"><a href="/cart" class="link-icon-right link-icon"><span class="title">My Cart</span> <i class="icon-shopping-cart"></i></a></li>
</ul></nav>  </div>

  
  </div>
</div>
  </div>
</div>
    </div>
  </div>
</div>  </div>
</div>  </div>
</div><div id="zone-advertising-top-wrapper" class="zone-wrapper zone-advertising-top-wrapper clearfix">  
  <div id="zone-advertising-top" class="zone zone-advertising-top clearfix container-30">
    <div class="grid-28 suffix-1 prefix-1 region region-ad-top" id="region-ad-top">
  <div class="region-inner region-ad-top-inner">
    <div class="block block-panels-mini block-home-page-top-banner-add block-panels-mini-home-page-top-banner-add odd block-without-title" id="block-panels-mini-home-page-top-banner-add">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <div class="panel-flexible panels-flexible-new clearfix" id="mini-panel-home_page_top_banner_add">
<div class="panel-flexible-inside panels-flexible-new-inside">
<div class="panels-flexible-region panels-flexible-region-new-center panels-flexible-region-first panels-flexible-region-last">
  <div class="inside panels-flexible-region-inside panels-flexible-region-new-center-inside panels-flexible-region-inside-first panels-flexible-region-inside-last">
<div class="panel-pane pane-dfp-pane rtecenter" >
  
      
  
  <div class="pane-content">
    <div id="dfp-ad-asm_leader_mob-wrapper" class="dfp-tag-wrapper">

<div  id="dfp-ad-asm_leader_mob" class="dfp-tag-wrapper">
  <script type="text/javascript">
    googletag.cmd.push(function() {
      googletag.display("dfp-ad-asm_leader_mob");
    });
  </script>
</div>
</div>  </div>

  
  </div>
  </div>
</div>
</div>
</div>
    </div>
  </div>
</div>  </div>
</div>  </div>
</div><div id="zone-superheader-wrapper" class="zone-wrapper zone-superheader-wrapper clearfix mobile-only print-hidden">  
  <div id="zone-superheader" class="zone zone-superheader clearfix mobile-only print-hidden container-30">
    <div class="grid-30 region region-superheader" id="region-superheader">
  <div class="region-inner region-superheader-inner">
    <div class="block block-panels-mini block-responsive-menu block-panels-mini-responsive-menu odd block-without-title" id="block-panels-mini-responsive-menu">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <div class="panel-display panel-1col clearfix" id="mini-panel-responsive_menu">
  <div class="panel-panel panel-col">
    <div><div id="unique-id3" class="highwire-responsive-toggle-group"><div class="panel-pane pane-panels-mini pane-responsive-menu-main-menu" >
  
        <h2 class="pane-title"><i class="icon-reorder"></i><span class="element-invisible">Main menu</span></h2>
    
  
  <div class="pane-content">
    <div class="panel-display panel-1col clearfix" id="mini-panel-responsive_menu_main_menu">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-menu-tree pane-main-menu" >
  
      
  
  <div class="pane-content">
    <div class="menu-block-wrapper menu-block-ctools-main-menu-1 menu-name-main-menu parent-mlid-main-menu:0 menu-level-1">
  <nav class="menubar-nav"><ul class="menu" role="menu"><li class="first leaf menu-mlid-862" role="menuitem"><a href="/" data-hide-link-title="0" class="" data-icon-position="">Home</a></li>
<li class="expanded menu-mlid-659" role="menuitem"><a href="/latest" data-hide-link-title="0" class="" data-icon-position="">Articles</a><nav class="menubar-nav"><ul class="menu" role="menu"><li class="first leaf menu-mlid-787" role="menuitem"><a href="/content/current" data-hide-link-title="0" class="" data-icon-position="">Current Issue</a></li>
<li class="leaf menu-mlid-1426" role="menuitem"><a href="/content/early/recent" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Accepted Manuscripts</a></li>
<li class="leaf menu-mlid-1517" role="menuitem"><a href="https://journals.asm.org/content/covid-19" data-hide-link-title="0" target="_blank" class="" data-icon-position="">COVID-19 Special Collection</a></li>
<li class="leaf menu-mlid-663" role="menuitem"><a href="/content/by/year" class="" data-icon-position="" data-hide-link-title="0">Archive</a></li>
<li class="last leaf menu-mlid-1424" role="menuitem"><a href="/content/by/section/Minireview" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Minireviews</a></li>
</ul></nav></li>
<li class="expanded menu-mlid-939" role="menuitem"><a href="/content/submit-manuscript" data-hide-link-title="0" class="" data-icon-position="">For Authors</a><nav class="menubar-nav"><ul class="menu" role="menu"><li class="first leaf menu-mlid-940" role="menuitem"><a href="/content/submit-manuscript" data-hide-link-title="0" class="" data-icon-position="">Submit a Manuscript</a></li>
<li class="leaf menu-mlid-666" role="menuitem"><a href="/content/scope" data-hide-link-title="0" class="" data-icon-position="">Scope</a></li>
<li class="leaf menu-mlid-667" role="menuitem"><a href="/content/editorial-policy" data-hide-link-title="0" class="" data-icon-position="">Editorial Policy</a></li>
<li class="leaf menu-mlid-668" role="menuitem"><a href="/content/submission-review-publication-processes" data-hide-link-title="0" class="" data-icon-position="">Submission, Review, &amp; Publication Processes</a></li>
<li class="leaf menu-mlid-669" role="menuitem"><a href="/content/organization-and-format" data-hide-link-title="0" class="" data-icon-position="">Organization and Format</a></li>
<li class="leaf menu-mlid-676" role="menuitem"><a href="/content/author-corrections-errata-retractions" data-hide-link-title="0" class="" data-icon-position="">Errata, Author Corrections, Retractions</a></li>
<li class="leaf menu-mlid-671" role="menuitem"><a href="/content/illustrations-and-tables" data-hide-link-title="0" class="" data-icon-position="">Illustrations and Tables</a></li>
<li class="leaf menu-mlid-678" role="menuitem"><a href="/content/nomenclature" data-hide-link-title="0" class="" data-icon-position="">Nomenclature</a></li>
<li class="leaf menu-mlid-672" role="menuitem"><a href="/content/abbreviations-and-conventions" data-hide-link-title="0" class="" data-icon-position="">Abbreviations and Conventions</a></li>
<li class="leaf menu-mlid-835" role="menuitem"><a href="/content/publication-fees" data-hide-link-title="0" class="" data-icon-position="">Publication Fees</a></li>
<li class="last leaf menu-mlid-948" role="menuitem"><a href="https://journals.asm.org/content/ethics-and-policies" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Ethics Resources and Policies </a></li>
</ul></nav></li>
<li class="expanded menu-mlid-664" role="menuitem"><a href="/content/about-aac" data-hide-link-title="0" class="" data-icon-position="">About the Journal</a><nav class="menubar-nav"><ul class="menu" role="menu"><li class="first leaf menu-mlid-1427" role="menuitem"><a href="/content/about-aac" data-hide-link-title="0" class="" data-icon-position="">About AAC</a></li>
<li class="leaf menu-mlid-823" role="menuitem"><a href="/content/board-editors" data-hide-link-title="0" class="" data-icon-position="">Editor in Chief</a></li>
<li class="leaf menu-mlid-824" role="menuitem"><a href="/content/board-editors" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Editorial Board</a></li>
<li class="leaf menu-mlid-830" role="menuitem"><a href="https://journals.asm.org/content/reviewers" data-hide-link-title="0" target="_blank" class="" data-icon-position="">For Reviewers</a></li>
<li class="leaf menu-mlid-833" role="menuitem"><a href="https://www.asm.org/Newsroom" data-hide-link-title="0" target="_blank" class="" data-icon-position="">For the Media</a></li>
<li class="leaf menu-mlid-831" role="menuitem"><a href="https://journals.asm.org/content/institutions" data-hide-link-title="0" target="_blank" class="" data-icon-position="">For Librarians</a></li>
<li class="leaf menu-mlid-832" role="menuitem"><a href="https://journals.asm.org/content/advertising" data-hide-link-title="0" target="_blank" class="" data-icon-position="">For Advertisers</a></li>
<li class="leaf menu-mlid-677" role="menuitem"><a href="https://journals.asm.org/alerts" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Alerts</a></li>
<li class="leaf menu-mlid-1516" role="menuitem"><a href="https://www.youtube.com/playlist?list=PL1DFmJFZvefiidG0t8jEKTdITXxJrmdO5" data-hide-link-title="0" target="_blank" class="" data-icon-position="">AAC Podcast</a></li>
<li class="leaf menu-mlid-829" role="menuitem"><a href="/content/rss" data-hide-link-title="0" class="" data-icon-position="">RSS</a></li>
<li class="last leaf menu-mlid-828" role="menuitem"><a href="/content/faq" data-hide-link-title="0" class="" data-icon-position="">FAQ</a></li>
</ul></nav></li>
<li class="last expanded menu-mlid-1434" role="menuitem"><a href="https://journals.asm.org/content/institutions" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Subscribe</a><nav class="menubar-nav"><ul class="menu" role="menu"><li class="first leaf menu-mlid-1435" role="menuitem"><a href="https://journals.asm.org/content/members" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Members</a></li>
<li class="last leaf menu-mlid-1436" role="menuitem"><a href="https://journals.asm.org/content/institutions" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Institutions</a></li>
</ul></nav></li>
</ul></nav></div>
  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-menu-tree pane-umbrella-menu" >
  
      
  
  <div class="pane-content">
    <div class="menu-block-wrapper menu-block-ctools-umbrella-menu-1 menu-name-umbrella-menu parent-mlid-umbrella-menu:0 menu-level-1">
  <nav class="menubar-nav"><ul class="menu" role="menu"><li class="first last expanded menu-mlid-653" role="menuitem"><a href="http://journals.asm.org/" data-hide-link-title="0" class="" data-icon-position="">ASM</a><nav class="menubar-nav"><ul class="menu" role="menu"><li class="first leaf menu-mlid-654" role="menuitem"><a href="http://aac.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Antimicrobial Agents and Chemotherapy</span></a></li>
<li class="leaf menu-mlid-765" role="menuitem"><a href="http://aem.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Applied and Environmental Microbiology</span></a></li>
<li class="leaf menu-mlid-767" role="menuitem"><a href="http://cmr.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Clinical Microbiology Reviews</span></a></li>
<li class="leaf menu-mlid-766" role="menuitem"><a href="http://cvi.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Clinical and Vaccine Immunology</span></a></li>
<li class="leaf menu-mlid-768" role="menuitem"><a href="http://www.asmscience.org/content/journal/ecosalplus" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">EcoSal Plus</span></a></li>
<li class="leaf menu-mlid-1425" role="menuitem"><a href="http://ec.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Eukaryotic Cell</span></a></li>
<li class="leaf menu-mlid-770" role="menuitem"><a href="http://iai.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Infection and Immunity</span></a></li>
<li class="leaf menu-mlid-771" role="menuitem"><a href="http://jb.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Journal of Bacteriology</span></a></li>
<li class="leaf menu-mlid-772" role="menuitem"><a href="http://jcm.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Journal of Clinical Microbiology</span></a></li>
<li class="leaf menu-mlid-773" role="menuitem"><a href="http://www.asmscience.org/content/journal/jmbe" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Journal of Microbiology &amp; Biology Education</span></a></li>
<li class="leaf menu-mlid-774" role="menuitem"><a href="http://jvi.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Journal of Virology</span></a></li>
<li class="leaf menu-mlid-775" role="menuitem"><a href="http://mbio.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">mBio</span></a></li>
<li class="leaf menu-mlid-776" role="menuitem"><a href="http://mmbr.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Microbiology and Molecular Biology Reviews</span></a></li>
<li class="leaf menu-mlid-769" role="menuitem"><a href="http://mra.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Microbiology Resource Announcements</span></a></li>
<li class="leaf menu-mlid-777" role="menuitem"><a href="http://www.asmscience.org/content/journal/microbiolspec" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Microbiology Spectrum </span></a></li>
<li class="leaf menu-mlid-778" role="menuitem"><a href="http://mcb.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">Molecular and Cellular Biology</span></a></li>
<li class="leaf menu-mlid-779" role="menuitem"><a href="http://msphere.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">mSphere</span></a></li>
<li class="last leaf menu-mlid-780" role="menuitem"><a href="http://msystems.asm.org/" target="_blank" data-font-position="before" class="link-icon"><i class="icon-caret-right"></i> <span class="title">mSystems</span></a></li>
</ul></nav></li>
</ul></nav></div>
  </div>

  
  </div>
</div>
  </div>
</div>
  </div>

  
  </div>
<div class="panel-pane pane-panels-mini pane-responsive-menu-user-menu" >
  
        <h2 class="pane-title"><i class="icon-gear"></i><span class="element-invisible">User menu</span></h2>
    
  
  <div class="pane-content">
    <div class="panel-display panel-1col clearfix" id="mini-panel-responsive_menu_user_menu">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-menu-tree pane-user-menu" >
  
      
  
  <div class="pane-content">
    <div class="menu-block-wrapper menu-block-ctools-user-menu-1 menu-name-user-menu parent-mlid-user-menu:0 menu-level-1">
  <nav class="menubar-nav"><ul class="menu" role="menu"><li class="first leaf menu-mlid-690" role="menuitem"><a href="/user/login?destination=/content/48/11/4322%3Fview%3Dlong%26pmid%3D15504859%26variant%3Dfull-text" class="" data-icon-position="" data-hide-link-title="0">Log in</a></li>
<li class="leaf menu-mlid-689" role="menuitem"><a href="/alerts" class="" data-icon-position="" data-hide-link-title="0">My alerts</a></li>
<li class="last leaf menu-mlid-1423" role="menuitem"><a href="/cart" class="link-icon-right link-icon"><span class="title">My Cart</span> <i class="icon-shopping-cart"></i></a></li>
</ul></nav></div>
  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-user-identities" >
  
      
  
  <div class="pane-content">
    <div class="highwire-user-message" data-separator="|"><span class="highwire-user-institution" data-id-type="institution" data-identity="a%3A2%3A%7Bs%3A4%3A%22show%22%3Bi%3A1%3Bs%3A7%3A%22message%22%3Bs%3A50%3A%22Institution%3A%20%5Bidentity%3Ainstitutional_display_name%5D%22%3B%7D"></span></div>  </div>

  
  </div>
</div>
  </div>
</div>
  </div>

  
  </div>
<div class="panel-pane pane-panels-mini pane-responsive-menu-search" >
  
        <h2 class="pane-title"><i class="icon-search"></i><span class="element-invisible">Search</span></h2>
    
  
  <div class="pane-content">
    <div class="panel-display panel-1col clearfix" id="mini-panel-responsive_menu_search">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-highwire-seach-qsearch-nocontext" >
  
      
  
  <div class="pane-content">
    <form class="highwire-quicksearch button-style-mini button-style-mini" action="/content/48/11/4322.full?view=long&amp;pmid=15504859" method="post" id="highwire-search-qsearch-nocontext-form" accept-charset="UTF-8"><div><div class="form-item form-item-label-invisible form-type-textfield form-item-keywords">
  <label class="element-invisible" for="edit-keywords">Search for this keyword </label>
 <input placeholder="Search..." type="text" id="edit-keywords" name="keywords" value="" size="60" maxlength="128" class="form-text" />
</div>
<div class="button-wrapper button-mini"><i class="icon-search"></i><input data-icon-only="1" data-font-icon="icon-search" data-icon-position="after" type="submit" id="edit-submit--5" name="op" value="Search" class="form-submit" /></div><input type="hidden" name="form_build_id" value="form-FY7Ij6ixohj2F_oxG1Ribc3m_Fpvhwq0aI7Su1-I5nU" />
<input type="hidden" name="form_id" value="highwire_search_qsearch_nocontext_form" />
</div></form>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-custom pane-2 highwire-responsive-advanced-search-link pane-menu-tree" >
  
      
  
  <div class="pane-content">
    <ul class="menu">
  <li><a href="/search" title="Advanced search">Advanced search</a></li>
  </ul>  </div>

  
  </div>
</div>
  </div>
</div>
  </div>

  
  </div>
</div></div>
  </div>
</div>
    </div>
  </div>
</div><div class="block block-panels-mini block-hw-small-logo block-panels-mini-hw-small-logo even block-without-title" id="block-panels-mini-hw-small-logo">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <div class="panel-display panel-1col clearfix" id="mini-panel-hw_small_logo">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-small-logo" >
  
      
  
  <div class="pane-content">
    <a href="/" class="" data-icon-position="" data-hide-link-title="0"><img src="https://aac.asm.org/sites/default/files/logo-mobile-AAC.png" alt="Antimicrobial Agents and Chemotherapy" title="Antimicrobial Agents and Chemotherapy" /></a>  </div>

  
  </div>
</div>
  </div>
</div>
    </div>
  </div>
</div>  </div>
</div>  </div>
</div>  
  <div id="zone-branding" class="zone zone-branding clearfix mobile-hidden print-display-block container-30">
    <div class="grid-19 prefix-1 region region-branding print-display-block" id="region-branding">
  <div class="region-inner region-branding-inner">
        <div class="block block-panels-mini block-banner-logo-image block-panels-mini-banner-logo-image odd block-without-title" id="block-panels-mini-banner-logo-image">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <div class="panel-display panel-1col clearfix" id="mini-panel-banner_logo_image">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-snippet pane-logo-image-banner" >
  
      
  
  <div class="pane-content">
    <div class="snippet logo-image-banner" id="logo-image-banner">
  
      
  <div class="snippet-content">
    <div class="logo-imgs"><a class="publisher-link" href="https://www.asm.org/" rel="home"><img alt="publisher-logo" class="publisher-logo" src="/sites/default/files/additional_assets/Site_Logo/publisher-logo.png" /></a><a class="site-link" href="/" rel="home"><img alt="site-logo" class="site-logo" src="/sites/default/files/additional_assets/Site_Logo/site-logo.png" /></a></div>
  </div>

</div>
  </div>

  
  </div>
</div>
  </div>
</div>
    </div>
  </div>
</div>  </div>
</div><div class="grid-9 suffix-1 region region-branding-second print-hidden" id="region-branding-second">
  <div class="region-inner region-branding-second-inner">
    <div class="block block-panels-mini highwire-inst-branding-block block-jnl-asm-inst-brand block-panels-mini-jnl-asm-inst-brand odd block-without-title" id="block-panels-mini-jnl-asm-inst-brand">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <div class="panel-display panel-1col clearfix" id="mini-panel-jnl_asm_inst_brand">
  <div class="panel-panel panel-col">
    <div></div>
  </div>
</div>
    </div>
  </div>
</div><div class="block block-panels-mini block-jnl-asm-search-box block-panels-mini-jnl-asm-search-box even block-without-title" id="block-panels-mini-jnl-asm-search-box">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <div class="panel-display panel-1col clearfix" id="mini-panel-jnl_asm_search_box">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-highwire-seach-quicksearch no-margin-bottom" >
  
      
  
  <div class="pane-content">
    <form class="highwire-quicksearch button-style-mini button-style-mini" action="/content/48/11/4322.full?view=long&amp;pmid=15504859" method="post" id="highwire-search-quicksearch-form-0" accept-charset="UTF-8"><div><div class="form-item form-item-label-invisible form-type-textfield form-item-keywords">
  <label class="element-invisible" for="edit-keywords--2">Search for this keyword </label>
 <input placeholder="search" type="text" id="edit-keywords--2" name="keywords" value="" size="60" maxlength="128" class="form-text" />
</div>
<div class="button-wrapper button-mini"><i class="icon-search"></i><input data-icon-only="1" data-font-icon="icon-search" data-icon-position="after" type="submit" id="edit-submit--6" name="op" value="Search" class="form-submit" /></div><input type="hidden" name="form_build_id" value="form-XuaHDNOe171rKtjjM98OYvSwdayD19jCxMWEgQPVRwA" />
<input type="hidden" name="form_id" value="highwire_search_quicksearch_form_0" />
</div></form>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-custom pane-3" >
  
      
  
  <div class="pane-content">
    <p><a href="/search">Advanced Search</a></p>  </div>

  
  </div>
</div>
  </div>
</div>
    </div>
  </div>
</div>  </div>
</div>  </div>
  
  <div id="zone-menu" class="zone zone-menu clearfix mobile-hidden container-30">
    <div class="grid-28 suffix-1 prefix-1 region region-menu main-menu-active-caret" id="region-menu">
  <div class="region-inner region-menu-inner">
        <div class="block block-nice-menus block-1 block-nice-menus-1 odd block-without-title" id="block-nice-menus-1">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <nav class="menubar-nav"><ul class="nice-menu nice-menu-down nice-menu-main-menu" id="nice-menu-1" role="menu"><li class="menu-862 menu-path-front first odd " role="menuitem"><a href="/" data-hide-link-title="0" class="" data-icon-position="">Home</a></li>
<li class="menu-659 menuparent  menu-path-latest  even " role="menuitem"><a href="/latest" data-hide-link-title="0" class="" data-icon-position="">Articles</a><ul role="menu"><li class="menu-787 menu-path-content-current first odd " role="menuitem"><a href="/content/current" data-hide-link-title="0" class="" data-icon-position="">Current Issue</a></li>
<li class="menu-1426 menu-path-content-early-recent  even " role="menuitem"><a href="/content/early/recent" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Accepted Manuscripts</a></li>
<li class="menu-1517 menu-path-sjournalsasmorg-content-covid-19  odd " role="menuitem"><a href="https://journals.asm.org/content/covid-19" data-hide-link-title="0" target="_blank" class="" data-icon-position="">COVID-19 Special Collection</a></li>
<li class="menu-663 menu-path-content-by-year  even " role="menuitem"><a href="/content/by/year" class="" data-icon-position="" data-hide-link-title="0">Archive</a></li>
<li class="menu-1424 menu-path-content-by-section-minireview  odd last" role="menuitem"><a href="/content/by/section/Minireview" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Minireviews</a></li>
</ul></li>
<li class="menu-939 menuparent  menu-path-node-1728  odd " role="menuitem"><a href="/content/submit-manuscript" data-hide-link-title="0" class="" data-icon-position="">For Authors</a><ul role="menu"><li class="menu-940 menu-path-node-1728 first odd " role="menuitem"><a href="/content/submit-manuscript" data-hide-link-title="0" class="" data-icon-position="">Submit a Manuscript</a></li>
<li class="menu-666 menu-path-node-1473  even " role="menuitem"><a href="/content/scope" data-hide-link-title="0" class="" data-icon-position="">Scope</a></li>
<li class="menu-667 menu-path-node-1467  odd " role="menuitem"><a href="/content/editorial-policy" data-hide-link-title="0" class="" data-icon-position="">Editorial Policy</a></li>
<li class="menu-668 menu-path-node-1468  even " role="menuitem"><a href="/content/submission-review-publication-processes" data-hide-link-title="0" class="" data-icon-position="">Submission, Review, &amp; Publication Processes</a></li>
<li class="menu-669 menu-path-node-1474  odd " role="menuitem"><a href="/content/organization-and-format" data-hide-link-title="0" class="" data-icon-position="">Organization and Format</a></li>
<li class="menu-676 menu-path-node-1  even " role="menuitem"><a href="/content/author-corrections-errata-retractions" data-hide-link-title="0" class="" data-icon-position="">Errata, Author Corrections, Retractions</a></li>
<li class="menu-671 menu-path-node-1475  odd " role="menuitem"><a href="/content/illustrations-and-tables" data-hide-link-title="0" class="" data-icon-position="">Illustrations and Tables</a></li>
<li class="menu-678 menu-path-node-1476  even " role="menuitem"><a href="/content/nomenclature" data-hide-link-title="0" class="" data-icon-position="">Nomenclature</a></li>
<li class="menu-672 menu-path-node-1477  odd " role="menuitem"><a href="/content/abbreviations-and-conventions" data-hide-link-title="0" class="" data-icon-position="">Abbreviations and Conventions</a></li>
<li class="menu-835 menu-path-node-1478  even " role="menuitem"><a href="/content/publication-fees" data-hide-link-title="0" class="" data-icon-position="">Publication Fees</a></li>
<li class="menu-948 menu-path-sjournalsasmorg-content-ethics-and-policies  odd last" role="menuitem"><a href="https://journals.asm.org/content/ethics-and-policies" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Ethics Resources and Policies </a></li>
</ul></li>
<li class="menu-664 menuparent  menu-path-node-17900  even " role="menuitem"><a href="/content/about-aac" data-hide-link-title="0" class="" data-icon-position="">About the Journal</a><ul role="menu"><li class="menu-1427 menu-path-node-17900 first odd " role="menuitem"><a href="/content/about-aac" data-hide-link-title="0" class="" data-icon-position="">About AAC</a></li>
<li class="menu-823 menu-path-node-8  even " role="menuitem"><a href="/content/board-editors" data-hide-link-title="0" class="" data-icon-position="">Editor in Chief</a></li>
<li class="menu-824 menu-path-node-8  odd " role="menuitem"><a href="/content/board-editors" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Editorial Board</a></li>
<li class="menu-830 menu-path-sjournalsasmorg-content-reviewers  even " role="menuitem"><a href="https://journals.asm.org/content/reviewers" data-hide-link-title="0" target="_blank" class="" data-icon-position="">For Reviewers</a></li>
<li class="menu-833 menu-path-sasmorg-newsroom  odd " role="menuitem"><a href="https://www.asm.org/Newsroom" data-hide-link-title="0" target="_blank" class="" data-icon-position="">For the Media</a></li>
<li class="menu-831 menu-path-sjournalsasmorg-content-institutions  even " role="menuitem"><a href="https://journals.asm.org/content/institutions" data-hide-link-title="0" target="_blank" class="" data-icon-position="">For Librarians</a></li>
<li class="menu-832 menu-path-sjournalsasmorg-content-advertising  odd " role="menuitem"><a href="https://journals.asm.org/content/advertising" data-hide-link-title="0" target="_blank" class="" data-icon-position="">For Advertisers</a></li>
<li class="menu-677 menu-path-sjournalsasmorg-alerts  even " role="menuitem"><a href="https://journals.asm.org/alerts" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Alerts</a></li>
<li class="menu-1516 menu-path-syoutubecom-playlistlistpl1dfmjfzvefiidg0t8jektditxxjrmdo5  odd " role="menuitem"><a href="https://www.youtube.com/playlist?list=PL1DFmJFZvefiidG0t8jEKTdITXxJrmdO5" data-hide-link-title="0" target="_blank" class="" data-icon-position="">AAC Podcast</a></li>
<li class="menu-829 menu-path-node-1471  even " role="menuitem"><a href="/content/rss" data-hide-link-title="0" class="" data-icon-position="">RSS</a></li>
<li class="menu-828 menu-path-node-1470  odd last" role="menuitem"><a href="/content/faq" data-hide-link-title="0" class="" data-icon-position="">FAQ</a></li>
</ul></li>
<li class="menu-1434 menuparent  menu-path-sjournalsasmorg-content-institutions  odd last" role="menuitem"><a href="https://journals.asm.org/content/institutions" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Subscribe</a><ul role="menu"><li class="menu-1435 menu-path-sjournalsasmorg-content-members first odd " role="menuitem"><a href="https://journals.asm.org/content/members" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Members</a></li>
<li class="menu-1436 menu-path-sjournalsasmorg-content-institutions  even last" role="menuitem"><a href="https://journals.asm.org/content/institutions" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Institutions</a></li>
</ul></li>
</ul></nav>
    </div>
  </div>
</div>  </div>
</div>
  </div>
  
  <div id="zone-header" class="zone zone-header clearfix container-30">
  	      </div>
</header>    
      <section id="section-content" class="section section-content">
    
  <div id="zone-content" class="zone zone-content clearfix container-30">    
        
    <div class="grid-28 suffix-1 prefix-1 region region-content" id="region-content">
  <div class="region-inner region-content-inner">
    <a id="main-content"></a>
                        <div class="block block-system block-main block-system-main odd block-without-title" id="block-system-main">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <div class="panel-display panels-960-layout jcore-2col-layout" >
	  <div class="panel-row-wrapper panel-row-first clearfix">
		
		<div class="top-wrapper">
			<div class="panel-panel panel-region-top">
			  <div class="inside"><div class="panel-pane pane-highwire-article-citation article-page-title-citation" >
  
      
  
  <div class="pane-content">
    <div class="highwire-article-citation highwire-citation-type-highwire-article" data-node-nid="79746" id="node79746--2" data-pisa="aac;48/11/4322" data-pisa-master="aac;48/11/4322" data-apath="/aac/48/11/4322.atom" data-hw-author-tooltip-instance="highwire_author_tooltip"><div class="highwire-cite highwire-cite-highwire-article highwire-citation-asm-article-title clearfix has-author-tooltip highwire-citation-highwire-article-top-a">
  
  
  
      <div class="highwire-cite-overline">Experimental Therapeutics</div>
  
      <h1 class="highwire-cite-title" id="page-title">LB11058, a New Cephalosporin with High Penicillin-Binding Protein 2a Affinity and Activity in Experimental Endocarditis Due to Homogeneously Methicillin-Resistant <em>Staphylococcus aureus</em></h1>  
    	<div class="highwire-cite-authors"><div class="highwire-citation-authors-type highwire-citation-authors-type-author"><span class="contributor-of-type"><em></em></span> <span  class="highwire-citation-authors"><span class="highwire-citation-author first" data-delta="0">Jacques Vouillamoz</span>, <span class="highwire-citation-author" data-delta="1">JosГ© M. Entenza</span>, <span class="highwire-citation-author" data-delta="2">Peter Hohl</span>, <span class="highwire-citation-author" data-delta="3">Philippe Moreillon</span></span></div></div>
  
  
  
  
  
</div>
<div id="hw-article-author-popups-node79746--2" style="display: none;"><div class="author-tooltip-0"><div class="author-tooltip-name">Jacques Vouillamoz </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'>
<span class='nlm-sup'>1</span>Department of Infectious Diseases, Centre Hospitalier Universitaire Vaudois</div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Jacques%2BVouillamoz%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Vouillamoz%20J&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AJacques%2BVouillamoz%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-1"><div class="author-tooltip-name">JosГ© M. Entenza </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'>
<span class='nlm-sup'>1</span>Department of Infectious Diseases, Centre Hospitalier Universitaire Vaudois</div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Jos%C3%A9%2BM.%2BEntenza%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Entenza%20JM&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3AJos%25C3%25A9%2BM.%2BEntenza%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-2"><div class="author-tooltip-name">Peter Hohl </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'>
<span class='nlm-sup'>2</span>Department of Fundamental Microbiology, University of Lausanne, Lausanne, Switzerland</div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Peter%2BHohl%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Hohl%20P&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link last"><a href="/search/author1%3APeter%2BHohl%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li></ul></div><div class="author-tooltip-3"><div class="author-tooltip-name">Philippe Moreillon </div><div class="author-tooltip-affiliation"><span class="author-tooltip-text"><div class='author-affiliation'>
<span class='nlm-sup'>2</span>Department of Fundamental Microbiology, University of Lausanne, Lausanne, Switzerland</div></span></div><ul class="author-tooltip-find-more"><li class="author-tooltip-gs-link first"><a href="/lookup/google-scholar?link_type=googlescholar&amp;gs_type=author&amp;author%5B0%5D=Philippe%2BMoreillon%2B" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on Google Scholar</a></li><li class="author-tooltip-pubmed-link"><a href="/lookup/external-ref?access_num=Moreillon%20P&amp;link_type=AUTHORSEARCH" target="_blank" class="" data-icon-position="" data-hide-link-title="0">Find this author on PubMed</a></li><li class="author-site-search-link"><a href="/search/author1%3APhilippe%2BMoreillon%2B" rel="nofollow" class="" data-icon-position="" data-hide-link-title="0">Search for this author on this site</a></li><li class="author-corresp-email-link last"><span>For correspondence: 
<a href="mailto:Philippe.Moreillon@imf.unil.ch" class="" data-icon-position="" data-hide-link-title="0">Philippe.Moreillon@imf.unil.ch</a></span></li></ul></div></div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-custom pane-1 article-page-header-doi" >
  
      
  
  <div class="pane-content">
    <div><strong>DOI:</strong>&nbsp;10.1128/AAC.48.11.4322-4327.2004</div>
  </div>

  
  </div>
</div>
			</div>
		</div>
	
	</div> <!-- /.panel-row-wrapper -->	
	  
  <div class="panel-row-wrapper clearfix">
		
		<div class="main-content-wrapper grid-17 suffix-1 alpha">
			<div class="panel-panel panel-region-content">
			  <div class="inside"><div class="panel-pane pane-highwire-panel-tabs pane-panels-ajax-tab-tabs" >
  
      
  
  <div class="pane-content">
    <div class="item-list"><ul class="tabs inline panels-ajax-tab"><li class="first"><a href="/content/48/11/4322" class="panels-ajax-tab-tab" data-panel-name="jnl_asm_tab_art" data-target-id="highwire_article_tabs" data-entity-context="node:79746" data-trigger="" data-url-enabled="1">Article</a><a href="/panels_ajax_tab/jnl_asm_tab_art/node:79746/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li><a href="/content/48/11/4322/figures-only" class="panels-ajax-tab-tab" data-panel-name="jnl_asm_tab_data" data-target-id="highwire_article_tabs" data-entity-context="node:79746" data-trigger="figures-only" data-url-enabled="1">Figures & Data</a><a href="/panels_ajax_tab/jnl_asm_tab_data/node:79746/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li><a href="/content/48/11/4322/article-info" class="panels-ajax-tab-tab" data-panel-name="jnl_asm_tab_info" data-target-id="highwire_article_tabs" data-entity-context="node:79746" data-trigger="article-info" data-url-enabled="1">Info & Metrics</a><a href="/panels_ajax_tab/jnl_asm_tab_info/node:79746/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li><li class="last"><a href="/content/aac/48/11/4322.full.pdf" class="panels-ajax-tab-tab" data-panel-name="jnl_asm_tab_pdf" data-target-id="highwire_article_tabs" data-entity-context="node:79746" data-trigger="full-text.pdf" data-url-enabled="1"><i class="icon-file-alt"></i> PDF</a><a href="/panels_ajax_tab/jnl_asm_tab_pdf/node:79746/1" rel="nofollow" style="display:none" class="js-crawler-link"></a></li></ul></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-panel-tabs-container" >
  
      
  
  <div class="pane-content">
    <div data-panels-ajax-tab-preloaded="jnl_asm_tab_art" id="panels-ajax-tab-container-highwire_article_tabs" class="panels-ajax-tab-container"><div class="panels-ajax-tab-loading" style ="display:none"><img class="loading" src="https://aac.asm.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif" alt="Loading" title="Loading" /></div><div class="panels-ajax-tab-wrap-jnl_asm_tab_art"><div class="panel-display panel-1col clearfix" >
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-highwire-markup" >
  
      
  
  <div class="pane-content">
    <div class="highwire-markup"><div xmlns="http://www.w3.org/1999/xhtml" id="content-block-markup" data-highwire-cite-ref-tooltip-instance="highwire_reflinks_tooltip" xmlns:xhtml="http://www.w3.org/1999/xhtml"><div class="article fulltext-view "><span class="highwire-journal-article-marker-start"></span><div class="section abstract" id="abstract-1"><h2 class="">ABSTRACT</h2><p id="p-2">LB11058 is a new synthetic cephalosporin with good affinity for staphylococcal penicillin-binding protein 2a (PBP2a). LB11058 was tested in vitro and in rats with experimental aortic endocarditis against three methicillin-resistant <em>Staphylococcus aureus</em> (MRSA) strains, one penicillinase-negative strain (strain COL), and two penicillinase-producing strains (COL-Bla+ and P8-Hom). The MICs of LB11058 for the organisms were 1 mg/liter. The MICs of vancomycin and ceftriaxone were 1 and в‰Ґ64 mg/liter, respectively. In population analysis profiles, none of the MRSA strains grew at в‰Ґ2 mg of LB11058/liter. Rats with endocarditis were treated for 5 days. LB11058 was highly bound to serum proteins in rats (в‰Ґ98%). However, binding was saturable above a threshold of 250 mg/liter. Therefore, continuous concentrations of 250 mg/liter in serum were infused to ensure a free fraction (в‰Ґ5 mg/liter) above the drug's MIC for the entire infusion period. Control treatments included simulation of human serum kinetics produced by intravenous vancomycin (1 g twice daily, free drug concentration above MIC, в‰Ґ90% of infusion period) or ceftriaxone (2 g/24 h, free drug concentrations above the MIC, 0% of infusion period). LB11058 successfully treated 10 of 10 (100%) and 13 of 14 (93%) of rats infected with COL-Bla+ and P8-Hom, respectively. This was comparable to vancomycin (sterilization of 8 of 12 [66%] and 6 of 8 [75%] rats, respectively). Ceftriaxone was inactive. Low concentrations of LB11058 (5 and 10 mg/liter, continuously infused) in serum were ineffective, as predicted by the pharmacodynamic parameters. At appropriate doses, LB11058 was highly effective both in vitro and in vivo. This finding supports the development of this beta-lactam with high PBP2a affinity for the treatment of MRSA infections.</p></div><p id="p-3">
<em>Staphylococcus aureus</em> is the cause of a vast array of illnesses, from relatively mild skin infections to deep abscesses, osteomyelitis, endocarditis, and bacteremia, as well as staphylococcal toxic shock syndrome and food intoxication (<a id="xref-ref-23-1" class="xref-bibr" href="#ref-23">23</a>). As a consequence, it is a frequent target of antimicrobial therapy. This has resulted in a steady escalation of drug resistance. The organism proved capable of accumulating resistance mechanisms to virtually all clinically available compounds, including the entire beta-lactam family, the recent anti-gram-positive quinolones, and the streptogramin and oxazolidinone families, as well as nonexperimental last-resort drugs such as glycopeptides (<a id="xref-ref-4-1" class="xref-bibr" href="#ref-4">4</a>, <a id="xref-ref-11-1" class="xref-bibr" href="#ref-11">11</a>, <a id="xref-ref-17-1" class="xref-bibr" href="#ref-17">17</a>, <a id="xref-ref-24-1" class="xref-bibr" href="#ref-24">24</a>, <a id="xref-ref-25-1" class="xref-bibr" href="#ref-25">25</a>, <a id="xref-ref-28-1" class="xref-bibr" href="#ref-28">28</a>). Today, <em>S. aureus</em> represents a major risk to public health (<a id="xref-ref-1-1" class="xref-bibr" href="#ref-1">1</a>).</p><p id="p-4">Among potential alternative therapies, the targeting of cell wall building penicillin-binding proteins (PBP) specific for staphylococci represents a promising antibacterial approach. Staphylococci can evade beta-lactam toxicity by at least two mechanisms, including the secretion of penicillinase (<a id="xref-ref-16-1" class="xref-bibr" href="#ref-16">16</a>) and the production of low beta-lactam affinity PBP2a (<a id="xref-ref-2-1" class="xref-bibr" href="#ref-2">2</a>). Low-affinity PBP2a can assemble the peptidoglycan wall when normal PBPs are blocked by beta-lactams, thus conferring intrinsic resistance to methicillin and to all other available beta-lactam molecules (<a id="xref-ref-2-2" class="xref-bibr" href="#ref-2">2</a>, <a id="xref-ref-6-1" class="xref-bibr" href="#ref-6">6</a>). However, it does so only at a certain expense. First, it requires a pentaglycine-decorated muramyl-pentapeptide precursor (<a id="xref-ref-6-2" class="xref-bibr" href="#ref-6">6</a>), which in turn depends on the integrity of the intracellular cell-wall-building machinery that involves a number of auxiliary genes (<a id="xref-ref-7-1" class="xref-bibr" href="#ref-7">7</a>). Second, because PBP2a has only a transpeptidase domain, it must hijack the transglycosidase function of the normal PBP2 to carry out both sugar-linking and peptide-linking processes (<a id="xref-ref-29-1" class="xref-bibr" href="#ref-29">29</a>). Hence, combined blocking of PBP2 and PBP2a should be a powerful approach to restore beta-lactam activity in <em>S. aureus</em> (<a id="xref-ref-15-1" class="xref-bibr" href="#ref-15">15</a>, <a id="xref-ref-22-1" class="xref-bibr" href="#ref-22">22</a>, <a id="xref-ref-33-1" class="xref-bibr" href="#ref-33">33</a>). This strategy has already demonstrated some success in experimental treatment models (<a id="xref-ref-10-1" class="xref-bibr" href="#ref-10">10</a>, <a id="xref-ref-15-2" class="xref-bibr" href="#ref-15">15</a>, <a id="xref-ref-20-1" class="xref-bibr" href="#ref-20">20</a>).</p><p id="p-5">LB11058 is a new cephalosporin with high PBP2 and PBP2a affinity. It is active both in vitro and in some in vivo models against methicillin-resistant <em>S. aureus</em> (MRSA) and several other gram-positive pathogens (Y. Cho, M. Kim, C. S. Lee, and H. Youn, Abstr. 42nd Intersci. Conf. Antimicrob. Agents Chemother., abstr. F-330, p. 173, 2002) (<a id="xref-ref-32-1" class="xref-bibr" href="#ref-32">32</a>). In the present study, we tested LB11058 against three well-described penicillinase-negative and penicillinase-producing homogeneously MRSA strains both in vitro and in the rat model of experimental endocarditis. To help determine the minimal drug concentration active in vivo, we tested several LB11058 levels in serum, which were maintained by steady-state continuous infusion to the animals.</p><div class="section" id="sec-1"><h2 class="">MATERIALS AND METHODS</h2><div id="sec-2" class="subsection"><p id="p-6"><span class="inline-l2-heading">Microorganisms and growth conditions.</span>Three isolates expressing homogeneous resistance to methicillin and extensively characterized in experimental endocarditis were used (<a id="xref-ref-10-2" class="xref-bibr" href="#ref-10">10</a>, <a id="xref-ref-15-3" class="xref-bibr" href="#ref-15">15</a>, <a id="xref-ref-30-1" class="xref-bibr" href="#ref-30">30</a>): (i) the penicillinase-negative reference MRSA strain COL, (ii) a penicillinase-producing transformant of strain COL (strain COL-Bla+) carrying the penicillinase-encoding plasmid pI524 (<a id="xref-ref-30-2" class="xref-bibr" href="#ref-30">30</a>), and (iii) the penicillinase-producing homogeneously methicillin-resistant strain P8-Hom, selected by serial passage of parent strain P8 on methicillin-containing medium (<a id="xref-ref-10-3" class="xref-bibr" href="#ref-10">10</a>). Unless stated otherwise, the bacteria were grown at 35В°C in tryptic soy broth (Difco Laboratories, Detroit, Mich.) with aeration or on tryptic soy agar (Difco) supplemented with 2% of NaCl (for methicillin). Bacterial stocks were kept at в€’70В°C in tryptic soy broth supplemented with 10% (vol/vol) glycerol.</p></div><div id="sec-3" class="subsection"><p id="p-7"><span class="inline-l2-heading">Antibiotics and reagents.</span>LB11058 was provided by LG Life Sciences, Ltd., Daejeon, Korea). Methicillin, flucloxacillin, amoxicillin, clavulanic acid, and amoxicillin-clavulanate (5:1 [wt/wt] ratio) were purchased from GlaxoSmithKline AG (Thoerishaus, Switzerland). Vancomycin was purchased from Eli Lilly (Vernier, Switzerland). All other chemicals were reagent-grade commercially available products.</p></div><div id="sec-4" class="subsection"><p id="p-8"><span class="inline-l2-heading">Susceptibility testing, population analysis profiles, and time-kill curves.</span>The MICs of the drugs for the tests bacteria were determined by a previously described broth macrodilution method (<a id="xref-ref-27-1" class="xref-bibr" href="#ref-27">27</a>) with a final inoculum of 10<sup>5</sup> to 10<sup>6</sup> CFU/ml. For MIC determinations of the combination of amoxicillin-clavulanate, the drugs were used in a ratio of 2:1 (wt/wt). MBCs were measured by subculturing 0.01-ml samples from each MIC tube showing no turbidity onto agar plates, followed by another 48 h of incubation at 35В°C. The MBC was defined as the lowest antibiotic concentration resulting in в‰Ґ99.9% killing of the original inoculum. The phenotypic expression of beta-lactam resistance was evaluated by population analysis profiles. Large bacterial inocula (10<sup>9</sup> CFU), as well as smaller inocula (10<sup>6</sup>, 10<sup>5</sup>, and 10<sup>3</sup> CFU) were spread onto tryptic soy agar plates containing twofold serial dilutions of antibiotics (<a id="xref-ref-15-4" class="xref-bibr" href="#ref-15">15</a>, <a id="xref-ref-30-3" class="xref-bibr" href="#ref-30">30</a>). The numbers of colonies growing on the plates were determined after 48 h of incubation at 35В°C. Population analysis profile curves were generated by plotting the number of CFU growing on the plates against the concentrations of antibiotic in the plates.</p><p id="p-9">For time-kill curves, series of flasks containing fresh prewarmed medium were inoculated with ca. 10<sup>6</sup> CFU/ml (final concentration) from an overnight culture of bacteria and further incubated at 35В°C. Immediately after inoculation, antibiotics were added to the flasks at final concentrations approximating either steady-state levels of free drug (for LB11058) or peak levels (for vancomycin and ceftriaxone) produced in the serum in humans after treatment with the selected standard doses and mimicked in our rat model (see Results). These concentrations were 5 mg/liter for LB11058, 40 mg/liter for vancomycin, and 200 mg/liter for ceftriaxone.</p><p id="p-10">Samples were removed from the flasks just before and at various times after antibiotic addition, serially diluted, and plated onto blood agar for colony counts. Antibiotic carryover was minimized both by appropriate sample dilution for all of the drugs and for beta-lactams by supplementation of the plates with 0.2% (vol/vol) of <em>Bacillus cereus</em> 569/H9 beta-lactamase (penicillin amino-beta-lactam hydrolase; Genzyme Diagnostics, Kent, England). Each time-kill experiment was performed on two independent occasions.</p></div><div id="sec-5" class="subsection"><p id="p-11"><span class="inline-l2-heading">Production of endocarditis and installation of the infusion pump.</span>Sterile aortic vegetations were produced in rats as previously described (<a id="xref-ref-19-1" class="xref-bibr" href="#ref-19">19</a>). An intravenous (i.v.) line was inserted via the jugular vein into the superior vena cava and connected to a programmable infusion pump (Pump 44; Harvard Apparatus, Inc., South Natick, Mass.) to deliver the antibiotics (<a id="xref-ref-14-1" class="xref-bibr" href="#ref-14">14</a>). The pump was set to release a volume of 0.1 ml of saline per h to keep the catheter patent until the onset of therapy. No i.v. lines were placed in the control animals. This did not affect the incidence of infection.</p><p id="p-12">Bacterial endocarditis was induced 24 h after catheterization by i.v. challenge of the animals with 0.5 ml of saline containing 10<sup>5</sup> CFU of either strain COL-Bla+ or strain P8-Hom. This inoculum size was 10 times larger than the minimum inoculum producing endocarditis in 90% of untreated rats irrespective of the infectious organisms.</p></div><div id="sec-6" class="subsection"><p id="p-13"><span class="inline-l2-heading">Antibiotic treatment of experimental endocarditis.</span>Therapy was started 12 h after inoculation and lasted 5 days. Antibiotics were administered at changing flow rates in order to produce either constant drug concentrations in serum of 5, 10, and 250 mg of LB11058/liter or to simulate drug kinetics in human serum during treatment with 1 g of vancomycin i.v. every 12 h (<a id="xref-ref-13-1" class="xref-bibr" href="#ref-13">13</a>) or 2 g of ceftriaxone i.v. every 24 h (<a id="xref-ref-8-1" class="xref-bibr" href="#ref-8">8</a>). This required total amounts of antibiotics (in milligrams per kilogram of body weight) of 14.3 mg, 30.1 mg, and 1.584 g of LB11058 per 24 h. Note that the concentrations of LB11058 in the serum and the amounts of drug delivered were not proportional. This was most likely due to a high level of LB11058 protein-binding, which became saturable over 250/liter (see Results). Above this threshold, free drug was likely to become distributed or secreted, thus necessitating more compound to maintain the steady-state concentration. Amounts for other drugs were 23.2 mg of vancomycin per 12 h and 1.06 g of ceftriaxone per 24 h (<a id="xref-ref-18-1" class="xref-bibr" href="#ref-18">18</a>). Before administration, LB11058 was diluted out to concentrations of up to 19.8 mg/ml in a 0.051 N NaOH solution containing 15% of PEG400. LB11058 was stable under these conditions and lost &lt;5% of activity per 6 h at room temperature (H. Youn, LG Life Sciences [unpublished data]).</p></div><div id="sec-7" class="subsection"><p id="p-14"><span class="inline-l2-heading">Pharmacokinetic and pharmacodynamic studies.</span>Concentrations of antibiotic in serum were determined on day 2 of therapy in groups of three to six uninfected or infected rats per experiments. Drug levels in the infected animals were derived from the internal controls of therapeutic experiments, in which adequate drug delivery was tested routinely. Blood was drawn by puncturing the periorbital sinuses of the animals (one puncture per animal) at several time points during and after antibiotic administration. Antibiotic concentrations were determined by an agar diffusion assay with antibiotic medium 1 (Difco) by using <em>Bacillus subtilis</em> ATCC 6633 as the indicator organism for LB11058 and vancomycin and <em>Escherichia coli</em> ATCC 25922 as the indicator organism for ceftriaxone. The diluent was pooled rat serum. The limits of detection of the assays were 2 mg/liter for LB11058, 0.6 mg/liter for vancomycin, and 3 mg/liter for ceftriaxone. The linearity of the standard curves was assessed by a regression coefficient of в‰Ґ0.996, and the intraplate and interplate variations were в‰¤10%.</p><p id="p-15">In certain experiments, antibiotic binding to rat and human serum proteins was determined by using an ultrafiltration technique reported earlier (<a id="xref-ref-5-1" class="xref-bibr" href="#ref-5">5</a>, <a id="xref-ref-12-1" class="xref-bibr" href="#ref-12">12</a>). LB11058 was diluted at increasing concentrations in either in 5% glucose or pooled (decomplemented) rat or human serum, let stand for 30 min at room temperature, and filtered by using the Amicon Centrifree System (Amicon, Inc., Beverly, Mass.). The drug concentrations in the original samples and in the ultrafiltrates were determined as described above. Of note, ca. 9% (at the concentrations tested) of LB11058 remained bound to the Centrifree cones. These values were subtracted to total drug concentrations for the calculation of protein binding. Serum binding of vancomycin (40%) and ceftriaxone (80%) were extrapolated from previous literature (<a id="xref-ref-18-2" class="xref-bibr" href="#ref-18">18</a>, <a id="xref-ref-21-1" class="xref-bibr" href="#ref-21">21</a>).</p></div><div id="sec-8" class="subsection"><p id="p-16"><span class="inline-l2-heading">Evaluation of infection.</span>Infected control rats were killed at the time of treatment onset, i.e., 12 h after inoculation, in order to determine both the frequency and the severity of valve infection at the start of therapy. Treated rats that completed therapy were sacrificed 12 h after the trough level of the last antibiotic dose of any of the test drugs was achieved when no residual antibiotic could be detected in the blood. Vegetations, blood, and spleens were cultured as previously described (<a id="xref-ref-10-4" class="xref-bibr" href="#ref-10">10</a>, <a id="xref-ref-13-2" class="xref-bibr" href="#ref-13">13</a>, <a id="xref-ref-30-4" class="xref-bibr" href="#ref-30">30</a>). Few animals died before or within the first 24 h of therapy. Only rats that received a minimum of 24 h of the treatment were subjected to vegetation bacterial counts. Bacterial densities in valves and vegetations were expressed as log<sub>10</sub> CFU per gram of tissue. The minimum detection level was в‰Ґ2 log<sub>10</sub> CFU/g of vegetation. For statistical comparisons, culture-negative vegetations were considered to contain 2 log<sub>10</sub> CFU/g.</p></div><div id="sec-9" class="subsection"><p id="p-17"><span class="inline-l2-heading">Statistical analysis.</span>The incidences of valve infection were compared by the Fisher exact test. The Mann-Whitney rank sum test for comparison of differences between residual bacterial titers in the vegetations was used in certain analyses. Differences were considered significant when the <em>P</em> value was &lt;0.05 as determined by using two-tailed significance levels.</p></div></div><div class="section" id="sec-10"><h2 class="">RESULTS</h2><p id="p-18">Antibiotic susceptibility, population analysis profiles, and time-kill curves. Table <a id="xref-table-wrap-1-1" class="xref-table" href="#T1">1</a> presents the MICs of LB11058 compared to those of other beta-lactams and vancomycin against MRSA COL, COL-Bla+, and P8-Hom. LB11058 was remarkably more active than all of the beta-lactam comparators, including amoxicillin and amoxicillin-clavulanate, which have some activity against penicillinase-negative and penicillinase-positive MRSA, respectively (<a id="xref-ref-9-1" class="xref-bibr" href="#ref-9">9</a>, <a id="xref-ref-10-5" class="xref-bibr" href="#ref-10">10</a>, <a id="xref-ref-15-5" class="xref-bibr" href="#ref-15">15</a>). The MICs of LB11058 were not affected by penicillinase, as demonstrated in the COL-Blaв€’ and COL-Bla+ background MICs.</p><div id="T1" class="table pos-float"><div class="table-inline table-callout-links"><div class="callout"><span>View this table:</span><ul class="callout-links"><li class="view-inline first"><a href="##" class="table-expand-inline" data-table-url="/highwire/markup/106550/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&amp;table-expand-inline=1" data-icon-position="" data-hide-link-title="0">View inline</a></li><li class="view-popup last"><a href="/highwire/markup/106550/expansion?width=1000&amp;height=500&amp;iframe=true&amp;postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed" class="colorbox colorbox-load table-expand-popup" rel="gallery-fragment-tables" data-icon-position="" data-hide-link-title="0">View popup</a></li></ul></div></div><div class="table-caption"><span class="table-label">TABLE 1.</span> <p id="p-35" class="first-child">MICs and MBCs of several beta-lactams and vancomycin for three homogeneously MRSA strains: penicillinase-negative MRSA COL, penicillinase-producing MRSA COL-Bla+, and penicillinase-producing MRSA P8-Hom</p><div class="sb-div caption-clear"></div></div></div><p id="p-19">The low MICs in standard tests were confirmed by population analysis profiles (Fig. <a id="xref-fig-1-1" class="xref-fig" href="#F1">1</a>). None of the test organisms was able to grow on agar plates containing more than 1 mg of LB11058 or vancomycin/liter, whereas all of them grew on plates containing &gt; 1000 mg/liter of ceftriaxone. As for standard MICs, the production of penicillinase did not affect the population analysis profile.</p><div id="F1" class="fig pos-float  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://aac.asm.org/content/aac/48/11/4322/F1.large.jpg?width=800&amp;height=600&amp;carousel=1" title="" class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-408103841" data-figure-caption="" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="FIG. 1." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://aac.asm.org/content/aac/48/11/4322/F1.medium.gif" width="290" height="440"/><noscript><img class="highwire-fragment fragment-image" alt="FIG. 1." src="https://aac.asm.org/content/aac/48/11/4322/F1.medium.gif" width="290" height="440"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="new-tab first"><a href="https://aac.asm.org/content/aac/48/11/4322/F1.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li><li class="download-ppt last"><a href="/highwire/powerpoint/106605" class="highwire-figure-link highwire-figure-link-ppt" data-icon-position="" data-hide-link-title="0">Download powerpoint</a></li></ul></div><div class="fig-caption" xmlns:xhtml="http://www.w3.org/1999/xhtml"><span class="fig-label">FIG. 1.</span> <p id="p-32" class="first-child">Population analysis profile of homogeneously methicillin-resistant, but penicillinase-negative MRSA COL (A) and its penicillinase-producing transformant COL-Bla+ (B). Various sizes of bacterial inocula were spread on agar plates containing increasing concentrations of either LB11058 (в™¦), vancomycin (в—‹), or ceftriaxone (в–Є). The datum points indicate the number of colonies growing on the plates after 48 h of incubation at 35В°C. Similar observations were made with MRSA P8-Hom (not depicted on the graph). The results are the mean of в‰Ґ3 individual experiments with a variation of &lt;15%.</p><div class="sb-div caption-clear"></div></div></div><p id="p-20">Figure <a id="xref-fig-2-1" class="xref-fig" href="#F2">2</a> presents the results of time-kill curves performed with 5 mg of LB11058 (five times the MIC, see Table <a id="xref-table-wrap-1-2" class="xref-table" href="#T1">1</a>)/liter and with peak levels of vancomycin (40 mg/liter, or 40 times the MIC) and ceftriaxone (200 mg/liter, or ca. &lt;1 times the MIC) in serum. Killing was slow, corresponding to previous observations with cell wall inhibitors against these rather tolerant organisms (<a id="xref-ref-10-6" class="xref-bibr" href="#ref-10">10</a>, <a id="xref-ref-11-2" class="xref-bibr" href="#ref-11">11</a>). MBCs confirmed the bactericidal effect of LB11058 (Table <a id="xref-table-wrap-1-3" class="xref-table" href="#T1">1</a>).</p><div id="F2" class="fig pos-float  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://aac.asm.org/content/aac/48/11/4322/F2.large.jpg?width=800&amp;height=600&amp;carousel=1" title="" class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-408103841" data-figure-caption="" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="FIG. 2." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://aac.asm.org/content/aac/48/11/4322/F2.medium.gif" width="192" height="440"/><noscript><img class="highwire-fragment fragment-image" alt="FIG. 2." src="https://aac.asm.org/content/aac/48/11/4322/F2.medium.gif" width="192" height="440"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="new-tab first"><a href="https://aac.asm.org/content/aac/48/11/4322/F2.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li><li class="download-ppt last"><a href="/highwire/powerpoint/106640" class="highwire-figure-link highwire-figure-link-ppt" data-icon-position="" data-hide-link-title="0">Download powerpoint</a></li></ul></div><div class="fig-caption"><span class="fig-label">FIG. 2.</span> <p id="p-33" class="first-child">Time-kill experiments performed with either 5 mg of LB11058/liter (в™¦), a concentration approximating the free fraction of the drug used in vivo (see the text and Fig. <a id="xref-fig-3-3" class="xref-fig" href="#F3">3</a>) or peak levels produced by therapeutic doses of vancomycin (40 mg/liter [Г—]) or ceftriaxone (200 mg/liter [в—‹]) in serum. в–ґ, Controls. Flasks containing prewarmed medium were inoculated with a final concentration of в€ј10<sup>6</sup> CFU from an overnight culture of either of the penicillinase-negative (COL [A]) or the penicillinase-producing (COL-Bla+ or P8-Hom [B and C, respectively]) strains. MRSA and antibiotics were added. Samples were removed at various times before and after antibiotic addition and plated for colony counts. The experiments were repeated в‰Ґ2 times and yielded similar results each time.</p><div class="sb-div caption-clear"></div></div></div><div id="sec-11" class="subsection"><p id="p-21"><span class="inline-l2-heading">Pharmacokinetics, pharmacodynamics, and drug delivery.</span>LB11058 binding to rat and human serum proteins was determined by ultrafiltration by using the Amicon Centrifree System. LB11058 was shown to be highly bound (96 to 98%) to serum proteins in rats (H. Y. Joo, J. E., Shin, L. H. Choi, D. H. Park, S. H. Kim, S. H. Lee, and H. Youn, Abstr. 42nd Intersci. Conf. Antimicrob. Agents Chemother., abstr. F-331, p. 174, 2002). Hence, it was important to set up a drug delivery system providing enough total drug in serum and tissues to ensure a minimum free fraction equal to or greater than the MIC for the test microorganisms. Figure <a id="xref-fig-3-1" class="xref-fig" href="#F3">3</a> depicts the profile of free LB11058 when diluted into pooled rat or human serum in vitro. It can be seen that the drug was highly bound up to concentrations of 250 mg/liter for rats and 200 mg/liter for humans. However, binding became saturable and free drug substantially increased above these cutoff concentrations. By comparison, vancomycin was bound in rat serum at 40% (<a id="xref-ref-21-2" class="xref-bibr" href="#ref-21">21</a>), and ceftriaxone was bound in rat serum at 80% (<a id="xref-ref-18-3" class="xref-bibr" href="#ref-18">18</a>). Thus, we inferred that, based on an MIC of 1 mg of LB11058/liter for MRSA, the concentrations of LB11058 in the serum of rats should be close to 250 mg/liter or more in order to be effective.</p><div id="F3" class="fig pos-float  odd"><div class="highwire-figure"><div class="fig-inline-img-wrapper"><div class="fig-inline-img"><a href="https://aac.asm.org/content/aac/48/11/4322/F3.large.jpg?width=800&amp;height=600&amp;carousel=1" title="" class="highwire-fragment fragment-images colorbox-load" rel="gallery-fragment-images-408103841" data-figure-caption="" data-icon-position="" data-hide-link-title="0"><span class="hw-responsive-img"><img class="highwire-fragment fragment-image lazyload" alt="FIG. 3." src="data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7" data-src="https://aac.asm.org/content/aac/48/11/4322/F3.medium.gif" width="440" height="243"/><noscript><img class="highwire-fragment fragment-image" alt="FIG. 3." src="https://aac.asm.org/content/aac/48/11/4322/F3.medium.gif" width="440" height="243"/></noscript></span></a></div></div><ul class="highwire-figure-links inline"><li class="new-tab first"><a href="https://aac.asm.org/content/aac/48/11/4322/F3.large.jpg" class="highwire-figure-link highwire-figure-link-newtab" target="_blank" data-icon-position="" data-hide-link-title="0">Open in new tab</a></li><li class="download-ppt last"><a href="/highwire/powerpoint/106631" class="highwire-figure-link highwire-figure-link-ppt" data-icon-position="" data-hide-link-title="0">Download powerpoint</a></li></ul></div><div class="fig-caption"><span class="fig-label">FIG. 3.</span> <p id="p-34" class="first-child">Free fraction of LB11058 in rat and human sera as determined by ultrafiltration, followed by antibiotic activity measurement by bioassay (<a id="xref-ref-5-2" class="xref-bibr" href="#ref-5">5</a>, <a id="xref-ref-12-2" class="xref-bibr" href="#ref-12">12</a>). Pooled rat serum (в–Є) and human serum (в–µ) were spiked with increasing concentrations of LB11058 and let stand at room temperature, and then the free fractions were recovered by ultrafiltration as described previously (<a id="xref-ref-5-3" class="xref-bibr" href="#ref-5">5</a>, <a id="xref-ref-12-3" class="xref-bibr" href="#ref-12">12</a>). The percentage of free over total fraction is plotted on the graph. Values of &lt;2 mg/liter could not be accurately determined due to the limit of detection of the dosing method (see Materials and Methods). Control experiments with amoxicillin in rat sera disclosed a free fraction of в‰Ґ80% at any of the tested concentrations (not depicted on the graph). Results are the means of в‰Ґ2 individual experiments with a variation of &lt;15%.</p><div class="sb-div caption-clear"></div></div></div><p id="p-22">To test this hypothesis in rats, three treatment protocols were used. In the first protocol the drug was administered to produce a constant concentration of 5 mg/liter of LB11058 in the serum (expected free fraction of 0.1 to 0.2 mg/liter; 0% time over the MIC). In the second protocol we targeted a constant concentration of 10 mg/liter (expected free fraction of 0.2 to 0.4 mg/liter; 0% time over the MIC). In the third protocol we targeted a constant concentration of ca. 250 mg/liter (expected free fraction of 5 to 10 mg/liter; 100% time over the MIC). Positive and negative controls with vancomycin and ceftriaxone ensured 100 and 0% time over the MIC, respectively.</p></div><div id="sec-12" class="subsection"><p id="p-23"><span class="inline-l2-heading">Treatment of experimental endocarditis.</span>Table <a id="xref-table-wrap-2-1" class="xref-table" href="#T2">2</a> indicates that low dosages to LB11058 failed to cure the infected animals. This was presumably due to insufficient amounts of free drug at the sites of infection. However, after increasing drug dosage to ensure free serum concentrations of 5 to 10 times the MIC, LB11058 proved highly effective. Control treatment with vancomycin was also effective but resulted in a greater number of treatment failures. Few negative controls treated with ceftriaxone failed to respond to therapy (Table <a id="xref-table-wrap-2-2" class="xref-table" href="#T2">2</a>).</p><div id="T2" class="table pos-float"><div class="table-inline table-callout-links"><div class="callout"><span>View this table:</span><ul class="callout-links"><li class="view-inline first"><a href="##" class="table-expand-inline" data-table-url="/highwire/markup/106507/expansion?postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed&amp;table-expand-inline=1" data-icon-position="" data-hide-link-title="0">View inline</a></li><li class="view-popup last"><a href="/highwire/markup/106507/expansion?width=1000&amp;height=500&amp;iframe=true&amp;postprocessors=highwire_tables%2Chighwire_reclass%2Chighwire_figures%2Chighwire_math%2Chighwire_inline_linked_media%2Chighwire_embed" class="colorbox colorbox-load table-expand-popup" rel="gallery-fragment-tables" data-icon-position="" data-hide-link-title="0">View popup</a></li></ul></div></div><div class="table-caption"><span class="table-label">TABLE 2.</span> <p id="p-37" class="first-child">Antibiotic dosage and therapeutic results in experimental endocarditis due to homogeneously methicillin-resistant and penicillinase-producing <em>S. aureus</em> COL-Bla+ and P8-Hom</p><div class="sb-div caption-clear"></div></div></div><p id="p-24">The overall mortality ranged between 10 and 20% in all groups. It occurred within first 24 h of therapy and was most likely due to postsurgery complications. Mortality tended to be lower in the high-dose LB11058 group, but this was not statistically significant. Spleens were infected (10 to &gt;1,000 CFU/g of tissue) in all rats with positive valve cultures, except for the single treatment failure in the high-dose LB11058 group infected with MRSA P8. This rat had a positive valve culture but a negative spleen culture. Thus, LB11058 dosage producing free drug concentrations as low as 5 to 10 times the MIC proved highly bactericidal against experimental endocarditis due to homogeneously methicillin-resistant MRSA.</p></div></div><div class="section" id="sec-13"><h2 class="">DISCUSSION</h2><p id="p-25">The present results confirm the excellent activity of LB11058 against well-characterized homogeneously MRSA both in standard MIC tests and in more stringent population analysis profiles (<a id="xref-ref-32-2" class="xref-bibr" href="#ref-32">32</a>). LB11058 was at least as effective as the other recently described anti-PBP2a cephalosporin BAL9141 (<a id="xref-ref-10-7" class="xref-bibr" href="#ref-10">10</a>), which is one of the most active anti-MRSA beta-lactam currently under development. Of note, both beta-lactams with good PBP2a affinity tended to be more effective than vancomycin, although this was not statistically significant when assessed in individual experiments (<a id="xref-ref-10-8" class="xref-bibr" href="#ref-10">10</a>).</p><p id="p-26">The good anti-MRSA activity of LB11058 correlated with its ability to inhibit to PBP2a (50% inhibitory concentration [IC<sub>50</sub>] = 0.8 mg/liter) (Cho et al., 42nd ICAAC). A similar correlation was previously described with a few older beta-lactams demonstrating inhibitory activity against penicillinase-negative MRSA (<a id="xref-ref-3-1" class="xref-bibr" href="#ref-3">3</a>, <a id="xref-ref-15-6" class="xref-bibr" href="#ref-15">15</a>). In short, methicillin and nafcillin had IC<sub>50</sub>s of 200 to 500 mg/liter and MICs of &gt;128 mg/liter, and penicillin G, ampicillin, and amoxicillin had IC<sub>50</sub>s of 20 to 40 mg/liter and MICs of 16 mg/liter (<a id="xref-ref-3-2" class="xref-bibr" href="#ref-3">3</a>, <a id="xref-ref-15-7" class="xref-bibr" href="#ref-15">15</a>). BAL9141 and LB11058 had IC<sub>50</sub>s between 0.5 and 1 mg/liter and MICs of 0.5 to 1 mg/liter (<a id="xref-ref-10-9" class="xref-bibr" href="#ref-10">10</a>, <a id="xref-ref-32-3" class="xref-bibr" href="#ref-32">32</a>). Thus, the IC<sub>50</sub> of the drug for PBP2a is predictive of its inhibitory power.</p><p id="p-27">LB11058 was highly effective in vivo provided that enough drug was delivered to overcome its high serum binding in rats (up to 98%) (Joo et al., 42nd ICAAC). Serum binding appeared to be saturable. Thus, any concentrations above a threshold value of 200 to 250 mg/liter gave a large increase in free drug in vitro (Fig. <a id="xref-fig-2-2" class="xref-fig" href="#F2">2</a>). The relevance of this pharmacodynamic property in rats was evaluated by using drug doses producing either low steady-state concentrations in the serum (5 and 10 mg/liter) or concentrations that were greater than the в€ј250-mg/liter cutoff. LB11058 was highly effective under the latter condition, even though it failed at subtherapeutic doses (5 and 10 mg/liter), as predicted by the pharmacodynamic parameters. Of note, the good in vivo efficacy of high-dose therapy was not due to untoward antibiotic carryover on agar plates. The terminal elimination half-life of the compound in rats is в€ј50 min (Joo et al., 42nd ICAAC), and no residual antibiotic was detected in the blood at the time of sacrifice, i.e., approximately 12 h after treatment termination.</p><p id="p-28">Whether high serum protein binding might be a limitation of LB11058 in human will require further studies. It is less bound in the serum of human (93%) (Joo et al., 42nd ICAAC) than in the serum of rats, and the saturation cutoff appeared somewhat lower in our experiments (Fig. <a id="xref-fig-3-2" class="xref-fig" href="#F3">3</a>). A concentration of 10 to 20 mg/liter in human serum would leave a free fraction of 0.7 to 1.4 mg/liter, i.e., approximately the MIC of LB11058 for our MRSA, and by and large at least threefold greater than its MICs for methicillin-susceptible staphylococci (0.25 mg/liter) and other gram-positive pathogens, including penicillin-susceptible and penicillin-resistant pneumococci (Cho et al., 42nd ICAAC) (<a id="xref-ref-32-4" class="xref-bibr" href="#ref-32">32</a>). Of note, LB11058 could be given at much higher concentrations to rats without apparent acute toxicity. The safety of such a dosage in humans needs to be tested.</p><p id="p-29">All in all, the present study supports the anti-PBP2a strategy as a well-suited approach against MRSA. Due to the lack of apparent toxicity for the rat, the novel anti-MRSA beta-lactam studied might be administered at high concentrations, possibly resulting in a wide therapeutic-toxic margin (<a id="xref-ref-26-1" class="xref-bibr" href="#ref-26">26</a>). This represents an advantage over many other new compounds, including quinupristin-dalfopristin, linezolid and quinolones because it offsets potential pharmacodynamic shortcomings (e.g., low tissue penetration) and could decrease the risk of resistance selection. The risk of resistance selection against anti-PBP2a beta-lactams in not known. However, preliminary experiments (<a id="xref-ref-10-10" class="xref-bibr" href="#ref-10">10</a>), as well as unpublished results, with amoxicillin-clavulanate indicate that it is very low (unpublished observations). We conclude that PBP2a-blocking beta-lactams are likely to become very promising new compounds against multiresistant staphylococci, including <em>S. aureus</em> and all coagulase-negative species (<a id="xref-ref-9-2" class="xref-bibr" href="#ref-9">9</a>, <a id="xref-ref-10-11" class="xref-bibr" href="#ref-10">10</a>, <a id="xref-ref-15-8" class="xref-bibr" href="#ref-15">15</a>, <a id="xref-ref-22-2" class="xref-bibr" href="#ref-22">22</a>, <a id="xref-ref-31-1" class="xref-bibr" href="#ref-31">31</a>, <a id="xref-ref-33-2" class="xref-bibr" href="#ref-33">33</a>).</p></div><div class="section ack" id="ack-1"><h2>ACKNOWLEDGMENTS</h2><p id="p-30">This study was partially supported by grant 32-65371.01 from the Swiss National Funds for Scientific Research and by an unrestricted grant from LG Life Sciences, Ltd.</p><p id="p-31">We thank Marlyse Giddey for outstanding technical assistance.</p></div><div class="section fn-group" id="fn-group-1"><h2>FOOTNOTES</h2><ul><ul class="history-list"><li xmlns:hwp="http://schema.highwire.org/Journal" class="received" hwp:start="2004-03-05"><span class="received-label">Received </span>5 March 2004.</li><li xmlns:hwp="http://schema.highwire.org/Journal" class="rev-recd" hwp:start="2004-04-10"><span class="rev-recd-label">Returned for modification </span>10 April 2004.</li><li xmlns:hwp="http://schema.highwire.org/Journal" class="accepted" hwp:start="2004-07-08"><span class="accepted-label">Accepted </span>8 July 2004.</li></ul></ul></div><ul class="copyright-statement"><li class="fn" id="copyright-statement-1">Copyright В© 2004 American Society for Microbiology</li></ul><div class="section ref-list" id="ref-list-1"><h2 class="">REFERENCES</h2><ol class="cit-list ref-use-labels"><li><span class="ref-label">1.</span><a class="rev-xref-ref" href="#xref-ref-1-1" title="View reference 1. in text" id="ref-1">в†µ</a><div class="cit ref-cit ref-other" id="cit-48.11.4322.1" data-doi="10.3201/eid0702.010204"><div class="cit-metadata"><cite><strong>Chambers, H. F.</strong>
<span class="cit-pub-date">2001</span>. The changing epidemiology of <em>Staphylococcus aureus</em>? <span class="cit-source">Emerg. Infect. Dis.</span><span class="cit-vol">7</span><strong>:</strong><span class="cit-fpage">178</span>-182.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DEmerging%2Binfectious%2Bdiseases%26rft.stitle%253DEmerg%2BInfect%2BDis%26rft.aulast%253DChambers%26rft.auinit1%253DH.%2BF.%26rft.volume%253D7%26rft.issue%253D2%26rft.spage%253D178%26rft.epage%253D182%26rft.atitle%253DThe%2Bchanging%2Bepidemiology%2Bof%2BStaphylococcus%2Baureus%253F%26rft_id%253Dinfo%253Adoi%252F10.3201%252Feid0702.010204%26rft_id%253Dinfo%253Apmid%252F11294701%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.3201/eid0702.010204&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=11294701&amp;link_type=MED&amp;atom=%2Faac%2F48%2F11%2F4322.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000168112000004&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">2.</span><a class="rev-xref-ref" href="#xref-ref-2-1" title="View reference 2. in text" id="ref-2">в†µ</a><div class="cit ref-cit ref-other" id="cit-48.11.4322.2" data-doi="10.1172/JCI111965"><div class="cit-metadata"><cite><strong>Chambers, H. F., B. J. Hartman, and A. Tomasz.</strong>
<span class="cit-pub-date">1985</span>. Increased amounts of a novel penicillin-binding protein in a strain of methicillin-resistant <em>Staphylococcus aureus.</em><span class="cit-source">J. Clin. Investig.</span><span class="cit-vol">76</span><strong>:</strong><span class="cit-fpage">325</span>-331.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJournal%2Bof%2BClinical%2BInvestigation%26rft.stitle%253DJCI%26rft.aulast%253DChambers%26rft.auinit1%253DH.%2BF.%26rft.volume%253D76%26rft.issue%253D1%26rft.spage%253D325%26rft.epage%253D331%26rft.atitle%253DIncreased%2Bamounts%2Bof%2Ba%2Bnovel%2Bpenicillin-binding%2Bprotein%2Bin%2Ba%2Bstrain%2Bof%2Bmethicillin-resistant%2BStaphylococcus%2Baureus%2Bexposed%2Bto%2Bnafcillin.%26rft_id%253Dinfo%253Adoi%252F10.1172%252FJCI111965%26rft_id%253Dinfo%253Apmid%252F4019783%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1172/JCI111965&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=4019783&amp;link_type=MED&amp;atom=%2Faac%2F48%2F11%2F4322.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=A1985AMF6100045&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">3.</span><a class="rev-xref-ref" href="#xref-ref-3-1" title="View reference 3. in text" id="ref-3">в†µ</a><div class="cit ref-cit ref-other" id="cit-48.11.4322.3" data-doi="10.1093/infdis/162.3.705"><div class="cit-metadata"><cite><strong>Chambers, H. F., M. Sachdeva, and S. Kennedy.</strong>
<span class="cit-pub-date">1990</span>. Binding affinity for penicillin-binding protein 2a correlates with in vivo activity of beta-lactam antibiotics against methicillin-resistant <em>Staphylococcus aureus.</em><span class="cit-source">J. Infect. Dis.</span><span class="cit-vol">162</span><strong>:</strong><span class="cit-fpage">705</span>-710.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ.%2BInfect.%2BDis.%26rft_id%253Dinfo%253Adoi%252F10.1093%252Finfdis%252F162.3.705%26rft_id%253Dinfo%253Apmid%252F2387996%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1093/infdis/162.3.705&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=2387996&amp;link_type=MED&amp;atom=%2Faac%2F48%2F11%2F4322.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">4.</span><a class="rev-xref-ref" href="#xref-ref-4-1" title="View reference 4. in text" id="ref-4">в†µ</a><div class="cit ref-cit ref-other" id="cit-48.11.4322.4" data-doi="10.1056/NEJMoa025025"><div class="cit-metadata"><cite><strong>Chang, S., D. M. Sievert, J. C. Hageman, M. L. Boulton, F. C. Tenover, F. P. Downes, S. Shah, J. T. Rudrik, G. R. Pupp, W. J. Brown, D. Cardo, and S. K. Fridkin.</strong>
<span class="cit-pub-date">2003</span>. Infection with vancomycin-resistant <em>Staphylococcus aureus</em> containing the <em>vanA</em> resistance gene. <span class="cit-source">N. Engl. J. Med.</span><span class="cit-vol">348</span><strong>:</strong><span class="cit-fpage">1342</span>-1347.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNew%2BEngland%2BJournal%2Bof%2BMedicine%26rft.stitle%253DNEJM%26rft.aulast%253DChang%26rft.auinit1%253DS.%26rft.volume%253D348%26rft.issue%253D14%26rft.spage%253D1342%26rft.epage%253D1347%26rft.atitle%253DInfection%2Bwith%2BVancomycin-Resistant%2BStaphylococcus%2Baureus%2BContaining%2Bthe%2BvanA%2BResistance%2BGene%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJMoa025025%26rft_id%253Dinfo%253Apmid%252F12672861%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1056/NEJMoa025025&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=12672861&amp;link_type=MED&amp;atom=%2Faac%2F48%2F11%2F4322.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000181949100005&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">5.</span><a class="rev-xref-ref" href="#xref-ref-5-1" title="View reference 5. in text" id="ref-5">в†µ</a><div class="cit ref-cit ref-other" id="cit-48.11.4322.5"><div class="cit-metadata"><cite><strong>Craig, W. A., and B. Suh.</strong>
<span class="cit-pub-date">1991</span>. Protein binding and the antimicrobial effects: methods for the determination of protein binding, p. <span class="cit-fpage">367</span>-402. <em>In</em> V. Lorian (ed.), <span class="cit-source">Antibiotics in laboratory medicine, 3rd ed.</span> The Williams and Wilkins Co., Baltimore, Md.</cite></div><div class="cit-extra"></div></div></li><li><span class="ref-label">6.</span><a class="rev-xref-ref" href="#xref-ref-6-1" title="View reference 6. in text" id="ref-6">в†µ</a><div class="cit ref-cit ref-other" id="cit-48.11.4322.6" data-doi="10.1128/AAC.37.2.342"><div class="cit-metadata"><cite><strong>de Jonge, B. L., and A. Tomasz.</strong>
<span class="cit-pub-date">1993</span>. Abnormal peptidoglycan produced in a methicillin-resistant strain of <em>Staphylococcus aureus</em> grown in the presence of methicillin: functional role for penicillin-binding protein 2A in cell wall synthesis. <span class="cit-source">Antimicrob. Agents Chemother.</span><span class="cit-vol">37</span><strong>:</strong><span class="cit-fpage">342</span>-346.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DAntimicrobial%2BAgents%2Band%2BChemotherapy%26rft.stitle%253DAntimicrob.%2BAgents%2BChemother.%26rft.aulast%253Dde%2BJonge%26rft.auinit1%253DB.%2BL.%2BM.%26rft.volume%253D37%26rft.issue%253D2%26rft.spage%253D342%26rft.epage%253D346%26rft.atitle%253DAbnormal%2BPeptidoglycan%2BProduced%2Bin%2Ba%2BMethicillin-Resistant%2BStrain%2Bof%2BStaphylococcus%2Baureus%2BGrown%2Bin%2Bthe%2BPresence%2Bof%2BMethicillin%253A%2BFunctional%2BRole%2Bfor%2BPenicillin-Binding%2BProtein%2B2A%2Bin%2BCell%2BWall%2BSynthesis%26rft_id%253Dinfo%253Adoi%252F10.1128%252FAAC.37.2.342%26rft_id%253Dinfo%253Apmid%252F8452368%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiYWFjIjtzOjU6InJlc2lkIjtzOjg6IjM3LzIvMzQyIjtzOjQ6ImF0b20iO3M6MjA6Ii9hYWMvNDgvMTEvNDMyMi5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">7.</span><a class="rev-xref-ref" href="#xref-ref-7-1" title="View reference 7. in text" id="ref-7">в†µ</a><div class="cit ref-cit ref-other" id="cit-48.11.4322.7" data-doi="10.1128/AAC.38.11.2590"><div class="cit-metadata"><cite><strong>de Lencastre, H., and A. Tomasz.</strong>
<span class="cit-pub-date">1994</span>. Reassessment of the number of auxiliary genes essential for expression of high-level methicillin resistance in <em>Staphylococcus aureus.</em><span class="cit-source">Antimicrob. Agents Chemother.</span><span class="cit-vol">38</span><strong>:</strong><span class="cit-fpage">2590</span>-2598.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DAntimicrobial%2BAgents%2Band%2BChemotherapy%26rft.stitle%253DAntimicrob.%2BAgents%2BChemother.%26rft.aulast%253Dde%2BLencastre%26rft.auinit1%253DH.%26rft.volume%253D38%26rft.issue%253D11%26rft.spage%253D2590%26rft.epage%253D2598%26rft.atitle%253DReassessment%2Bof%2Bthe%2Bnumber%2Bof%2Bauxiliary%2Bgenes%2Bessential%2Bfor%2Bexpression%2Bof%2Bhigh-level%2Bmethicillin%2Bresistance%2Bin%2BStaphylococcus%2Baureus.%26rft_id%253Dinfo%253Adoi%252F10.1128%252FAAC.38.11.2590%26rft_id%253Dinfo%253Apmid%252F7872753%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiYWFjIjtzOjU6InJlc2lkIjtzOjEwOiIzOC8xMS8yNTkwIjtzOjQ6ImF0b20iO3M6MjA6Ii9hYWMvNDgvMTEvNDMyMi5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">8.</span><a class="rev-xref-ref" href="#xref-ref-8-1" title="View reference 8. in text" id="ref-8">в†µ</a><div class="cit ref-cit ref-other" id="cit-48.11.4322.8" data-doi="10.1093/jac/44.6.775"><div class="cit-metadata"><cite><strong>Entenza, J. M., I. Caldelari, M. P. Glauser, and P. Moreillon.</strong>
<span class="cit-pub-date">1999</span>. Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci. <span class="cit-source">J. Antimicrob. Chemother.</span><span class="cit-vol">44</span><strong>:</strong><span class="cit-fpage">775</span>-786.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJournal%2Bof%2BAntimicrobial%2BChemotherapy%26rft.stitle%253DJ%2BAntimicrob%2BChemother%26rft.aulast%253DEntenza%26rft.auinit1%253DJ.%2BM.%26rft.volume%253D44%26rft.issue%253D6%26rft.spage%253D775%26rft.epage%253D786%26rft.atitle%253DEfficacy%2Bof%2Blevofloxacin%2Bin%2Bthe%2Btreatment%2Bof%2Bexperimental%2Bendocarditis%2Bcaused%2Bby%2Bviridans%2Bgroup%2Bstreptococci%26rft_id%253Dinfo%253Adoi%252F10.1093%252Fjac%252F44.6.775%26rft_id%253Dinfo%253Apmid%252F10590278%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1093/jac/44.6.775&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=10590278&amp;link_type=MED&amp;atom=%2Faac%2F48%2F11%2F4322.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000084294400008&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">9.</span><a class="rev-xref-ref" href="#xref-ref-9-1" title="View reference 9. in text" id="ref-9">в†µ</a><div class="cit ref-cit ref-other" id="cit-48.11.4322.9" data-doi="10.1093/infdis/170.1.100"><div class="cit-metadata"><cite><strong>Entenza, J. M., U. Fluckiger, M. P. Glauser, and P. Moreillon.</strong>
<span class="cit-pub-date">1994</span>. Antibiotic treatment of experimental endocarditis due to methicillin-resistant <em>Staphylococcus epidermidis.</em><span class="cit-source">J. Infect. Dis.</span><span class="cit-vol">170</span><strong>:</strong><span class="cit-fpage">100</span>-109.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ.%2BInfect.%2BDis.%26rft_id%253Dinfo%253Adoi%252F10.1093%252Finfdis%252F170.1.100%26rft_id%253Dinfo%253Apmid%252F8014483%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1093/infdis/170.1.100&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=8014483&amp;link_type=MED&amp;atom=%2Faac%2F48%2F11%2F4322.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">10.</span><a class="rev-xref-ref" href="#xref-ref-10-1" title="View reference 10. in text" id="ref-10">в†µ</a><div class="cit ref-cit ref-other" id="cit-48.11.4322.10" data-doi="10.1128/AAC.46.1.171-177.2002"><div class="cit-metadata"><cite><strong>Entenza, J. M., P. Hohl, I. Heinze-Krauss, M. P. Glauser, and P. Moreillon.</strong>
<span class="cit-pub-date">2002</span>. BAL9141, a novel extended-spectrum cephalosporin active against methicillin-resistant <em>Staphylococcus aureus</em> in treatment of experimental endocarditis. <span class="cit-source">Antimicrob. Agents Chemother.</span><span class="cit-vol">46</span><strong>:</strong><span class="cit-fpage">171</span>-177.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DAntimicrobial%2BAgents%2Band%2BChemotherapy%26rft.stitle%253DAntimicrob.%2BAgents%2BChemother.%26rft.aulast%253DEntenza%26rft.auinit1%253DJ.%2BM.%26rft.volume%253D46%26rft.issue%253D1%26rft.spage%253D171%26rft.epage%253D177%26rft.atitle%253DBAL9141%252C%2Ba%2BNovel%2BExtended-Spectrum%2BCephalosporin%2BActive%2Bagainst%2BMethicillin-Resistant%2BStaphylococcus%2Baureus%2Bin%2BTreatment%2Bof%2BExperimental%2BEndocarditis%26rft_id%253Dinfo%253Adoi%252F10.1128%252FAAC.46.1.171-177.2002%26rft_id%253Dinfo%253Apmid%252F11751129%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiYWFjIjtzOjU6InJlc2lkIjtzOjg6IjQ2LzEvMTcxIjtzOjQ6ImF0b20iO3M6MjA6Ii9hYWMvNDgvMTEvNDMyMi5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">11.</span><a class="rev-xref-ref" href="#xref-ref-11-1" title="View reference 11. in text" id="ref-11">в†µ</a><div class="cit ref-cit ref-other" id="cit-48.11.4322.11" data-doi="10.1128/AAC.45.11.3076-3083.2001"><div class="cit-metadata"><cite><strong>Entenza, J. M., Y. A. Que, J. Vouillamoz, M. P. Glauser, and P. Moreillon.</strong>
<span class="cit-pub-date">2001</span>. Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant <em>Staphylococcus aureus</em> expressing various degrees of ciprofloxacin resistance. <span class="cit-source">Antimicrob. Agents Chemother.</span><span class="cit-vol">45</span><strong>:</strong><span class="cit-fpage">3076</span>-3083.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DAntimicrobial%2BAgents%2Band%2BChemotherapy%26rft.stitle%253DAntimicrob.%2BAgents%2BChemother.%26rft.aulast%253DEntenza%26rft.auinit1%253DJ.%2BM.%26rft.volume%253D45%26rft.issue%253D11%26rft.spage%253D3076%26rft.epage%253D3083%26rft.atitle%253DEfficacies%2Bof%2BMoxifloxacin%252C%2BCiprofloxacin%252C%2Band%2BVancomycin%2Bagainst%2BExperimental%2BEndocarditis%2BDue%2Bto%2BMethicillin-ResistantStaphylococcus%2Baureus%2BExpressing%2BVarious%2BDegrees%2Bof%2BCiprofloxacin%2BResistance%26rft_id%253Dinfo%253Adoi%252F10.1128%252FAAC.45.11.3076-3083.2001%26rft_id%253Dinfo%253Apmid%252F11600359%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiYWFjIjtzOjU6InJlc2lkIjtzOjEwOiI0NS8xMS8zMDc2IjtzOjQ6ImF0b20iO3M6MjA6Ii9hYWMvNDgvMTEvNDMyMi5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">12.</span><a class="rev-xref-ref" href="#xref-ref-12-1" title="View reference 12. in text" id="ref-12">в†µ</a><div class="cit ref-cit ref-other" id="cit-48.11.4322.12" data-doi="10.1128/AAC.43.1.77"><div class="cit-metadata"><cite><strong>Entenza, J. M., J. Vouillamoz, M. P. Glauser, and P. Moreillon.</strong>
<span class="cit-pub-date">1999</span>. Efficacy of trovafloxacin in treatment of experimental staphylococcal or streptococcal endocarditis. <span class="cit-source">Antimicrob. Agents Chemother.</span><span class="cit-vol">43</span><strong>:</strong><span class="cit-fpage">77</span>-84.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DAntimicrobial%2BAgents%2Band%2BChemotherapy%26rft.stitle%253DAntimicrob.%2BAgents%2BChemother.%26rft.aulast%253DEntenza%26rft.auinit1%253DJ.%2BM.%26rft.volume%253D43%26rft.issue%253D1%26rft.spage%253D77%26rft.epage%253D84%26rft.atitle%253DEfficacy%2Bof%2BTrovafloxacin%2Bin%2BTreatment%2Bof%2BExperimental%2BStaphylococcal%2Bor%2BStreptococcal%2BEndocarditis%26rft_id%253Dinfo%253Adoi%252F10.1128%252FAAC.43.1.77%26rft_id%253Dinfo%253Apmid%252F9869569%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiYWFjIjtzOjU6InJlc2lkIjtzOjc6IjQzLzEvNzciO3M6NDoiYXRvbSI7czoyMDoiL2FhYy80OC8xMS80MzIyLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">13.</span><a class="rev-xref-ref" href="#xref-ref-13-1" title="View reference 13. in text" id="ref-13">в†µ</a><div class="cit ref-cit ref-other" id="cit-48.11.4322.13" data-doi="10.1128/AAC.41.8.1662"><div class="cit-metadata"><cite><strong>Entenza, J. M., J. Vouillamoz, M. P. Glauser, and P. Moreillon.</strong>
<span class="cit-pub-date">1997</span>. Levofloxacin versus ciprofloxacin, flucloxacillin, or vancomycin for treatment of experimental endocarditis due to methicillin-susceptible or -resistant <em>Staphylococcus aureus.</em><span class="cit-source">Antimicrob. Agents Chemother.</span><span class="cit-vol">41</span><strong>:</strong><span class="cit-fpage">1662</span>-1667.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DAntimicrobial%2BAgents%2Band%2BChemotherapy%26rft.stitle%253DAntimicrob.%2BAgents%2BChemother.%26rft.aulast%253DEntenza%26rft.auinit1%253DJ.%2BM.%26rft.volume%253D41%26rft.issue%253D8%26rft.spage%253D1662%26rft.epage%253D1667%26rft.atitle%253DLevofloxacin%2Bversus%2Bciprofloxacin%252C%2Bflucloxacillin%252C%2Bor%2Bvancomycin%2Bfor%2Btreatment%2Bof%2Bexperimental%2Bendocarditis%2Bdue%2Bto%2Bmethicillin-susceptible%2Bor%2B-resistant%2BStaphylococcus%2Baureus.%26rft_id%253Dinfo%253Adoi%252F10.1128%252FAAC.41.8.1662%26rft_id%253Dinfo%253Apmid%252F9257737%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiYWFjIjtzOjU6InJlc2lkIjtzOjk6IjQxLzgvMTY2MiI7czo0OiJhdG9tIjtzOjIwOiIvYWFjLzQ4LzExLzQzMjIuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">14.</span><a class="rev-xref-ref" href="#xref-ref-14-1" title="View reference 14. in text" id="ref-14">в†µ</a><div class="cit ref-cit ref-other" id="cit-48.11.4322.14" data-doi="10.1093/infdis/169.6.1397"><div class="cit-metadata"><cite><strong>Fluckiger, U., P. Francioli, J. Blaser, M. P. Glauser, and P. Moreillon.</strong>
<span class="cit-pub-date">1994</span>. Role of amoxicillin serum levels for successful prophylaxis of experimental endocarditis due to tolerant streptococci. <span class="cit-source">J. Infect. Dis.</span><span class="cit-vol">169</span><strong>:</strong><span class="cit-fpage">1397</span>-1400.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ.%2BInfect.%2BDis.%26rft_id%253Dinfo%253Adoi%252F10.1093%252Finfdis%252F169.6.1397%26rft_id%253Dinfo%253Apmid%252F8195626%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1093/infdis/169.6.1397&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=8195626&amp;link_type=MED&amp;atom=%2Faac%2F48%2F11%2F4322.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=A1994NX99100037&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">15.</span><a class="rev-xref-ref" href="#xref-ref-15-1" title="View reference 15. in text" id="ref-15">в†µ</a><div class="cit ref-cit ref-other" id="cit-48.11.4322.15" data-doi="10.1093/infdis/163.3.514"><div class="cit-metadata"><cite><strong>Franciolli, M., J. Bille, M. P. Glauser, and P. Moreillon.</strong>
<span class="cit-pub-date">1991</span>. Beta-lactam resistance mechanisms of methicillin-resistant <em>Staphylococcus aureus.</em><span class="cit-source">J. Infect. Dis.</span><span class="cit-vol">163</span><strong>:</strong><span class="cit-fpage">514</span>-523.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ.%2BInfect.%2BDis.%26rft_id%253Dinfo%253Adoi%252F10.1093%252Finfdis%252F163.3.514%26rft_id%253Dinfo%253Apmid%252F1995724%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1093/infdis/163.3.514&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=1995724&amp;link_type=MED&amp;atom=%2Faac%2F48%2F11%2F4322.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">16.</span><a class="rev-xref-ref" href="#xref-ref-16-1" title="View reference 16. in text" id="ref-16">в†µ</a><div class="cit ref-cit ref-other" id="cit-48.11.4322.16" data-doi="10.1099/00222615-19-2-137"><div class="cit-metadata"><cite><strong>Gillespie, M. T., J. W. May, and R. A. Skurray.</strong>
<span class="cit-pub-date">1985</span>. Antibiotic resistance in <em>Staphylococcus aureus</em> isolated at an Australian hospital between 1946 and 1981. <span class="cit-source">J. Med. Microbiol.</span><span class="cit-vol">19</span><strong>:</strong><span class="cit-fpage">137</span>-147.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJournal%2Bof%2BMedical%2BMicrobiology%26rft.stitle%253DJ%2BMed%2BMicrobiol%26rft.aulast%253DGillespie%26rft.auinit1%253DM.%2BT.%26rft.volume%253D19%26rft.issue%253D2%26rft.spage%253D137%26rft.epage%253D147%26rft.atitle%253DAntibiotic%2BResistance%2Bin%2BStaphylococcus%2BAureus%2BIsolated%2Bat%2Ban%2BAustralian%2BHospital%2Bbetween%2B1946%2Band%2B1981%26rft_id%253Dinfo%253Adoi%252F10.1099%252F00222615-19-2-137%26rft_id%253Dinfo%253Apmid%252F3845119%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1099/00222615-19-2-137&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=3845119&amp;link_type=MED&amp;atom=%2Faac%2F48%2F11%2F4322.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=A1985AFG6900001&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">17.</span><a class="rev-xref-ref" href="#xref-ref-17-1" title="View reference 17. in text" id="ref-17">в†µ</a><div class="cit ref-cit ref-other" id="cit-48.11.4322.17" data-doi="10.1016/S1473-3099(03)00510-3"><div class="cit-metadata"><cite><strong>Gonzalez-Zorn, B., and P. Courvalin.</strong>
<span class="cit-pub-date">2003</span>. VanA-mediated high level glycopeptide resistance in MRSA. <span class="cit-source">Lancet Infect. Dis.</span><span class="cit-vol">3</span><strong>:</strong><span class="cit-fpage">67</span>-68.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DThe%2BLancet%2Binfectious%2Bdiseases%26rft.stitle%253DLancet%2BInfect%2BDis%26rft.aulast%253DGonz%25C3%25A1lez-Zorn%26rft.auinit1%253DB.%26rft.volume%253D3%26rft.issue%253D2%26rft.spage%253D67%26rft.epage%253D68%26rft.atitle%253DVanA-mediated%2Bhigh%2Blevel%2Bglycopeptide%2Bresistance%2Bin%2BMRSA.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS1473-3099%252803%252900510-3%26rft_id%253Dinfo%253Apmid%252F12560187%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/S1473-3099(03)00510-3&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=12560187&amp;link_type=MED&amp;atom=%2Faac%2F48%2F11%2F4322.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">18.</span><a class="rev-xref-ref" href="#xref-ref-18-1" title="View reference 18. in text" id="ref-18">в†µ</a><div class="cit ref-cit ref-other" id="cit-48.11.4322.18"><div class="cit-metadata"><cite><strong>Hakim, L., D. W. Bourne, and E. J. Triggs.</strong>
<span class="cit-pub-date">1989</span>. Disposition of ceftriaxone in rat: application of a pharmacokinetic-protein binding model and comparison with cefotaxime. <span class="cit-source">Xenobiotica</span><span class="cit-vol">19</span><strong>:</strong><span class="cit-fpage">815</span>-822.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DXenobiotica%253B%2Bthe%2Bfate%2Bof%2Bforeign%2Bcompounds%2Bin%2Bbiological%2Bsystems%26rft.stitle%253DXenobiotica%26rft.aulast%253DHakim%26rft.auinit1%253DL.%26rft.volume%253D19%26rft.issue%253D8%26rft.spage%253D815%26rft.epage%253D822%26rft.atitle%253DDisposition%2Bof%2Bceftriaxone%2Bin%2Brat%253A%2Bapplication%2Bof%2Ba%2Bpharmacokinetic-protein%2Bbinding%2Bmodel%2Band%2Bcomparison%2Bwith%2Bcefotaxime.%26rft_id%253Dinfo%253Apmid%252F2815824%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=2815824&amp;link_type=MED&amp;atom=%2Faac%2F48%2F11%2F4322.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">19.</span><a class="rev-xref-ref" href="#xref-ref-19-1" title="View reference 19. in text" id="ref-19">в†µ</a><div class="cit ref-cit ref-other" id="cit-48.11.4322.19"><div class="cit-metadata"><cite><strong>Heraief, E., M. P. Glauser, and L. R. Freedman.</strong>
<span class="cit-pub-date">1982</span>. Natural history of aortic valve endocarditis in rats. <span class="cit-source">Infect. Immun.</span><span class="cit-vol">37</span><strong>:</strong><span class="cit-fpage">127</span>-131.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DInfection%2Band%2BImmunity%26rft.stitle%253DInfect.%2BImmun.%26rft.aulast%253DHeraief%26rft.auinit1%253DE%26rft.volume%253D37%26rft.issue%253D1%26rft.spage%253D127%26rft.epage%253D131%26rft.atitle%253DNatural%2Bhistory%2Bof%2Baortic%2Bvalve%2Bendocarditis%2Bin%2Brats.%26rft_id%253Dinfo%253Apmid%252F7049946%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiaWFpIjtzOjU6InJlc2lkIjtzOjg6IjM3LzEvMTI3IjtzOjQ6ImF0b20iO3M6MjA6Ii9hYWMvNDgvMTEvNDMyMi5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">20.</span><a class="rev-xref-ref" href="#xref-ref-20-1" title="View reference 20. in text" id="ref-20">в†µ</a><div class="cit ref-cit ref-other" id="cit-48.11.4322.20" data-doi="10.1128/AAC.35.4.685"><div class="cit-metadata"><cite><strong>Hirano, L., and A. S. Bayer.</strong>
<span class="cit-pub-date">1991</span>. Beta-lactam-beta-lactamase inhibitor combinations are active in experimental endocarditis caused by beta-lactamase-producing oxacillin-resistant staphylococci. <span class="cit-source">Antimicrob. Agents Chemother.</span><span class="cit-vol">35</span><strong>:</strong><span class="cit-fpage">685</span>-690.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DAntimicrobial%2BAgents%2Band%2BChemotherapy%26rft.stitle%253DAntimicrob.%2BAgents%2BChemother.%26rft.aulast%253DHirano%26rft.auinit1%253DL.%26rft.volume%253D35%26rft.issue%253D4%26rft.spage%253D685%26rft.epage%253D690%26rft.atitle%253DBeta-Lactam-beta-lactamase-inhibitor%2Bcombinations%2Bare%2Bactive%2Bin%2Bexperimental%2Bendocarditis%2Bcaused%2Bby%2Bbeta-lactamase-producing%2Boxacillin-resistant%2Bstaphylococci.%26rft_id%253Dinfo%253Adoi%252F10.1128%252FAAC.35.4.685%26rft_id%253Dinfo%253Apmid%252F2069374%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiYWFjIjtzOjU6InJlc2lkIjtzOjg6IjM1LzQvNjg1IjtzOjQ6ImF0b20iO3M6MjA6Ii9hYWMvNDgvMTEvNDMyMi5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">21.</span><a class="rev-xref-ref" href="#xref-ref-21-1" title="View reference 21. in text" id="ref-21">в†µ</a><div class="cit ref-cit ref-other" id="cit-48.11.4322.21" data-doi="10.1021/js9801135"><div class="cit-metadata"><cite><strong>Kusama, M., K. Yamamoto, H. Kotaki, H. Sato, and T. Iga.</strong>
<span class="cit-pub-date">1998</span>. Effect of cilastatin on renal handling of vancomycin in rats. <span class="cit-source">J. Pharm. Sci.</span><span class="cit-vol">87</span><strong>:</strong><span class="cit-fpage">1173</span>-1176.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJournal%2Bof%2Bpharmaceutical%2Bsciences%26rft.stitle%253DJ%2BPharm%2BSci%26rft.aulast%253DKusama%26rft.auinit1%253DM.%26rft.volume%253D87%26rft.issue%253D9%26rft.spage%253D1173%26rft.epage%253D1176%26rft.atitle%253DEffect%2Bof%2Bcilastatin%2Bon%2Brenal%2Bhandling%2Bof%2Bvancomycin%2Bin%2Brats.%26rft_id%253Dinfo%253Adoi%252F10.1021%252Fjs9801135%26rft_id%253Dinfo%253Apmid%252F9724573%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1021/js9801135&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=9724573&amp;link_type=MED&amp;atom=%2Faac%2F48%2F11%2F4322.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">22.</span><a class="rev-xref-ref" href="#xref-ref-22-1" title="View reference 22. in text" id="ref-22">в†µ</a><div class="cit ref-cit ref-other" id="cit-48.11.4322.22" data-doi="10.1038/nsb85"><div class="cit-metadata"><cite><strong>Lim, D., and N. C. Strynadka.</strong>
<span class="cit-pub-date">2002</span>. Structural basis for the beta lactam resistance of PBP2a from methicillin-resistant <em>Staphylococcus aureus.</em><span class="cit-source">Nat. Struct. Biol.</span><span class="cit-vol">9</span><strong>:</strong><span class="cit-fpage">870</span>-876.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNature%2Bstructural%2Bbiology%26rft.stitle%253DNat%2BStruct%2BBiol%26rft.aulast%253DLim%26rft.auinit1%253DD.%26rft.volume%253D9%26rft.issue%253D11%26rft.spage%253D870%26rft.epage%253D876%26rft.atitle%253DStructural%2Bbasis%2Bfor%2Bthe%2Bbeta%2Blactam%2Bresistance%2Bof%2BPBP2a%2Bfrom%2Bmethicillin-resistant%2BStaphylococcus%2Baureus.%26rft_id%253Dinfo%253Adoi%252F10.1038%252Fnsb85%26rft_id%253Dinfo%253Apmid%252F12389036%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1038/nsb85&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=12389036&amp;link_type=MED&amp;atom=%2Faac%2F48%2F11%2F4322.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000178884700019&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">23.</span><a class="rev-xref-ref" href="#xref-ref-23-1" title="View reference 23. in text" id="ref-23">в†µ</a><div class="cit ref-cit ref-other" id="cit-48.11.4322.23" data-doi="10.1056/NEJM199808203390806"><div class="cit-metadata"><cite><strong>Lowy, F. D.</strong>
<span class="cit-pub-date">1998</span>. <em>Staphylococcus aureus</em> infections. <span class="cit-source">N. Engl. J. Med.</span><span class="cit-vol">339</span><strong>:</strong><span class="cit-fpage">520</span>-532.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DNew%2BEngland%2BJournal%2Bof%2BMedicine%26rft.stitle%253DNEJM%26rft.aulast%253DLowy%26rft.auinit1%253DF.%2BD.%26rft.volume%253D339%26rft.issue%253D8%26rft.spage%253D520%26rft.epage%253D532%26rft.atitle%253DStaphylococcus%2Baureus%2BInfections%26rft_id%253Dinfo%253Adoi%252F10.1056%252FNEJM199808203390806%26rft_id%253Dinfo%253Apmid%252F9709046%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1056/NEJM199808203390806&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=9709046&amp;link_type=MED&amp;atom=%2Faac%2F48%2F11%2F4322.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000075447000006&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">24.</span><a class="rev-xref-ref" href="#xref-ref-24-1" title="View reference 24. in text" id="ref-24">в†µ</a><div class="cit ref-cit ref-other" id="cit-48.11.4322.24" data-doi="10.1128/AAC.46.7.2200-2207.2002"><div class="cit-metadata"><cite><strong>Malbruny, B., A. Canu, B. Bozdogan, B. Fantin, V. Zarrouk, S. Dutka-Malen, C. Feger, and R. Leclercq.</strong>
<span class="cit-pub-date">2002</span>. Resistance to quinupristin-dalfopristin due to mutation of L22 ribosomal protein in <em>Staphylococcus aureus.</em><span class="cit-source">Antimicrob. Agents Chemother.</span><span class="cit-vol">46</span><strong>:</strong><span class="cit-fpage">2200</span>-2207.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DAntimicrobial%2BAgents%2Band%2BChemotherapy%26rft.stitle%253DAntimicrob.%2BAgents%2BChemother.%26rft.aulast%253DMalbruny%26rft.auinit1%253DB.%26rft.volume%253D46%26rft.issue%253D7%26rft.spage%253D2200%26rft.epage%253D2207%26rft.atitle%253DResistance%2Bto%2BQuinupristin-Dalfopristin%2BDue%2Bto%2BMutation%2Bof%2BL22%2BRibosomal%2BProtein%2Bin%2BStaphylococcus%2Baureus%26rft_id%253Dinfo%253Adoi%252F10.1128%252FAAC.46.7.2200-2207.2002%26rft_id%253Dinfo%253Apmid%252F12069975%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiYWFjIjtzOjU6InJlc2lkIjtzOjk6IjQ2LzcvMjIwMCI7czo0OiJhdG9tIjtzOjIwOiIvYWFjLzQ4LzExLzQzMjIuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">25.</span><a class="rev-xref-ref" href="#xref-ref-25-1" title="View reference 25. in text" id="ref-25">в†µ</a><div class="cit ref-cit ref-other" id="cit-48.11.4322.25" data-doi="10.1128/AAC.47.4.1262-1266.2003"><div class="cit-metadata"><cite><strong>Moore, M. R., F. Perdreau-Remington, and H. F. Chambers.</strong>
<span class="cit-pub-date">2003</span>. Vancomycin treatment failure associated with heterogeneous vancomycin-intermediate <em>Staphylococcus aureus</em> in a patient with endocarditis and in the rabbit model of endocarditis. <span class="cit-source">Antimicrob. Agents Chemother.</span><span class="cit-vol">47</span><strong>:</strong><span class="cit-fpage">1262</span>-1266.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DAntimicrobial%2BAgents%2Band%2BChemotherapy%26rft.stitle%253DAntimicrob.%2BAgents%2BChemother.%26rft.aulast%253DMoore%26rft.auinit1%253DM.%2BR.%26rft.volume%253D47%26rft.issue%253D4%26rft.spage%253D1262%26rft.epage%253D1266%26rft.atitle%253DVancomycin%2BTreatment%2BFailure%2BAssociated%2Bwith%2BHeterogeneous%2BVancomycin-Intermediate%2BStaphylococcus%2Baureus%2Bin%2Ba%2BPatient%2Bwith%2BEndocarditis%2Band%2Bin%2Bthe%2BRabbit%2BModel%2Bof%2BEndocarditis%26rft_id%253Dinfo%253Adoi%252F10.1128%252FAAC.47.4.1262-1266.2003%26rft_id%253Dinfo%253Apmid%252F12654656%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiYWFjIjtzOjU6InJlc2lkIjtzOjk6IjQ3LzQvMTI2MiI7czo0OiJhdG9tIjtzOjIwOiIvYWFjLzQ4LzExLzQzMjIuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">26.</span><a class="rev-xref-ref" href="#xref-ref-26-1" title="View reference 26. in text" id="ref-26">в†µ</a><div class="cit ref-cit ref-other" id="cit-48.11.4322.26"><div class="cit-metadata"><cite><strong>Moreillon, P., and P. Majcherczyk.</strong>
<span class="cit-pub-date">2000</span>. Is there still a role for penicillins and cephalosporins in the treatment of bacterial infections? <span class="cit-source">Int. J. Clin. Pract. Suppl.</span><span class="cit-vol">2000</span><strong>:</strong><span class="cit-fpage">99</span>-105.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DInt.%2BJ.%2BClin.%2BPract.%2BSuppl.%26rft.volume%253D2000%26rft.spage%253D99%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a></div></div></li><li><span class="ref-label">27.</span><a class="rev-xref-ref" href="#xref-ref-27-1" title="View reference 27. in text" id="ref-27">в†µ</a><div class="cit ref-cit ref-other" id="cit-48.11.4322.27"><div class="cit-metadata"><cite><strong>National Committee for Clinical Laboratory Standards.</strong>
<span class="cit-pub-date">2000</span>. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th ed. Document M7-A5. National Committee for Clinical Laboratory Standards, Wayne, Pa.</cite></div><div class="cit-extra"></div></div></li><li><span class="ref-label">28.</span><a class="rev-xref-ref" href="#xref-ref-28-1" title="View reference 28. in text" id="ref-28">в†µ</a><div class="cit ref-cit ref-other" id="cit-48.11.4322.28" data-doi="10.1086/345368"><div class="cit-metadata"><cite><strong>Pillai, S. K., G. Sakoulas, C. Wennersten, G. M. Eliopoulos, R. C. Moellering, Jr., M. J. Ferraro, and H. S. Gold.</strong>
<span class="cit-pub-date">2002</span>. Linezolid resistance in <em>Staphylococcus aureus</em>: characterization and stability of resistant phenotype. <span class="cit-source">J. Infect. Dis.</span><span class="cit-vol">186</span><strong>:</strong><span class="cit-fpage">1603</span>-1607.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ.%2BInfect.%2BDis.%26rft_id%253Dinfo%253Adoi%252F10.1086%252F345368%26rft_id%253Dinfo%253Apmid%252F12447736%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1086/345368&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=12447736&amp;link_type=MED&amp;atom=%2Faac%2F48%2F11%2F4322.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a><a href="/lookup/external-ref?access_num=000179144900009&amp;link_type=ISI" class="cit-ref-sprinkles cit-ref-sprinkles-newisilink cit-ref-sprinkles-webofscience"><span>Web of Science</span></a></div></div></li><li><span class="ref-label">29.</span><a class="rev-xref-ref" href="#xref-ref-29-1" title="View reference 29. in text" id="ref-29">в†µ</a><div class="cit ref-cit ref-other" id="cit-48.11.4322.29" data-doi="10.1073/pnas.191260798"><div class="cit-metadata"><cite><strong>Pinho, M. G., H. de Lencastre, and A. Tomasz.</strong>
<span class="cit-pub-date">2001</span>. An acquired and a native penicillin-binding protein cooperate in building the cell wall of drug-resistant staphylococci. <span class="cit-source">Proc. Natl. Acad. Sci. USA</span><span class="cit-vol">98</span><strong>:</strong><span class="cit-fpage">10886</span>-10891.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DProc.%2BNatl.%2BAcad.%2BSci.%2BUSA%26rft_id%253Dinfo%253Adoi%252F10.1073%252Fpnas.191260798%26rft_id%253Dinfo%253Apmid%252F11517340%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NDoicG5hcyI7czo1OiJyZXNpZCI7czoxMToiOTgvMTkvMTA4ODYiO3M6NDoiYXRvbSI7czoyMDoiL2FhYy80OC8xMS80MzIyLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">30.</span><a class="rev-xref-ref" href="#xref-ref-30-1" title="View reference 30. in text" id="ref-30">в†µ</a><div class="cit ref-cit ref-other" id="cit-48.11.4322.30" data-doi="10.1086/513805"><div class="cit-metadata"><cite><strong>Que, Y. A., J. M. Entenza, P. Francioli, and P. Moreillon.</strong>
<span class="cit-pub-date">1998</span>. The impact of penicillinase on cefamandole treatment and prophylaxis of experimental endocarditis due to methicillin-resistant <em>Staphylococcus aureus.</em><span class="cit-source">J. Infect. Dis.</span><span class="cit-vol">177</span><strong>:</strong><span class="cit-fpage">146</span>-154.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DJ.%2BInfect.%2BDis.%26rft_id%253Dinfo%253Adoi%252F10.1086%252F513805%26rft_id%253Dinfo%253Apmid%252F9419181%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1086/513805&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=9419181&amp;link_type=MED&amp;atom=%2Faac%2F48%2F11%2F4322.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li><li><span class="ref-label">31.</span><a class="rev-xref-ref" href="#xref-ref-31-1" title="View reference 31. in text" id="ref-31">в†µ</a><div class="cit ref-cit ref-other" id="cit-48.11.4322.31" data-doi="10.1128/AAC.40.1.97"><div class="cit-metadata"><cite><strong>Ramos, M. C., M. Ing, E. Kim, M. D. Witt, and A. S. Bayer.</strong>
<span class="cit-pub-date">1996</span>. Ampicillin-sulbactam is effective in prevention and therapy of experimental endocarditis caused by beta-lactamase-producing coagulase-negative staphylococci. <span class="cit-source">Antimicrob. Agents Chemother.</span><span class="cit-vol">40</span><strong>:</strong><span class="cit-fpage">97</span>-101.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DAntimicrobial%2BAgents%2Band%2BChemotherapy%26rft.stitle%253DAntimicrob.%2BAgents%2BChemother.%26rft.aulast%253DRamos%26rft.auinit1%253DM.%2BC.%26rft.volume%253D40%26rft.issue%253D1%26rft.spage%253D97%26rft.epage%253D101%26rft.atitle%253DAmpicillin-sulbactam%2Bis%2Beffective%2Bin%2Bprevention%2Band%2Btherapy%2Bof%2Bexperimental%2Bendocarditis%2Bcaused%2Bby%2Bbeta-lactamase-producing%2Bcoagulase-negative%2Bstaphylococci.%26rft_id%253Dinfo%253Adoi%252F10.1128%252FAAC.40.1.97%26rft_id%253Dinfo%253Apmid%252F8787887%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiYWFjIjtzOjU6InJlc2lkIjtzOjc6IjQwLzEvOTciO3M6NDoiYXRvbSI7czoyMDoiL2FhYy80OC8xMS80MzIyLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">32.</span><a class="rev-xref-ref" href="#xref-ref-32-1" title="View reference 32. in text" id="ref-32">в†µ</a><div class="cit ref-cit ref-other" id="cit-48.11.4322.32" data-doi="10.1128/AAC.48.1.53-62.2004"><div class="cit-metadata"><cite><strong>Sader, H. S., D. M. Johnson, and R. N. Jones.</strong>
<span class="cit-pub-date">2004</span>. In vitro activities of the novel cephalosporin LB 11058 against multidrug-resistant staphylococci and streptococci. <span class="cit-source">Antimicrob. Agents Chemother.</span><span class="cit-vol">48</span><strong>:</strong><span class="cit-fpage">53</span>-62.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DAntimicrobial%2BAgents%2Band%2BChemotherapy%26rft.stitle%253DAntimicrob.%2BAgents%2BChemother.%26rft.aulast%253DSader%26rft.auinit1%253DH.%2BS.%26rft.volume%253D48%26rft.issue%253D1%26rft.spage%253D53%26rft.epage%253D62%26rft.atitle%253DIn%2BVitro%2BActivities%2Bof%2Bthe%2BNovel%2BCephalosporin%2BLB%2B11058%2Bagainst%2BMultidrug-Resistant%2BStaphylococci%2Band%2BStreptococci%26rft_id%253Dinfo%253Adoi%252F10.1128%252FAAC.48.1.53-62.2004%26rft_id%253Dinfo%253Apmid%252F14693518%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiYWFjIjtzOjU6InJlc2lkIjtzOjc6IjQ4LzEvNTMiO3M6NDoiYXRvbSI7czoyMDoiL2FhYy80OC8xMS80MzIyLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==" class="cit-ref-sprinkles cit-ref-sprinkles-ijlink"><span><span class="cit-reflinks-abstract">Abstract</span><span class="cit-sep cit-reflinks-variant-name-sep">/</span><span class="cit-reflinks-full-text"><span class="free-full-text">FREE </span>Full Text</span></span></a></div></div></li><li><span class="ref-label">33.</span><a class="rev-xref-ref" href="#xref-ref-33-1" title="View reference 33. in text" id="ref-33">в†µ</a><div class="cit ref-cit ref-other" id="cit-48.11.4322.33" data-doi="10.1016/S0140-6736(03)12719-5"><div class="cit-metadata"><cite><strong>Tomasz, A.</strong>
<span class="cit-pub-date">2003</span>. вЂњIntelligence coupвЂќ for drug designers: crystal structure of <em>Staphylococcus aureus</em> beta-lactam resistance protein PBP2A. <span class="cit-source">Lancet</span><span class="cit-vol">361</span><strong>:</strong><span class="cit-fpage">795</span>-796.</cite></div><div class="cit-extra"><a href="{openurl}?query=rft.jtitle%253DLancet%26rft.stitle%253DLancet%26rft.aulast%253DTomasz%26rft.auinit1%253DA.%26rft.volume%253D361%26rft.issue%253D9360%26rft.spage%253D795%26rft.epage%253D796%26rft.atitle%253D%2526quot%253BIntelligence%2Bcoup%2526quot%253B%2Bfor%2Bdrug%2Bdesigners%253A%2Bcrystal%2Bstructure%2Bof%2BStaphylococcus%2Baureus%2Bbeta-lactam%2Bresistance%2Bprotein%2BPBP2A.%26rft_id%253Dinfo%253Adoi%252F10.1016%252FS0140-6736%252803%252912719-5%26rft_id%253Dinfo%253Apmid%252F12642041%26rft.genre%253Darticle%26rft_val_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Ajournal%26ctx_ver%253DZ39.88-2004%26url_ver%253DZ39.88-2004%26url_ctx_fmt%253Dinfo%253Aofi%252Ffmt%253Akev%253Amtx%253Actx" class="cit-ref-sprinkles cit-ref-sprinkles-openurl cit-ref-sprinkles-open-url"><span>OpenUrl</span></a><a href="/lookup/external-ref?access_num=10.1016/S0140-6736(03)12719-5&amp;link_type=DOI" class="cit-ref-sprinkles cit-ref-sprinkles-doi cit-ref-sprinkles-crossref"><span>CrossRef</span></a><a href="/lookup/external-ref?access_num=12642041&amp;link_type=MED&amp;atom=%2Faac%2F48%2F11%2F4322.atom" class="cit-ref-sprinkles cit-ref-sprinkles-medline"><span>PubMed</span></a></div></div></li></ol></div><span class="highwire-journal-article-marker-end"></span></div><span id="related-urls"></span></div><a href="https://aac.asm.org/content/48/11/4322.abstract" class="hw-link hw-link-article-abstract" data-icon-position="" data-hide-link-title="0">View Abstract</a></div>  </div>

  
  </div>
</div>
  </div>
</div>
</div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-node-pager" >
  
      
  
  <div class="pane-content">
    <div class="pager highwire-pager pager-mini clearfix highwire-node-pager highwire-article-pager"><span class="pager-prev"><a href="/content/48/11/4286" title="Activity of the New Triazole Derivative Albaconazole against Trypanosoma (Schizotrypanum) cruzi in Dog Hosts" rel="prev" class="pager-link-prev link-icon"><i class="icon-circle-arrow-left"></i> <span class="title">Previous</span></a></span><span class="pager-next"><a href="/content/48/11/4414" title="Anti-Aspergillus fumigatus Efficacy of Pentraxin 3 Alone and in Combination with Antifungals" rel="next" class="pager-link-next link-icon-right link-icon"><span class="title">Next</span> <i class="icon-circle-arrow-right"></i></a></span></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-back-to-top" >
  
      
  
  <div class="pane-content">
    <a href="#page" class="back-to-top" data-icon-position="" data-hide-link-title="0"><i class="icon-chevron-up"></i> Back to top</a>  </div>

  
  </div>
</div>
			</div>
		</div>
		
		<div class="sidebar-right-wrapper grid-10 omega">
			<div class="panel-panel panel-region-sidebar-right">
			  <div class="inside"><div class="panel-pane pane-add-to-cart" >
  
      
  
  <div class="pane-content">
    <span  data-font-icon="icon-shopping-cart" data-text="Add to Cart (%short-price)" data-apath="/aac/48/11/4322.atom" data-type="link" data-parent-id="66526" class="highwire-foxycart-add-to-cart-ahah"></span>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-panels-mini pane-jnl-asm-art-tools  pane-style-alt-content" >
  
      
  
  <div class="pane-content">
    <div id="mini-panel-jnl_asm_art_tools" class="highwire-2col-stacked panel-display">
	  
  <div class="panel-row-wrapper clearfix">
		<div class="content-left-wrapper content-column">
          <div class="panel-panel panel-region-content-left">
            <div class="inside"><div class="panel-pane pane-highwire-variant-link" >
  
      
  
  <div class="pane-content">
    <a href="/content/aac/48/11/4322.full-text.pdf" target="_blank" class="link-icon"><i class="icon-download"></i> <span class="title">Download PDF</span></a>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-minipanel-dialog-link pane-jnl-asm-cite-tool" >
  
      
  
  <div class="pane-content">
    <div class='minipanel-dialog-wrapper'><div class='minipanel-dialog-link-link'><a href="/highwire/citation/79746/download" oncontextmenu="javascript: return false;" class="minipanel-dialog-link-trigger link-icon" title=""><i class="icon-globe"></i> <span class="title">Citation Tools</span></a></div><div class='minipanel-dialog-link-mini' style='display:none'><div class="panel-display panel-1col clearfix" id="mini-panel-jnl_asm_cite_tool">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-highwire-citation-export" >
  
      
  
  <div class="pane-content">
    <div class="highwire-citation-export">  
  <div class="highwire-citation-info">
      <div class="highwire-article-citation highwire-citation-type-highwire-article" data-node-nid="79746" id="node79746" data-pisa="aac;48/11/4322" data-pisa-master="aac;48/11/4322" data-apath="/aac/48/11/4322.atom"><div class="highwire-cite highwire-cite-highwire-article highwire-citation-asm-article-toolbox-citation clearfix">
  
  
  
  
      <div class="highwire-cite-title">LB11058, a New Cephalosporin with High Penicillin-Binding Protein 2a Affinity and Activity in Experimental Endocarditis Due to Homogeneously Methicillin-Resistant <em>Staphylococcus aureus</em></div>  
    	<div class="highwire-cite-authors"><span  class="highwire-citation-authors"><span class="highwire-citation-author first" data-delta="0"><span class="nlm-given-names">Jacques</span> <span class="nlm-surname">Vouillamoz</span></span>, <span class="highwire-citation-author" data-delta="1"><span class="nlm-given-names">JosГ© M.</span> <span class="nlm-surname">Entenza</span></span>, <span class="highwire-citation-author" data-delta="2"><span class="nlm-given-names">Peter</span> <span class="nlm-surname">Hohl</span></span>, <span class="highwire-citation-author" data-delta="3"><span class="nlm-given-names">Philippe</span> <span class="nlm-surname">Moreillon</span></span></span></div>
  
    	<div class="highwire-cite-metadata"><span  class="highwire-cite-metadata-journal highwire-cite-metadata">Antimicrobial Agents and Chemotherapy </span><span  class="highwire-cite-metadata-date highwire-cite-metadata">Oct 2004, </span><span  class="highwire-cite-metadata-volume highwire-cite-metadata">48 </span><span  class="highwire-cite-metadata-issue highwire-cite-metadata">(11) </span><span  class="highwire-cite-metadata-pages highwire-cite-metadata">4322-4327; </span><span  class="highwire-cite-metadata-doi highwire-cite-metadata"><span class="label">DOI:</span> 10.1128/AAC.48.11.4322-4327.2004 </span></div>
  
  
  
</div>
</div>  </div>
  <div class="highwire-citation-formats">
  	      <h2>Citation Manager Formats</h2>
        <div class="highwire-citation-formats-links">
      <span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&amp;rft.spage=4322&amp;rft.epage=4327&amp;rft.atitle=LB11058%2C%20a%20New%20Cephalosporin%20with%20High%20Penicillin-Binding%20Protein%202a%20Affinity%20and%20Activity%20in%20Experimental%20Endocarditis%20Due%20to%20Homogeneously%20Methicillin-Resistant%20Staphylococcus%20aureus&amp;rft.volume=48&amp;rft.issue=11&amp;rft.date=2004-11-01%2000%3A00%3A00&amp;rft.stitle&amp;rft.jtitle=Antimicrobial%20Agents%20and%20Chemotherapy&amp;rft.au=Vouillamoz%2C+Jacques&amp;rft.au=Entenza%2C+Jos%C3%A9+M.&amp;rft.au=Hohl%2C+Peter&amp;rft.au=Moreillon%2C+Philippe"></span><ul class="hw-citation-links inline button button-alt button-grid clearfix"><li class="bibtext first"><a href="/highwire/citation/79746/bibtext" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">BibTeX</a></li><li class="bookends"><a href="/highwire/citation/79746/bookends" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Bookends</a></li><li class="easybib"><a href="/highwire/citation/79746/easybib" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">EasyBib</a></li><li class="endnote-tagged"><a href="/highwire/citation/79746/endnote-tagged" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">EndNote (tagged)</a></li><li class="endnote-8-xml"><a href="/highwire/citation/79746/endnote-8-xml" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">EndNote 8 (xml)</a></li><li class="medlars"><a href="/highwire/citation/79746/medlars" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Medlars</a></li><li class="mendeley"><a href="/highwire/citation/79746/mendeley" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Mendeley</a></li><li class="papers"><a href="/highwire/citation/79746/papers" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Papers</a></li><li class="refworks-tagged"><a href="/highwire/citation/79746/refworks-tagged" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">RefWorks Tagged</a></li><li class="reference-manager"><a href="/highwire/citation/79746/reference-manager" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Ref Manager</a></li><li class="ris"><a href="/highwire/citation/79746/ris" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">RIS</a></li><li class="zotero last"><a href="/highwire/citation/79746/zotero" class="hw-download-citation-link" data-icon-position="" data-hide-link-title="0">Zotero</a></li></ul>    </div>
  </div>
</div>
  </div>

  
  </div>
</div>
  </div>
</div>
</div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-variant-link" >
  
      
  
  <div class="pane-content">
    <a href="/content/aac/48/11/4322.full-text.pdf" target="_blank" rel="nofollow" class="link-icon"><i class="icon-print"></i> <span class="title">Print</span></a>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-panels-ajax-pane-content pane-highwire-permission-link" >
  
        <h2 class="pane-title"><span class='panels-ajax-pane-title' data-pid='new-20'></span></h2>
    
  
  <div class="pane-content">
    <div class='panels-ajax-pane panels-ajax-pane-new-20' data-pid='new-20'></div>  </div>

  
  </div>
</div>
          </div>
        </div>
        
        <div class="content-right-wrapper content-column">
          <div class="panel-panel panel-region-content-right">
            <div class="inside"><div class="panel-pane pane-minipanel-dialog-link pane-jnl-asm-art-alert" >
  
      
  
  <div class="pane-content">
    <div class='minipanel-dialog-wrapper'><div class='minipanel-dialog-link-link'><a href="/" oncontextmenu="javascript: return false;" class="minipanel-dialog-link-trigger link-icon" title=""><i class="icon-bullhorn"></i> <span class="title">Alerts</span></a></div><div class='minipanel-dialog-link-mini' style='display:none'><div class="panel-display panel-1col clearfix" id="mini-panel-jnl_asm_art_alert">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-article-add-form" >
  
      
  
  <div class="pane-content">
    <div id = "alerts-form-wrapper"><form action="/content/48/11/4322.full?view=long&amp;pmid=15504859" method="post" id="highwire-user-opportunity-login" accept-charset="UTF-8"><div><div class="form-item form-item-label-before form-type-textfield form-item-name">
  <label for="edit-name">User Name <span class="form-required" title="This field is required.">*</span></label>
 <input type="text" id="edit-name" name="name" value="" size="60" maxlength="128" class="form-text required" />
</div>
<div class="form-item form-item-label-before form-type-password form-item-pass">
  <label for="edit-pass">Password <span class="form-required" title="This field is required.">*</span></label>
 <input type="password" id="edit-pass" name="pass" size="60" maxlength="128" class="form-text required" />
</div>
<div id="alerts_email">Sign In to Email Alerts with your Email Address</div><div class="form-item form-item-label-before form-type-textfield form-item-highwire-alerts-email">
  <label for="edit-highwire-alerts-email">Email <span class="form-required" title="This field is required.">*</span></label>
 <input type="text" id="edit-highwire-alerts-email" name="highwire_alerts_email" value="" size="60" maxlength="128" class="form-text required" />
</div>
<input type="submit" id="edit-submit--3" name="op" value="Submit" class="form-submit" /><input type="hidden" name="form_build_id" value="form-RO7uVRdm5dGjGyssKOLiOT2sOEGyIoR1ILQl7g5qTcc" />
<input type="hidden" name="form_id" value="highwire_alerts_article_sign_up_form" />
<input type="hidden" name="current_path" value="content/48/11/4322.full" />
</div></form></div>  </div>

  
  </div>
</div>
  </div>
</div>
</div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-minipanel-dialog-link pane-jnl-asm-art-email" >
  
      
  
  <div class="pane-content">
    <div class='minipanel-dialog-wrapper'><div class='minipanel-dialog-link-link'><a href="/" oncontextmenu="javascript: return false;" class="minipanel-dialog-link-trigger" title="" data-icon-position="" data-hide-link-title="0"><i class = 'icon-envelope'></i> Email</a></div><div class='minipanel-dialog-link-mini' style='display:none'><div class="panel-display panel-1col clearfix" id="mini-panel-jnl_asm_art_email">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-block pane-forward-form pane-forward" >
  
      
  
  <div class="pane-content">
    <form action="/content/48/11/4322.full?view=long&amp;pmid=15504859" method="post" id="forward-form" accept-charset="UTF-8"><div><div id="edit-instructions" class="form-item form-item-label-before form-type-item">
 <p>Thank you for sharing this Antimicrobial Agents and Chemotherapy article.</p><p>NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.</p>
</div>
<div class="form-item form-item-label-before form-type-textfield form-item-email">
  <label for="edit-email">Your Email <span class="form-required" title="This field is required.">*</span></label>
 <input type="text" id="edit-email" name="email" value="" size="58" maxlength="256" class="form-text required" />
</div>
<div class="form-item form-item-label-before form-type-textfield form-item-name">
  <label for="edit-name--2">Your Name <span class="form-required" title="This field is required.">*</span></label>
 <input type="text" id="edit-name--2" name="name" value="" size="58" maxlength="256" class="form-text required" />
</div>
<div class="form-item form-item-label-before form-type-textarea form-item-recipients">
  <label for="edit-recipients">Send To <span class="form-required" title="This field is required.">*</span></label>
 <div class="form-textarea-wrapper resizable"><textarea id="edit-recipients" name="recipients" cols="50" rows="5" class="form-textarea required"></textarea></div>
<div class="description">Enter multiple addresses on separate lines or separate them with commas.</div>
</div>
<div id="edit-page" class="form-item form-item-label-before form-type-item">
  <label for="edit-page">You are going to email the following </label>
 <a href="/content/48/11/4322" class="active" data-icon-position="" data-hide-link-title="0">LB11058, a New Cephalosporin with High Penicillin-Binding Protein 2a Affinity and Activity in Experimental Endocarditis Due to Homogeneously Methicillin-Resistant Staphylococcus aureus</a>
</div>
<div id="edit-subject" class="form-item form-item-label-before form-type-item">
  <label for="edit-subject">Message Subject </label>
 (Your Name) has forwarded a page to you from Antimicrobial Agents and Chemotherapy
</div>
<div id="edit-body" class="form-item form-item-label-before form-type-item">
  <label for="edit-body">Message Body </label>
 (Your Name) thought you would be interested in this article in Antimicrobial Agents and Chemotherapy.
</div>
<div class="form-item form-item-label-before form-type-textarea form-item-message">
  <label for="edit-message--2">Your Personal Message </label>
 <div class="form-textarea-wrapper resizable"><textarea id="edit-message--2" name="message" cols="50" rows="10" class="form-textarea"></textarea></div>
</div>
<input type="hidden" name="path" value="node/79746" />
<input type="hidden" name="path_cid" value="" />
<input type="hidden" name="forward_footer" value=" " />
<input type="hidden" name="form_build_id" value="form-LV-9r_DoNTPXwC8-85zr0n86DVTOa-8XdlCdfymaqbM" />
<input type="hidden" name="form_id" value="forward_form" />
<fieldset class="captcha form-wrapper"><legend><span class="fieldset-legend">CAPTCHA</span></legend><div class="fieldset-wrapper"><div class="fieldset-description">This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.</div><input type="hidden" name="captcha_sid" value="13388247" />
<input type="hidden" name="captcha_token" value="cde126ad06034480d4d14f6b008d4daf" />
<input type="hidden" name="captcha_response" value="Google no captcha" />
<div class="g-recaptcha" data-sitekey="6LfnJVIUAAAAAE-bUOMg0MJGki4lqSvDmhJp19fN" data-theme="light" data-type="image"></div></div></fieldset>
<div class="form-actions form-wrapper" id="edit-actions"><input type="submit" id="edit-submit--4" name="op" value="Send Message" class="form-submit" /></div></div></form>  </div>

  
  </div>
</div>
  </div>
</div>
</div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-share-link highwire_clipboard_link_ajax"  id="shareit">
  
      
  
  <div class="pane-content">
    <a href="/" class="link-icon"><i class="icon-share-alt"></i> <span class="title">Share</span></a>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-panels-mini pane-jnl-asm-share highwire_clipboard_form_ajax_shareit" >
  
      
  
  <div class="pane-content">
    
<div class="panel-display omega-12-onecol" id="mini-panel-jnl_asm_share">

		  <div class="panel-panel grid-12 panel-region-preface">
		  <div class="inside"><div class="panel-pane pane-highwire-article-citation" >
  
      
  
  <div class="pane-content">
    <div class="highwire-article-citation highwire-citation-type-highwire-article" data-node-nid="79746" id="node79746" data-pisa="aac;48/11/4322" data-pisa-master="aac;48/11/4322" data-apath="/aac/48/11/4322.atom"><div class="highwire-cite highwire-cite-highwire-article highwire-citation-asm-article-toolbox-citation clearfix">
  
  
  
  
      <div class="highwire-cite-title">LB11058, a New Cephalosporin with High Penicillin-Binding Protein 2a Affinity and Activity in Experimental Endocarditis Due to Homogeneously Methicillin-Resistant <em>Staphylococcus aureus</em></div>  
    	<div class="highwire-cite-authors"><span  class="highwire-citation-authors"><span class="highwire-citation-author first" data-delta="0"><span class="nlm-given-names">Jacques</span> <span class="nlm-surname">Vouillamoz</span></span>, <span class="highwire-citation-author" data-delta="1"><span class="nlm-given-names">JosГ© M.</span> <span class="nlm-surname">Entenza</span></span>, <span class="highwire-citation-author" data-delta="2"><span class="nlm-given-names">Peter</span> <span class="nlm-surname">Hohl</span></span>, <span class="highwire-citation-author" data-delta="3"><span class="nlm-given-names">Philippe</span> <span class="nlm-surname">Moreillon</span></span></span></div>
  
    	<div class="highwire-cite-metadata"><span  class="highwire-cite-metadata-journal highwire-cite-metadata">Antimicrobial Agents and Chemotherapy </span><span  class="highwire-cite-metadata-date highwire-cite-metadata">Oct 2004, </span><span  class="highwire-cite-metadata-volume highwire-cite-metadata">48 </span><span  class="highwire-cite-metadata-issue highwire-cite-metadata">(11) </span><span  class="highwire-cite-metadata-pages highwire-cite-metadata">4322-4327; </span><span  class="highwire-cite-metadata-doi highwire-cite-metadata"><span class="label">DOI:</span> 10.1128/AAC.48.11.4322-4327.2004 </span></div>
  
  
  
</div>
</div>  </div>

  
  </div>
</div>
	  </div>
	
  <div class="panel-panel grid-12 panel-region-content">
  	<div class="inside"><div class="panel-pane pane-highwire-article-clipboard-copy" >
  
      
  
  <div class="pane-content">
    <div class = "clipboard-copy">
  <span class="label-url">
    <label for="dynamic">Share This Article:</label>
  </span>
  <span class="input-text-url">
    <input type="text" id="dynamic" value="https://aac.asm.org/content/48/11/4322" size="50"/>
  </span>
  <span class="copy-button button">
    <button id="copy-dynamic" class="clipboardjs-button" data-clipboard-target="#dynamic" data-clipboard-alert-style="tooltip" data-clipboard-alert-text="Copied!">Copy</button>
  </span>
</div>
  </div>

  
  </div>
</div>
  </div>
	
		  <div class="panel-panel grid-12 panel-region-postscript">
	    <div class="inside"><div class="panel-pane pane-service-links" >
  
      
  
  <div class="pane-content">
    <div class="service-links"><a href="http://del.icio.us/post?url=https%3A//aac.asm.org/content/48/11/4322&amp;title=LB11058%2C%20a%20New%20Cephalosporin%20with%20High%20Penicillin-Binding%20Protein%202a%20Affinity%20and%20Activity%20in%20Experimental%20Endocarditis%20Due%20to%20Homogeneously%20Methicillin-Resistant%20Staphylococcus%20aureus" id="delicious" title="Bookmark this post on del.icio.us" class="service-links-delicious" rel="nofollow" target="_blank" data-icon-position="" data-hide-link-title="0"><img src="https://aac.asm.org/sites/all/modules/highwire/highwire/images/delicious-32.png" alt="del.icio.us logo" /></a> <a href="http://digg.com/submit?phase=2&amp;url=https%3A//aac.asm.org/content/48/11/4322&amp;title=LB11058%2C%20a%20New%20Cephalosporin%20with%20High%20Penicillin-Binding%20Protein%202a%20Affinity%20and%20Activity%20in%20Experimental%20Endocarditis%20Due%20to%20Homogeneously%20Methicillin-Resistant%20Staphylococcus%20aureus" id="digg" title="Digg this post on digg.com" class="service-links-digg" rel="nofollow" target="_blank" data-icon-position="" data-hide-link-title="0"><img src="https://aac.asm.org/sites/all/modules/highwire/highwire/images/digg.png" alt="Digg logo" /></a> <a href="http://reddit.com/submit?url=https%3A//aac.asm.org/content/48/11/4322&amp;title=LB11058%2C%20a%20New%20Cephalosporin%20with%20High%20Penicillin-Binding%20Protein%202a%20Affinity%20and%20Activity%20in%20Experimental%20Endocarditis%20Due%20to%20Homogeneously%20Methicillin-Resistant%20Staphylococcus%20aureus" id="reddit" title="Submit this post on reddit.com" class="service-links-reddit" rel="nofollow" target="_blank" data-icon-position="" data-hide-link-title="0"><img src="https://aac.asm.org/sites/all/modules/highwire/highwire/images/reddit.png" alt="Reddit logo" /></a> <a href="http://twitter.com/share?url=https%3A//aac.asm.org/content/48/11/4322&amp;text=LB11058%2C%20a%20New%20Cephalosporin%20with%20High%20Penicillin-Binding%20Protein%202a%20Affinity%20and%20Activity%20in%20Experimental%20Endocarditis%20Due%20to%20Homogeneously%20Methicillin-Resistant%20Staphylococcus%20aureus" id="twitter" title="Share this on Twitter" class="service-links-twitter" rel="nofollow" target="_blank" data-icon-position="" data-hide-link-title="0"><img src="https://aac.asm.org/sites/all/modules/highwire/highwire/images/twitter.png" alt="Twitter logo" /></a> <a href="http://www.citeulike.org/posturl?url=https%3A//aac.asm.org/content/48/11/4322&amp;title=LB11058%2C%20a%20New%20Cephalosporin%20with%20High%20Penicillin-Binding%20Protein%202a%20Affinity%20and%20Activity%20in%20Experimental%20Endocarditis%20Due%20to%20Homogeneously%20Methicillin-Resistant%20Staphylococcus%20aureus" id="citeulike" title="Share on CiteULike" class="service-links-citeulike" rel="nofollow" target="_blank" data-icon-position="" data-hide-link-title="0"><img src="https://aac.asm.org/sites/all/modules/highwire/highwire/images/citeyoulike.png" alt="CiteULike logo" /></a> <a href="http://www.facebook.com/sharer.php?u=https%3A//aac.asm.org/content/48/11/4322&amp;t=LB11058%2C%20a%20New%20Cephalosporin%20with%20High%20Penicillin-Binding%20Protein%202a%20Affinity%20and%20Activity%20in%20Experimental%20Endocarditis%20Due%20to%20Homogeneously%20Methicillin-Resistant%20Staphylococcus%20aureus" id="facebook" title="Share on Facebook" class="service-links-facebook" rel="nofollow" target="_blank" data-icon-position="" data-hide-link-title="0"><img src="https://aac.asm.org/sites/all/modules/highwire/highwire/images/fb-blue.png" alt="Facebook logo" /></a> <a href="http://www.google.com/bookmarks/mark?op=add&amp;bkmk=https%3A//aac.asm.org/content/48/11/4322&amp;title=LB11058%2C%20a%20New%20Cephalosporin%20with%20High%20Penicillin-Binding%20Protein%202a%20Affinity%20and%20Activity%20in%20Experimental%20Endocarditis%20Due%20to%20Homogeneously%20Methicillin-Resistant%20Staphylococcus%20aureus" id="google" title="Bookmark this post on Google" class="service-links-google" rel="nofollow" target="_blank" data-icon-position="" data-hide-link-title="0"><img src="https://aac.asm.org/sites/all/modules/highwire/highwire/images/google-32.png" alt="Google logo" /></a> <a href="http://www.mendeley.com/import/?url=https%3A//aac.asm.org/content/48/11/4322&amp;title=LB11058%2C%20a%20New%20Cephalosporin%20with%20High%20Penicillin-Binding%20Protein%202a%20Affinity%20and%20Activity%20in%20Experimental%20Endocarditis%20Due%20to%20Homogeneously%20Methicillin-Resistant%20Staphylococcus%20aureus" id="mendeley" title="Share on Mendeley" class="service-links-mendeley" rel="nofollow" target="_blank" data-icon-position="" data-hide-link-title="0"><img src="https://aac.asm.org/sites/all/modules/highwire/highwire/images/mendeley.png" alt="Mendeley logo" /></a></div>  </div>

  
  </div>
</div>
	  </div>
	
</div>
  </div>

  
  </div>
</div>
          </div>
        </div>
	</div> <!-- /.panel-row-wrapper -->	
	
	</div>

  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-article-nav mobile-hidden  pane-style-alt-content" >
  
      
  
  <div class="pane-content">
    <div class="highwire-list-wrapper highwire-article-nav highwire-nav-float"><div class="highwire-list"><ul data-highwire-float="1" data-highwire-float-class="grid-10 alpha omega"><li class="first odd"><a href="#skip-link" class="" data-icon-position="" data-hide-link-title="0">Top</a></li><li class="parent even"><a href="/content/48/11/4322" class="highwire-article-nav-jumplink" data-panel-ajax-tab="jnl_asm_tab_art" data-is-tab-link="true" data-icon-position="" data-hide-link-title="0">Article</a><div class="highwire-list"><ul><li class="first odd"><a href="#abstract-1" class="highwire-article-nav-jumplink first" data-panel-ajax-tab="jnl_asm_tab_art" data-icon-position="" data-hide-link-title="0">ABSTRACT</a></li><li class="even"><a href="#sec-1" class="highwire-article-nav-jumplink" data-panel-ajax-tab="jnl_asm_tab_art" data-icon-position="" data-hide-link-title="0">MATERIALS AND METHODS</a></li><li class="odd"><a href="#sec-10" class="highwire-article-nav-jumplink" data-panel-ajax-tab="jnl_asm_tab_art" data-icon-position="" data-hide-link-title="0">RESULTS</a></li><li class="even"><a href="#sec-13" class="highwire-article-nav-jumplink" data-panel-ajax-tab="jnl_asm_tab_art" data-icon-position="" data-hide-link-title="0">DISCUSSION</a></li><li class="odd"><a href="#ack-1" class="highwire-article-nav-jumplink" data-panel-ajax-tab="jnl_asm_tab_art" data-icon-position="" data-hide-link-title="0">ACKNOWLEDGMENTS</a></li><li class="even"><a href="#fn-group-1" class="highwire-article-nav-jumplink" data-panel-ajax-tab="jnl_asm_tab_art" data-icon-position="" data-hide-link-title="0">FOOTNOTES</a></li><li class="last odd"><a href="#ref-list-1" class="highwire-article-nav-jumplink last" data-panel-ajax-tab="jnl_asm_tab_art" data-icon-position="" data-hide-link-title="0">REFERENCES</a></li></ul></div></li><li class="odd"><a href="/content/48/11/4322/figures-only" class="highwire-article-nav-jumplink" data-panel-ajax-tab="jnl_asm_tab_data" data-is-tab-link="true" data-icon-position="" data-hide-link-title="0">Figures & Data</a></li><li class="even"><a href="/content/48/11/4322/article-info" class="highwire-article-nav-jumplink" data-panel-ajax-tab="jnl_asm_tab_info" data-is-tab-link="true" data-icon-position="" data-hide-link-title="0">Info & Metrics</a></li><li class="last odd"><a href="/content/48/11/4322.full.pdf" class="highwire-article-nav-jumplink" data-icon-position="" data-hide-link-title="0"><i class="icon-file-alt"></i> PDF</a></li></ul></div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-entity-field pane-node-field-highwire-article-keyword  pane-style-alt-content" >
  
        <h2 class="pane-title">KEYWORDS</h2>
    
  
  <div class="pane-content">
    <div class="field field-name-field-highwire-article-keyword field-type-taxonomy-term-reference field-label-hidden"><div class="field-items"><div class="field-item even"><a href="/keyword/cephalosporins" class="" data-icon-position="" data-hide-link-title="0">cephalosporins</a></div><div class="field-item odd"><a href="/keyword/endocarditis-bacterial" class="" data-icon-position="" data-hide-link-title="0">Endocarditis, Bacterial</a></div><div class="field-item even"><a href="/keyword/methicillin-resistance" class="" data-icon-position="" data-hide-link-title="0">methicillin resistance</a></div><div class="field-item odd"><a href="/keyword/penicillin-binding-proteins" class="" data-icon-position="" data-hide-link-title="0">penicillin-binding proteins</a></div><div class="field-item even"><a href="/keyword/staphylococcal-infections" class="" data-icon-position="" data-hide-link-title="0">staphylococcal infections</a></div><div class="field-item odd"><a href="/keyword/staphylococcus-aureus" class="" data-icon-position="" data-hide-link-title="0">Staphylococcus aureus</a></div></div></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-panels-mini pane-jnl-asm-accordion" >
  
      
  
  <div class="pane-content">
    <div class="panel-display panel-1col clearfix" id="mini-panel-jnl_asm_accordion">
  <div class="panel-panel panel-col">
    <div><div id="highwire_article_accordion_container"><h3 ><i class="icon-file"></i> Related Articles</h3><div><div class='panels-ajax-pane panels-ajax-pane-new-1' data-pid='new-1'></div></div><h3 ><i class="icon-retweet"></i> Cited By...</h3><div><div class='panels-ajax-pane panels-ajax-pane-new-2' data-pid='new-2'></div></div></div></div>
  </div>
</div>
  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-highwire-article-trendmd" >
  
      
  
  <div class="pane-content">
    <div id="trendmd-suggestions"></div>  </div>

  
  </div>
<div class="panel-separator"></div><div class="panel-pane pane-panels-mini pane-asm-box-ads rtecenter" >
  
      
  
  <div class="pane-content">
    <div class="panel-display panel-1col clearfix" id="mini-panel-asm_box_ads">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-dfp-pane rtecenter" >
  
      
  
  <div class="pane-content">
    <div id="dfp-ad-asm_box-wrapper" class="dfp-tag-wrapper">

<div  id="dfp-ad-asm_box" class="dfp-tag-wrapper">
  <script type="text/javascript">
    googletag.cmd.push(function() {
      googletag.display("dfp-ad-asm_box");
    });
  </script>
</div>
</div>  </div>

  
  </div>
</div>
  </div>
</div>
  </div>

  
  </div>
</div>
			</div>
		</div>
	
	</div> <!-- /.panel-row-wrapper -->	
	
	</div>

    </div>
  </div>
</div>      </div>
</div>  </div>
</section>    
  
      <footer id="section-footer" class="section section-footer">
    
  <div id="zone-postscript" class="zone zone-postscript clearfix container-30">
    <div class="grid-7 prefix-1 region region-postscript-first" id="region-postscript-first">
  <div class="region-inner region-postscript-first-inner">
    <section class="block block-menu block-menu-about-the-journal block-menu-menu-about-the-journal odd" id="block-menu-menu-about-the-journal">
  <div class="block-inner clearfix">
              <h2 class="block-title">About</h2>
            
    <div class="content clearfix">
      <nav class="menubar-nav"><ul class="menu" role="menu"><li class="first leaf" role="menuitem"><a href="/content/about-aac" data-hide-link-title="0" target="_blank" class="" data-icon-position="">About AAC</a></li>
<li class="leaf" role="menuitem"><a href="/content/board-editors" data-hide-link-title="0" class="" data-icon-position="">Editor in Chief</a></li>
<li class="leaf" role="menuitem"><a href="/content/board-editors" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Editorial Board</a></li>
<li class="leaf" role="menuitem"><a href="https://journals.asm.org/content/ethics-and-policies" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Policies</a></li>
<li class="leaf" role="menuitem"><a href="https://journals.asm.org/content/reviewers" data-hide-link-title="0" target="_blank" class="" data-icon-position="">For Reviewers</a></li>
<li class="leaf" role="menuitem"><a href="https://www.asm.org/Newsroom" data-hide-link-title="0" target="_blank" class="" data-icon-position="">For the Media</a></li>
<li class="leaf" role="menuitem"><a href="https://journals.asm.org/content/institutions" data-hide-link-title="0" target="_blank" class="" data-icon-position="">For Librarians</a></li>
<li class="leaf" role="menuitem"><a href="https://journals.asm.org/content/advertising" data-hide-link-title="0" target="_blank" class="" data-icon-position="">For Advertisers</a></li>
<li class="leaf" role="menuitem"><a href="https://journals.asm.org/alerts" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Alerts</a></li>
<li class="leaf" role="menuitem"><a href="https://www.youtube.com/playlist?list=PL1DFmJFZvefiidG0t8jEKTdITXxJrmdO5" data-hide-link-title="0" target="_blank" class="" data-icon-position="">AAC Podcast</a></li>
<li class="leaf" role="menuitem"><a href="/content/rss" data-hide-link-title="0" class="" data-icon-position="">RSS</a></li>
<li class="leaf" role="menuitem"><a href="/content/faq" data-hide-link-title="0" class="" data-icon-position="">FAQ</a></li>
<li class="leaf" role="menuitem"><a href="https://journals.asm.org/content/permissions" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Permissions</a></li>
<li class="last leaf" role="menuitem"><a href="https://journals.asm.org/content/journal-announcements" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Journal Announcements</a></li>
</ul></nav>    </div>
  </div>
</section>  </div>
</div><div class="grid-7 region region-postscript-second" id="region-postscript-second">
  <div class="region-inner region-postscript-second-inner">
    <section class="block block-menu block-menu-for-authors block-menu-menu-for-authors odd" id="block-menu-menu-for-authors">
  <div class="block-inner clearfix">
              <h2 class="block-title">Authors</h2>
            
    <div class="content clearfix">
      <nav class="menubar-nav"><ul class="menu" role="menu"><li class="first leaf" role="menuitem"><a href="https://journals.asm.org/content/asm-author-center" data-hide-link-title="0" target="_blank" class="" data-icon-position="">ASM Author Center</a></li>
<li class="leaf" role="menuitem"><a href="/content/submit-manuscript" data-hide-link-title="0" class="" data-icon-position="">Submit a Manuscript</a></li>
<li class="leaf" role="menuitem"><a href="http://bit.ly/AACArticleTypes" data-hide-link-title="0" class="" data-icon-position="">Article Types</a></li>
<li class="leaf" role="menuitem"><a href="https://journals.asm.org/content/ethics" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Ethics</a></li>
<li class="last leaf" role="menuitem"><a href="https://journals.asm.org/content/contact-us" data-hide-link-title="0" target="_blank" class="" data-icon-position="">Contact Us</a></li>
</ul></nav>    </div>
  </div>
</section>  </div>
</div><div class="grid-7 region region-postscript-third" id="region-postscript-third">
  <div class="region-inner region-postscript-third-inner">
    <div class="block block-panels-mini block-snippet-for-social-icons block-panels-mini-snippet-for-social-icons odd block-without-title" id="block-panels-mini-snippet-for-social-icons">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <div class="panel-display panel-1col clearfix" id="mini-panel-snippet_for_social_icons">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-snippet pane-snippet-for-social-icons" >
  
      
  
  <div class="pane-content">
    <div class="snippet snippet-for-social-icons" id="snippet-for-social-icons">
  
      
  <div class="snippet-content">
    <p style="color:#FFF;"><strong>Follow #AACJournal</strong></p>

<p style="color:#FFF;"><strong>@ASMicrobiology</strong></p>

<p><a href="http://www.facebook.com/asmfan"><img alt="" src="/sites/default/files/additional-assets/icn-facebook.png" style="width: 32px; height: 32px;" /></a>&nbsp;&nbsp; <a href="https://twitter.com/asmicrobiology"><img alt="" src="/sites/default/files/additional-assets/icn-twitter.png" style="width: 32px; height: 32px;" /></a> &nbsp;&nbsp;<!--<a href="https://www.asm.org/index.php/mbiosphere"><img alt="podcast" src="/sites/default/files/additional-assets/blog.png" style="width: 32px; height: 32px;" /></a>-->&nbsp;&nbsp; <a href="/content/rss"><img alt="" src="/sites/default/files/additional-assets/icn-rss.png" style="width: 32px; height: 32px;" /></a></p>
  </div>

</div>
  </div>

  
  </div>
</div>
  </div>
</div>
    </div>
  </div>
</div>  </div>
</div><div class="grid-7 suffix-1 region region-postscript-fourth" id="region-postscript-fourth">
  <div class="region-inner region-postscript-fourth-inner">
    <div class="block block-panels-mini block-snippet-about-asa block-panels-mini-snippet-about-asa odd block-without-title" id="block-panels-mini-snippet-about-asa">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <div class="panel-display panel-1col clearfix" id="mini-panel-snippet_about_asa">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-snippet pane-snippet-about-asa" >
  
      
  
  <div class="pane-content">
    <div class="snippet snippet-about-asa" id="snippet-about-asa">
  
      
  <div class="snippet-content">
    <p><a href="http://journals.asm.org" target="_blank"><img alt="ASM Journals" src="/sites/default/files/additional_assets/footer/logo-footer-JournalsASMorg2x.png" style="width: 225px; height: auto;" /></a></p>

<p style="color: #ccc;">ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.</p>

<p><a href="https://www.asm.org/about-asm" target="_blank">About ASM</a> <span style="color: #ccc;">|</span> <a href="https://journals.asm.org/content/contact-us
">Contact Us</a> <span style="color: #ccc;">|</span> <a href="https://www.asm.org/Browse-By-Audience/Press" target="_blank">Press Room</a></p>

<p>&nbsp;</p>

<p>ASM is a member of</p>

<p><a href="https://byscientistsforscience.org/" target="_blank"><img alt="Scientific Society Publisher Alliance" src="/sites/default/files/additional_assets/footer/logo-footer-sspa2x.png" style="width: 175px; height: auto;" /></a></p>

<p>&nbsp;</p>

<p>American Society for Microbiology<br/>
1752 N St. NW<br/>
Washington, DC 20036<br/>
Phone: (202) 737-3600</p>
  </div>

</div>
  </div>

  
  </div>
</div>
  </div>
</div>
    </div>
  </div>
</div>  </div>
</div>  </div>
  
  <div id="zone-footer" class="zone zone-footer clearfix container-30">
    <div class="grid-28 suffix-1 prefix-1 region region-footer-second" id="region-footer-second">
  <div class="region-inner region-footer-second-inner">
    <div class="block block-panels-mini block-footer-bottom block-panels-mini-footer-bottom odd block-without-title" id="block-panels-mini-footer-bottom">
  <div class="block-inner clearfix">
                
    <div class="content clearfix">
      <div class="panel-display panel-1col clearfix" id="mini-panel-footer_bottom">
  <div class="panel-panel panel-col">
    <div><div class="panel-pane pane-snippet pane-copyright-footer" >
  
      
  
  <div class="pane-content">
    <div class="snippet copyright-footer" id="copyright-footer">
  
      
  <div class="snippet-content">
    <p class="rtecenter" style="font-size:small;"><a href="https://journals.asm.org/content/copyright-notice-and-license-information" target="_blank">Copyright &copy; 2020</a> <a href="https://www.asm.org/" target="_blank"><span style="white-space:nowrap;"> American Society for Microbiology</span></a> | <a href="https://www.asm.org/cookie-policy" target="_blank">Privacy Policy</a> | <a href="/feedback">Website feedback</a></p>

<p class="rtecenter" style="font-size:small;">Print ISSN: 0066-4804; Online ISSN: 1098-6596</p>
  </div>

</div>
  </div>

  
  </div>
</div>
  </div>
</div>
    </div>
  </div>
</div>  </div>
</div>  </div>
</footer>  </div>    <div class="region region-page-bottom" id="region-page-bottom">
  <div class="region-inner region-page-bottom-inner">
      </div>
</div><script type="text/javascript" src="https://aac.asm.org/sites/default/files/advagg_js/js__bnwyEQSuZLC-kZnFqCi5iE02nOCzM7DjY7zYxcN9nsQ__VBiBT_qq_eHMMO2Q1rXK1u-hHff31XLUkmi9dgjuPeY__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.js"></script>
<script type="text/javascript" src="https://aac.asm.org/sites/default/files/advagg_js/js__GM3GJPR36rRIz0TRkjC5OQwrioSyN9aoYRivDhCO_AM__qAl84FcCv2jyN22yFGS5Oc85cjd9zKX6p_cFNLGhe-M__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.js" async="async"></script>
<script type="text/javascript" src="https://aac.asm.org/sites/default/files/advagg_js/js__oG4YIK4vOM0kZaFGZ9tW8cW21AH_tz72H9yFAn40-3c__LYiQGqUNwCwMgKPn4rDHxT7k2cpaEGGK9difJ3_Pdwo__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.js"></script>
<script type="text/javascript" src="https://aac.asm.org/sites/default/files/advagg_js/js__2WRbxlwOW0MEUc_hSWU5MBepQg6Lch6O5SZwefpJ6IE__HCL0YQJqLkOhrLPZZYGqosGvtFsEHMGghHIkSx4y9vA__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.js" defer="defer"></script>
<script type="text/javascript" src="https://aac.asm.org/sites/default/files/advagg_js/js__7wIZ-Fggxuz1XBq4W-gV9zVqSKOKMJ9F8HRNs4UfDbQ__LYpq6x97AHkV6nczZd2iqB4USQvZg7peOb7zH4R__4U__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.js"></script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
function euCookieComplianceLoadScripts() {}
//--><!]]>
</script>
<script type="text/javascript">
<!--//--><![CDATA[//><!--
var eu_cookie_compliance_cookie_name = "";
//--><!]]>
</script>
<script type="text/javascript" defer="defer" src="https://aac.asm.org/sites/all/modules/highwire/highwire/highwire_foxycart/highwire_foxycart.js?qjdf71"></script>
<script type="text/javascript" src="https://aac.asm.org/sites/default/files/advagg_js/js__WcTpt-w0y1FyXrxZNriX8Ts1KjsFTDpdvZaw9yhRn24__aFJpdvsZPb1v9rWrq-WXbz_WQ9IThQN-mFTCdm1cfXc__otBlrgJT9Sii4m34rcz9KVjGixj6sxdxPd7C0bM_PgU.js"></script>
  </body>
</html>
